id	sid	tid	token	lemma	pos
ajlm-1398	1	1	abstract	abstract	ADJ
ajlm-1398	1	2	introduction	introduction	NOUN
ajlm-1398	1	3	methods	method	NOUN
ajlm-1398	1	4	results	result	VERB
ajlm-1398	1	5	discussion	discussion	NOUN
ajlm-1398	1	6	acknowledgements	acknowledgement	NOUN
ajlm-1398	1	7	references	reference	NOUN
ajlm-1398	1	8	about	about	ADP
ajlm-1398	1	9	the	the	DET
ajlm-1398	1	10	author(s	author(s	NOUN
ajlm-1398	1	11	)	)	PUNCT
ajlm-1398	1	12	thapelo	thapelo	NOUN
ajlm-1398	1	13	mbhele	mbhele	PROPN
ajlm-1398	2	1	molecular	molecular	PROPN
ajlm-1398	2	2	sciences	sciences	PROPN
ajlm-1398	2	3	institute	institute	PROPN
ajlm-1398	2	4	,	,	PUNCT
ajlm-1398	2	5	school	school	NOUN
ajlm-1398	2	6	of	of	ADP
ajlm-1398	2	7	chemistry	chemistry	NOUN
ajlm-1398	2	8	,	,	PUNCT
ajlm-1398	2	9	faculty	faculty	NOUN
ajlm-1398	2	10	of	of	ADP
ajlm-1398	2	11	science	science	NOUN
ajlm-1398	2	12	,	,	PUNCT
ajlm-1398	2	13	university	university	NOUN
ajlm-1398	2	14	of	of	ADP
ajlm-1398	2	15	the	the	DET
ajlm-1398	2	16	witwatersrand	witwatersrand	NOUN
ajlm-1398	2	17	,	,	PUNCT
ajlm-1398	2	18	johannesburg	johannesburg	PROPN
ajlm-1398	2	19	,	,	PUNCT
ajlm-1398	2	20	south	south	PROPN
ajlm-1398	2	21	africa	africa	PROPN
ajlm-1398	2	22	donald	donald	PROPN
ajlm-1398	2	23	m.	m.	PROPN
ajlm-1398	2	24	tanyanyiwa	tanyanyiwa	PROPN
ajlm-1398	2	25	school	school	NOUN
ajlm-1398	2	26	of	of	ADP
ajlm-1398	2	27	pathology	pathology	PROPN
ajlm-1398	2	28	,	,	PUNCT
ajlm-1398	2	29	faculty	faculty	NOUN
ajlm-1398	2	30	of	of	ADP
ajlm-1398	2	31	health	health	NOUN
ajlm-1398	2	32	sciences	sciences	PROPN
ajlm-1398	2	33	,	,	PUNCT
ajlm-1398	2	34	university	university	NOUN
ajlm-1398	2	35	of	of	ADP
ajlm-1398	2	36	the	the	DET
ajlm-1398	2	37	witwatersrand	witwatersrand	NOUN
ajlm-1398	2	38	,	,	PUNCT
ajlm-1398	2	39	johannesburg	johannesburg	PROPN
ajlm-1398	2	40	,	,	PUNCT
ajlm-1398	2	41	south	south	PROPN
ajlm-1398	2	42	africa	africa	PROPN
ajlm-1398	2	43	department	department	PROPN
ajlm-1398	2	44	of	of	ADP
ajlm-1398	2	45	chemical	chemical	PROPN
ajlm-1398	2	46	pathology	pathology	PROPN
ajlm-1398	2	47	,	,	PUNCT
ajlm-1398	2	48	faculty	faculty	NOUN
ajlm-1398	2	49	of	of	ADP
ajlm-1398	2	50	health	health	NOUN
ajlm-1398	2	51	sciences	sciences	PROPN
ajlm-1398	2	52	,	,	PUNCT
ajlm-1398	2	53	sefako	sefako	VERB
ajlm-1398	2	54	makgatho	makgatho	PROPN
ajlm-1398	2	55	health	health	PROPN
ajlm-1398	2	56	sciences	sciences	PROPN
ajlm-1398	2	57	university	university	PROPN
ajlm-1398	2	58	,	,	PUNCT
ajlm-1398	2	59	pretoria	pretoria	PROPN
ajlm-1398	2	60	,	,	PUNCT
ajlm-1398	2	61	south	south	PROPN
ajlm-1398	2	62	africa	africa	PROPN
ajlm-1398	2	63	refilwe	refilwe	PROPN
ajlm-1398	2	64	j.	j.	PROPN
ajlm-1398	2	65	moepya	moepya	PROPN
ajlm-1398	2	66	molecular	molecular	PROPN
ajlm-1398	2	67	sciences	sciences	PROPN
ajlm-1398	2	68	institute	institute	PROPN
ajlm-1398	2	69	,	,	PUNCT
ajlm-1398	2	70	school	school	NOUN
ajlm-1398	2	71	of	of	ADP
ajlm-1398	2	72	chemistry	chemistry	NOUN
ajlm-1398	2	73	,	,	PUNCT
ajlm-1398	2	74	faculty	faculty	NOUN
ajlm-1398	2	75	of	of	ADP
ajlm-1398	2	76	science	science	NOUN
ajlm-1398	2	77	,	,	PUNCT
ajlm-1398	2	78	university	university	NOUN
ajlm-1398	2	79	of	of	ADP
ajlm-1398	2	80	the	the	DET
ajlm-1398	2	81	witwatersrand	witwatersrand	NOUN
ajlm-1398	2	82	,	,	PUNCT
ajlm-1398	2	83	johannesburg	johannesburg	PROPN
ajlm-1398	2	84	,	,	PUNCT
ajlm-1398	2	85	south	south	PROPN
ajlm-1398	2	86	africa	africa	PROPN
ajlm-1398	2	87	sindeep	sindeep	PROPN
ajlm-1398	2	88	bhana	bhana	VERB
ajlm-1398	2	89	school	school	NOUN
ajlm-1398	2	90	of	of	ADP
ajlm-1398	2	91	medicine	medicine	NOUN
ajlm-1398	2	92	,	,	PUNCT
ajlm-1398	2	93	faculty	faculty	NOUN
ajlm-1398	2	94	of	of	ADP
ajlm-1398	2	95	health	health	NOUN
ajlm-1398	2	96	sciences	sciences	PROPN
ajlm-1398	2	97	,	,	PUNCT
ajlm-1398	2	98	university	university	NOUN
ajlm-1398	2	99	of	of	ADP
ajlm-1398	2	100	the	the	DET
ajlm-1398	2	101	witwatersrand	witwatersrand	NOUN
ajlm-1398	2	102	,	,	PUNCT
ajlm-1398	2	103	johannesburg	johannesburg	PROPN
ajlm-1398	2	104	,	,	PUNCT
ajlm-1398	3	1	south	south	PROPN
ajlm-1398	3	2	africa	africa	PROPN
ajlm-1398	3	3	maya	maya	PROPN
ajlm-1398	3	4	m.	m.	PROPN
ajlm-1398	3	5	makatini	makatini	PROPN
ajlm-1398	3	6	molecular	molecular	PROPN
ajlm-1398	3	7	sciences	sciences	PROPN
ajlm-1398	3	8	institute	institute	PROPN
ajlm-1398	3	9	,	,	PUNCT
ajlm-1398	3	10	school	school	NOUN
ajlm-1398	3	11	of	of	ADP
ajlm-1398	3	12	chemistry	chemistry	NOUN
ajlm-1398	3	13	,	,	PUNCT
ajlm-1398	3	14	faculty	faculty	NOUN
ajlm-1398	3	15	of	of	ADP
ajlm-1398	3	16	science	science	NOUN
ajlm-1398	3	17	,	,	PUNCT
ajlm-1398	3	18	university	university	NOUN
ajlm-1398	3	19	of	of	ADP
ajlm-1398	3	20	the	the	DET
ajlm-1398	3	21	witwatersrand	witwatersrand	NOUN
ajlm-1398	3	22	,	,	PUNCT
ajlm-1398	3	23	johannesburg	johannesburg	PROPN
ajlm-1398	3	24	,	,	PUNCT
ajlm-1398	3	25	south	south	PROPN
ajlm-1398	3	26	africa	africa	PROPN
ajlm-1398	3	27	citation	citation	PROPN
ajlm-1398	3	28	mbhele	mbhele	PROPN
ajlm-1398	3	29	t	t	PROPN
ajlm-1398	3	30	,	,	PUNCT
ajlm-1398	3	31	tanyanyiwa	tanyanyiwa	PROPN
ajlm-1398	3	32	dm	dm	PROPN
ajlm-1398	3	33	,	,	PUNCT
ajlm-1398	3	34	moepya	moepya	PROPN
ajlm-1398	3	35	rm	rm	PROPN
ajlm-1398	3	36	,	,	PUNCT
ajlm-1398	3	37	bhana	bhana	VERB
ajlm-1398	3	38	s	s	PROPN
ajlm-1398	3	39	,	,	PUNCT
ajlm-1398	3	40	makatini	makatini	PROPN
ajlm-1398	3	41	mm	mm	PROPN
ajlm-1398	3	42	.	.	PROPN
ajlm-1398	3	43	relationship	relationship	NOUN
ajlm-1398	3	44	between	between	ADP
ajlm-1398	3	45	amino	amino	NOUN
ajlm-1398	3	46	acid	acid	NOUN
ajlm-1398	3	47	ratios	ratio	NOUN
ajlm-1398	3	48	and	and	CCONJ
ajlm-1398	3	49	decline	decline	VERB
ajlm-1398	3	50	in	in	ADP
ajlm-1398	3	51	estimated	estimate	VERB
ajlm-1398	3	52	glomerular	glomerular	ADJ
ajlm-1398	3	53	filtration	filtration	NOUN
ajlm-1398	3	54	rate	rate	NOUN
ajlm-1398	3	55	in	in	ADP
ajlm-1398	3	56	diabetic	diabetic	ADJ
ajlm-1398	3	57	and	and	CCONJ
ajlm-1398	3	58	non	non	ADJ
ajlm-1398	3	59	-	-	ADJ
ajlm-1398	3	60	diabetic	diabetic	ADJ
ajlm-1398	3	61	patients	patient	NOUN
ajlm-1398	3	62	in	in	ADP
ajlm-1398	3	63	south	south	PROPN
ajlm-1398	3	64	africa	africa	PROPN
ajlm-1398	3	65	.	.	PUNCT
ajlm-1398	4	1	afr	afr	PROPN
ajlm-1398	4	2	j	j	PROPN
ajlm-1398	4	3	lab	lab	PROPN
ajlm-1398	4	4	med	med	PROPN
ajlm-1398	4	5	.	.	PUNCT
ajlm-1398	5	1	2021;10(1	2021;10(1	NUM
ajlm-1398	5	2	)	)	PUNCT
ajlm-1398	5	3	,	,	PUNCT
ajlm-1398	5	4	a1398	a1398	PROPN
ajlm-1398	5	5	https://doi.org/10.4102/ajlm.v10i1.1398	https://doi.org/10.4102/ajlm.v10i1.1398	PUNCT
ajlm-1398	5	6	original	original	ADJ
ajlm-1398	5	7	research	research	NOUN
ajlm-1398	5	8	relationship	relationship	NOUN
ajlm-1398	5	9	between	between	ADP
ajlm-1398	5	10	amino	amino	NOUN
ajlm-1398	5	11	acid	acid	NOUN
ajlm-1398	5	12	ratios	ratio	NOUN
ajlm-1398	5	13	and	and	CCONJ
ajlm-1398	5	14	decline	decline	VERB
ajlm-1398	5	15	in	in	ADP
ajlm-1398	5	16	estimated	estimate	VERB
ajlm-1398	5	17	glomerular	glomerular	ADJ
ajlm-1398	5	18	filtration	filtration	NOUN
ajlm-1398	5	19	rate	rate	NOUN
ajlm-1398	5	20	in	in	ADP
ajlm-1398	5	21	diabetic	diabetic	ADJ
ajlm-1398	5	22	and	and	CCONJ
ajlm-1398	5	23	non	non	ADJ
ajlm-1398	5	24	-	-	ADJ
ajlm-1398	5	25	diabetic	diabetic	ADJ
ajlm-1398	5	26	patients	patient	NOUN
ajlm-1398	5	27	in	in	ADP
ajlm-1398	5	28	south	south	PROPN
ajlm-1398	5	29	africa	africa	PROPN
ajlm-1398	5	30	thapelo	thapelo	PROPN
ajlm-1398	6	1	mbhele	mbhele	PROPN
ajlm-1398	6	2	,	,	PUNCT
ajlm-1398	6	3	donald	donald	PROPN
ajlm-1398	6	4	m.	m.	PROPN
ajlm-1398	6	5	tanyanyiwa	tanyanyiwa	PROPN
ajlm-1398	6	6	,	,	PUNCT
ajlm-1398	6	7	refilwe	refilwe	PROPN
ajlm-1398	6	8	j.	j.	PROPN
ajlm-1398	6	9	moepya	moepya	PROPN
ajlm-1398	6	10	,	,	PUNCT
ajlm-1398	6	11	sindeep	sindeep	PROPN
ajlm-1398	6	12	bhana	bhana	PROPN
ajlm-1398	6	13	,	,	PUNCT
ajlm-1398	6	14	maya	maya	PROPN
ajlm-1398	6	15	m.	m.	NOUN
ajlm-1398	6	16	makatini	makatini	PROPN
ajlm-1398	6	17	received	receive	VERB
ajlm-1398	6	18	:	:	PUNCT
ajlm-1398	6	19	26	26	NUM
ajlm-1398	6	20	sept	sept	PROPN
ajlm-1398	6	21	.	.	PROPN
ajlm-1398	6	22	2020	2020	NUM
ajlm-1398	6	23	;	;	PUNCT
ajlm-1398	6	24	accepted	accept	VERB
ajlm-1398	6	25	:	:	PUNCT
ajlm-1398	6	26	16	16	NUM
ajlm-1398	6	27	july	july	PROPN
ajlm-1398	6	28	2021	2021	NUM
ajlm-1398	6	29	;	;	PUNCT
ajlm-1398	6	30	published	publish	VERB
ajlm-1398	6	31	:	:	PUNCT
ajlm-1398	6	32	10	10	NUM
ajlm-1398	6	33	dec	dec	PROPN
ajlm-1398	6	34	.	.	PROPN
ajlm-1398	6	35	2021	2021	NUM
ajlm-1398	7	1	copyright	copyright	NOUN
ajlm-1398	7	2	:	:	PUNCT
ajlm-1398	7	3	©	©	PROPN
ajlm-1398	7	4	2021	2021	NUM
ajlm-1398	7	5	.	.	PUNCT
ajlm-1398	8	1	the	the	DET
ajlm-1398	8	2	author(s	author(s	PROPN
ajlm-1398	8	3	)	)	PUNCT
ajlm-1398	8	4	.	.	PUNCT
ajlm-1398	9	1	licensee	licensee	NOUN
ajlm-1398	9	2	:	:	PUNCT
ajlm-1398	9	3	aosis	aosis	NOUN
ajlm-1398	9	4	.	.	PUNCT
ajlm-1398	10	1	this	this	PRON
ajlm-1398	10	2	is	be	AUX
ajlm-1398	10	3	an	an	DET
ajlm-1398	10	4	open	open	ADJ
ajlm-1398	10	5	access	access	NOUN
ajlm-1398	10	6	article	article	NOUN
ajlm-1398	10	7	distributed	distribute	VERB
ajlm-1398	10	8	under	under	ADP
ajlm-1398	10	9	the	the	DET
ajlm-1398	10	10	terms	term	NOUN
ajlm-1398	10	11	of	of	ADP
ajlm-1398	10	12	the	the	DET
ajlm-1398	10	13	creative	creative	ADJ
ajlm-1398	10	14	commons	common	NOUN
ajlm-1398	10	15	attribution	attribution	NOUN
ajlm-1398	10	16	license	license	NOUN
ajlm-1398	10	17	,	,	PUNCT
ajlm-1398	10	18	which	which	PRON
ajlm-1398	10	19	permits	permit	VERB
ajlm-1398	10	20	unrestricted	unrestricted	ADJ
ajlm-1398	10	21	use	use	NOUN
ajlm-1398	10	22	,	,	PUNCT
ajlm-1398	10	23	distribution	distribution	NOUN
ajlm-1398	10	24	,	,	PUNCT
ajlm-1398	10	25	and	and	CCONJ
ajlm-1398	10	26	reproduction	reproduction	NOUN
ajlm-1398	10	27	in	in	ADP
ajlm-1398	10	28	any	any	DET
ajlm-1398	10	29	medium	medium	NOUN
ajlm-1398	10	30	,	,	PUNCT
ajlm-1398	10	31	provided	provide	VERB
ajlm-1398	10	32	the	the	DET
ajlm-1398	10	33	original	original	ADJ
ajlm-1398	10	34	work	work	NOUN
ajlm-1398	10	35	is	be	AUX
ajlm-1398	10	36	properly	properly	ADV
ajlm-1398	10	37	cited	cite	VERB
ajlm-1398	10	38	.	.	PUNCT
ajlm-1398	11	1	abstract	abstract	ADJ
ajlm-1398	11	2	background	background	NOUN
ajlm-1398	11	3	:	:	PUNCT
ajlm-1398	11	4	diabetic	diabetic	ADJ
ajlm-1398	11	5	kidney	kidney	NOUN
ajlm-1398	11	6	disease	disease	NOUN
ajlm-1398	11	7	is	be	AUX
ajlm-1398	11	8	a	a	DET
ajlm-1398	11	9	major	major	ADJ
ajlm-1398	11	10	complication	complication	NOUN
ajlm-1398	11	11	resulting	result	VERB
ajlm-1398	11	12	from	from	ADP
ajlm-1398	11	13	type	type	NOUN
ajlm-1398	11	14	1	1	NUM
ajlm-1398	11	15	and	and	CCONJ
ajlm-1398	11	16	type	type	NOUN
ajlm-1398	11	17	2	2	NUM
ajlm-1398	11	18	diabetes	diabetes	NOUN
ajlm-1398	11	19	.	.	PUNCT
ajlm-1398	12	1	currently	currently	ADV
ajlm-1398	12	2	,	,	PUNCT
ajlm-1398	12	3	the	the	DET
ajlm-1398	12	4	microalbuminuria	microalbuminuria	ADJ
ajlm-1398	12	5	test	test	NOUN
ajlm-1398	12	6	is	be	AUX
ajlm-1398	12	7	used	use	VERB
ajlm-1398	12	8	to	to	PART
ajlm-1398	12	9	monitor	monitor	VERB
ajlm-1398	12	10	renal	renal	ADJ
ajlm-1398	12	11	function	function	NOUN
ajlm-1398	12	12	;	;	PUNCT
ajlm-1398	12	13	however	however	ADV
ajlm-1398	12	14	,	,	PUNCT
ajlm-1398	12	15	it	it	PRON
ajlm-1398	12	16	does	do	AUX
ajlm-1398	12	17	not	not	PART
ajlm-1398	12	18	detect	detect	VERB
ajlm-1398	12	19	albumin	albumin	NOUN
ajlm-1398	12	20	until	until	SCONJ
ajlm-1398	12	21	progressive	progressive	ADJ
ajlm-1398	12	22	loss	loss	NOUN
ajlm-1398	12	23	of	of	ADP
ajlm-1398	12	24	renal	renal	ADJ
ajlm-1398	12	25	function	function	NOUN
ajlm-1398	12	26	has	have	AUX
ajlm-1398	12	27	occurred	occur	VERB
ajlm-1398	12	28	.	.	PUNCT
ajlm-1398	13	1	objective	objective	NOUN
ajlm-1398	13	2	:	:	PUNCT
ajlm-1398	13	3	this	this	DET
ajlm-1398	13	4	study	study	NOUN
ajlm-1398	13	5	analysed	analyse	VERB
ajlm-1398	13	6	the	the	DET
ajlm-1398	13	7	relationship	relationship	NOUN
ajlm-1398	13	8	between	between	ADP
ajlm-1398	13	9	changes	change	NOUN
ajlm-1398	13	10	in	in	ADP
ajlm-1398	13	11	amino	amino	NOUN
ajlm-1398	13	12	acid	acid	NOUN
ajlm-1398	13	13	ratios	ratio	NOUN
ajlm-1398	13	14	and	and	CCONJ
ajlm-1398	13	15	estimated	estimate	VERB
ajlm-1398	13	16	glomerular	glomerular	ADJ
ajlm-1398	13	17	filtration	filtration	NOUN
ajlm-1398	13	18	rate	rate	NOUN
ajlm-1398	13	19	(	(	PUNCT
ajlm-1398	13	20	egfr	egfr	X
ajlm-1398	13	21	)	)	PUNCT
ajlm-1398	13	22	decline	decline	NOUN
ajlm-1398	13	23	in	in	ADP
ajlm-1398	13	24	diabetic	diabetic	ADJ
ajlm-1398	13	25	and	and	CCONJ
ajlm-1398	13	26	non	non	ADJ
ajlm-1398	13	27	-	-	ADJ
ajlm-1398	13	28	diabetic	diabetic	ADJ
ajlm-1398	13	29	patients	patient	NOUN
ajlm-1398	13	30	.	.	PUNCT
ajlm-1398	14	1	methods	method	NOUN
ajlm-1398	14	2	:	:	PUNCT
ajlm-1398	14	3	urine	urine	NOUN
ajlm-1398	14	4	samples	sample	NOUN
ajlm-1398	14	5	were	be	AUX
ajlm-1398	14	6	collected	collect	VERB
ajlm-1398	14	7	from	from	ADP
ajlm-1398	14	8	participants	participant	NOUN
ajlm-1398	14	9	between	between	ADP
ajlm-1398	14	10	february	february	PROPN
ajlm-1398	14	11	2019	2019	NUM
ajlm-1398	14	12	to	to	ADP
ajlm-1398	14	13	april	april	PROPN
ajlm-1398	14	14	2019	2019	NUM
ajlm-1398	14	15	and	and	CCONJ
ajlm-1398	14	16	analysed	analyse	VERB
ajlm-1398	14	17	from	from	ADP
ajlm-1398	14	18	november	november	PROPN
ajlm-1398	14	19	2020	2020	NUM
ajlm-1398	14	20	to	to	ADP
ajlm-1398	14	21	january	january	PROPN
ajlm-1398	14	22	2021	2021	NUM
ajlm-1398	14	23	.	.	PUNCT
ajlm-1398	15	1	diabetic	diabetic	NOUN
ajlm-1398	15	2	(	(	PUNCT
ajlm-1398	15	3	glycated	glycate	VERB
ajlm-1398	15	4	haemoglobin	haemoglobin	PROPN
ajlm-1398	15	5	>	>	X
ajlm-1398	15	6	6.4	6.4	NUM
ajlm-1398	15	7	%	%	NOUN
ajlm-1398	15	8	)	)	PUNCT
ajlm-1398	15	9	and	and	CCONJ
ajlm-1398	15	10	non	non	ADJ
ajlm-1398	15	11	-	-	ADJ
ajlm-1398	15	12	diabetic	diabetic	ADJ
ajlm-1398	15	13	patients	patient	NOUN
ajlm-1398	15	14	(	(	PUNCT
ajlm-1398	15	15	glycated	glycate	VERB
ajlm-1398	15	16	haemoglobin	haemoglobin	NOUN
ajlm-1398	15	17	≤	≤	ADJ
ajlm-1398	15	18	6.4	6.4	NUM
ajlm-1398	15	19	%	%	NOUN
ajlm-1398	15	20	)	)	PUNCT
ajlm-1398	15	21	from	from	ADP
ajlm-1398	15	22	chris	chris	PROPN
ajlm-1398	15	23	hani	hani	PROPN
ajlm-1398	15	24	baragwanath	baragwanath	PROPN
ajlm-1398	15	25	hospital	hospital	PROPN
ajlm-1398	15	26	,	,	PUNCT
ajlm-1398	15	27	south	south	PROPN
ajlm-1398	15	28	africa	africa	PROPN
ajlm-1398	15	29	,	,	PUNCT
ajlm-1398	15	30	were	be	AUX
ajlm-1398	15	31	further	far	ADV
ajlm-1398	15	32	categorised	categorise	VERB
ajlm-1398	15	33	based	base	VERB
ajlm-1398	15	34	on	on	ADP
ajlm-1398	15	35	the	the	DET
ajlm-1398	15	36	degree	degree	NOUN
ajlm-1398	15	37	of	of	ADP
ajlm-1398	15	38	renal	renal	ADJ
ajlm-1398	15	39	function	function	NOUN
ajlm-1398	15	40	predicted	predict	VERB
ajlm-1398	15	41	by	by	ADP
ajlm-1398	15	42	the	the	DET
ajlm-1398	15	43	egfrs	egfrs	NOUN
ajlm-1398	15	44	.	.	PUNCT
ajlm-1398	16	1	amino	amino	ADJ
ajlm-1398	16	2	acids	acid	NOUN
ajlm-1398	16	3	were	be	AUX
ajlm-1398	16	4	quantified	quantify	VERB
ajlm-1398	16	5	using	use	VERB
ajlm-1398	16	6	tandem	tandem	NOUN
ajlm-1398	16	7	mass	mass	ADJ
ajlm-1398	16	8	spectrometry	spectrometry	NOUN
ajlm-1398	16	9	to	to	PART
ajlm-1398	16	10	determine	determine	VERB
ajlm-1398	16	11	the	the	DET
ajlm-1398	16	12	concentrations	concentration	NOUN
ajlm-1398	16	13	and	and	CCONJ
ajlm-1398	16	14	ratios	ratio	NOUN
ajlm-1398	16	15	of	of	ADP
ajlm-1398	16	16	tyrosine	tyrosine	NOUN
ajlm-1398	16	17	/	/	SYM
ajlm-1398	16	18	phenylalanine	phenylalanine	NOUN
ajlm-1398	16	19	,	,	PUNCT
ajlm-1398	16	20	ornithine	ornithine	NOUN
ajlm-1398	16	21	/	/	SYM
ajlm-1398	16	22	arginine	arginine	NOUN
ajlm-1398	16	23	,	,	PUNCT
ajlm-1398	16	24	arginine	arginine	NOUN
ajlm-1398	16	25	/	/	SYM
ajlm-1398	16	26	citrulline	citrulline	NOUN
ajlm-1398	16	27	and	and	CCONJ
ajlm-1398	16	28	citrulline	citrulline	NOUN
ajlm-1398	16	29	/	/	SYM
ajlm-1398	16	30	ornithine	ornithine	NOUN
ajlm-1398	16	31	at	at	ADP
ajlm-1398	16	32	different	different	ADJ
ajlm-1398	16	33	stages	stage	NOUN
ajlm-1398	16	34	of	of	ADP
ajlm-1398	16	35	the	the	DET
ajlm-1398	16	36	chronic	chronic	ADJ
ajlm-1398	16	37	kidney	kidney	NOUN
ajlm-1398	16	38	disease	disease	NOUN
ajlm-1398	16	39	.	.	PUNCT
ajlm-1398	17	1	results	result	NOUN
ajlm-1398	17	2	:	:	PUNCT
ajlm-1398	17	3	among	among	ADP
ajlm-1398	17	4	diabetic	diabetic	ADJ
ajlm-1398	17	5	patients	patient	NOUN
ajlm-1398	17	6	,	,	PUNCT
ajlm-1398	17	7	the	the	DET
ajlm-1398	17	8	tyrosine	tyrosine	NOUN
ajlm-1398	17	9	/	/	SYM
ajlm-1398	17	10	phenylalanine	phenylalanine	NOUN
ajlm-1398	17	11	ratio	ratio	NOUN
ajlm-1398	17	12	showed	show	VERB
ajlm-1398	17	13	a	a	DET
ajlm-1398	17	14	statistically	statistically	ADV
ajlm-1398	17	15	significant	significant	ADJ
ajlm-1398	17	16	increase	increase	NOUN
ajlm-1398	17	17	(	(	PUNCT
ajlm-1398	17	18	p	p	X
ajlm-1398	17	19	=	=	NOUN
ajlm-1398	17	20	0.04	0.04	NUM
ajlm-1398	17	21	)	)	PUNCT
ajlm-1398	17	22	as	as	SCONJ
ajlm-1398	17	23	the	the	DET
ajlm-1398	17	24	egfr	egfr	NOUN
ajlm-1398	17	25	declined	decline	VERB
ajlm-1398	17	26	from	from	ADP
ajlm-1398	17	27	stage	stage	NOUN
ajlm-1398	17	28	1	1	NUM
ajlm-1398	17	29	to	to	PART
ajlm-1398	17	30	stage	stage	VERB
ajlm-1398	17	31	4	4	NUM
ajlm-1398	17	32	;	;	PUNCT
ajlm-1398	17	33	the	the	DET
ajlm-1398	17	34	ornithine	ornithine	NOUN
ajlm-1398	17	35	/	/	SYM
ajlm-1398	17	36	arginine	arginine	NOUN
ajlm-1398	17	37	ratio	ratio	NOUN
ajlm-1398	17	38	showed	show	VERB
ajlm-1398	17	39	a	a	DET
ajlm-1398	17	40	strong	strong	ADJ
ajlm-1398	17	41	negative	negative	ADJ
ajlm-1398	17	42	correlation	correlation	NOUN
ajlm-1398	17	43	with	with	ADP
ajlm-1398	17	44	egfr	egfr	NOUN
ajlm-1398	17	45	.	.	PUNCT
ajlm-1398	18	1	the	the	DET
ajlm-1398	18	2	citrulline	citrulline	NOUN
ajlm-1398	18	3	/	/	SYM
ajlm-1398	18	4	ornithine	ornithine	NOUN
ajlm-1398	18	5	ratio	ratio	NOUN
ajlm-1398	18	6	differed	differ	VERB
ajlm-1398	18	7	between	between	ADP
ajlm-1398	18	8	the	the	DET
ajlm-1398	18	9	diabetic	diabetic	ADJ
ajlm-1398	18	10	and	and	CCONJ
ajlm-1398	18	11	non	non	ADJ
ajlm-1398	18	12	-	-	ADJ
ajlm-1398	18	13	diabetic	diabetic	ADJ
ajlm-1398	18	14	patients	patient	NOUN
ajlm-1398	18	15	in	in	ADP
ajlm-1398	18	16	stage	stage	NOUN
ajlm-1398	18	17	1	1	NUM
ajlm-1398	18	18	of	of	ADP
ajlm-1398	18	19	chronic	chronic	ADJ
ajlm-1398	18	20	kidney	kidney	NOUN
ajlm-1398	18	21	disease	disease	NOUN
ajlm-1398	18	22	.	.	PUNCT
ajlm-1398	19	1	conclusion	conclusion	NOUN
ajlm-1398	19	2	:	:	PUNCT
ajlm-1398	19	3	amino	amino	ADJ
ajlm-1398	19	4	acid	acid	NOUN
ajlm-1398	19	5	ratios	ratio	NOUN
ajlm-1398	19	6	(	(	PUNCT
ajlm-1398	19	7	ornithine	ornithine	NOUN
ajlm-1398	19	8	/	/	SYM
ajlm-1398	19	9	arginine	arginine	NOUN
ajlm-1398	19	10	and	and	CCONJ
ajlm-1398	19	11	tyrosine	tyrosine	NOUN
ajlm-1398	19	12	/	/	SYM
ajlm-1398	19	13	phenylalanine	phenylalanine	NOUN
ajlm-1398	19	14	)	)	PUNCT
ajlm-1398	19	15	are	be	AUX
ajlm-1398	19	16	affected	affect	VERB
ajlm-1398	19	17	by	by	ADP
ajlm-1398	19	18	the	the	DET
ajlm-1398	19	19	progression	progression	NOUN
ajlm-1398	19	20	of	of	ADP
ajlm-1398	19	21	diabetes	diabetes	NOUN
ajlm-1398	19	22	and	and	CCONJ
ajlm-1398	19	23	can	can	AUX
ajlm-1398	19	24	be	be	AUX
ajlm-1398	19	25	correlated	correlate	VERB
ajlm-1398	19	26	to	to	ADP
ajlm-1398	19	27	renal	renal	ADJ
ajlm-1398	19	28	function	function	NOUN
ajlm-1398	19	29	.	.	PUNCT
ajlm-1398	20	1	the	the	DET
ajlm-1398	20	2	citrulline	citrulline	NOUN
ajlm-1398	20	3	/	/	SYM
ajlm-1398	20	4	ornithine	ornithine	NOUN
ajlm-1398	20	5	ratios	ratio	NOUN
ajlm-1398	20	6	differ	differ	VERB
ajlm-1398	20	7	between	between	ADP
ajlm-1398	20	8	the	the	DET
ajlm-1398	20	9	studied	study	VERB
ajlm-1398	20	10	groups	group	NOUN
ajlm-1398	20	11	in	in	ADP
ajlm-1398	20	12	stage	stage	NOUN
ajlm-1398	20	13	1	1	NUM
ajlm-1398	20	14	of	of	ADP
ajlm-1398	20	15	the	the	DET
ajlm-1398	20	16	disease	disease	NOUN
ajlm-1398	20	17	and	and	CCONJ
ajlm-1398	20	18	may	may	AUX
ajlm-1398	20	19	be	be	AUX
ajlm-1398	20	20	utilised	utilise	VERB
ajlm-1398	20	21	to	to	PART
ajlm-1398	20	22	predict	predict	VERB
ajlm-1398	20	23	the	the	DET
ajlm-1398	20	24	onset	onset	NOUN
ajlm-1398	20	25	of	of	ADP
ajlm-1398	20	26	chronic	chronic	ADJ
ajlm-1398	20	27	kidney	kidney	NOUN
ajlm-1398	20	28	disease	disease	NOUN
ajlm-1398	20	29	.	.	PUNCT
ajlm-1398	21	1	keywords	keyword	NOUN
ajlm-1398	21	2	:	:	PUNCT
ajlm-1398	21	3	diabetic	diabetic	ADJ
ajlm-1398	21	4	nephropathy	nephropathy	NOUN
ajlm-1398	21	5	;	;	PUNCT
ajlm-1398	21	6	albuminuria	albuminuria	NOUN
ajlm-1398	21	7	;	;	PUNCT
ajlm-1398	21	8	amino	amino	NOUN
ajlm-1398	21	9	acids	acid	NOUN
ajlm-1398	21	10	;	;	PUNCT
ajlm-1398	21	11	lc	lc	PROPN
ajlm-1398	21	12	-	-	PUNCT
ajlm-1398	21	13	ms	ms	PROPN
ajlm-1398	21	14	/	/	SYM
ajlm-1398	21	15	ms	ms	PROPN
ajlm-1398	21	16	;	;	PUNCT
ajlm-1398	21	17	chronic	chronic	ADJ
ajlm-1398	21	18	kidney	kidney	NOUN
ajlm-1398	21	19	disease	disease	NOUN
ajlm-1398	21	20	;	;	PUNCT
ajlm-1398	21	21	glomerular	glomerular	ADJ
ajlm-1398	21	22	filtration	filtration	NOUN
ajlm-1398	21	23	rate	rate	NOUN
ajlm-1398	21	24	.	.	PUNCT
ajlm-1398	22	1	introduction	introduction	NOUN
ajlm-1398	22	2	diabetic	diabetic	ADJ
ajlm-1398	22	3	nephropathy	nephropathy	NOUN
ajlm-1398	22	4	or	or	CCONJ
ajlm-1398	22	5	chronic	chronic	ADJ
ajlm-1398	22	6	kidney	kidney	NOUN
ajlm-1398	22	7	disease	disease	NOUN
ajlm-1398	22	8	(	(	PUNCT
ajlm-1398	22	9	ckd	ckd	PROPN
ajlm-1398	22	10	)	)	PUNCT
ajlm-1398	22	11	,	,	PUNCT
ajlm-1398	22	12	resulting	result	VERB
ajlm-1398	22	13	from	from	ADP
ajlm-1398	22	14	both	both	DET
ajlm-1398	22	15	type	type	NOUN
ajlm-1398	22	16	1	1	NUM
ajlm-1398	22	17	and	and	CCONJ
ajlm-1398	22	18	type	type	NOUN
ajlm-1398	22	19	2	2	NUM
ajlm-1398	22	20	diabetes	diabetes	NOUN
ajlm-1398	22	21	,	,	PUNCT
ajlm-1398	22	22	is	be	AUX
ajlm-1398	22	23	one	one	NUM
ajlm-1398	22	24	of	of	ADP
ajlm-1398	22	25	the	the	DET
ajlm-1398	22	26	leading	lead	VERB
ajlm-1398	22	27	causes	cause	NOUN
ajlm-1398	22	28	of	of	ADP
ajlm-1398	22	29	death	death	NOUN
ajlm-1398	22	30	in	in	ADP
ajlm-1398	22	31	the	the	DET
ajlm-1398	22	32	world	world	NOUN
ajlm-1398	22	33	among	among	ADP
ajlm-1398	22	34	non	non	ADJ
ajlm-1398	22	35	-	-	ADJ
ajlm-1398	22	36	communicable	communicable	ADJ
ajlm-1398	22	37	diseases.1,2	diseases.1,2	ADJ
ajlm-1398	22	38	diabetic	diabetic	ADJ
ajlm-1398	22	39	nephropathy	nephropathy	NOUN
ajlm-1398	22	40	usually	usually	ADV
ajlm-1398	22	41	develops	develop	VERB
ajlm-1398	22	42	about	about	ADV
ajlm-1398	22	43	10	10	NUM
ajlm-1398	22	44	years	year	NOUN
ajlm-1398	22	45	after	after	SCONJ
ajlm-1398	22	46	the	the	DET
ajlm-1398	22	47	onset	onset	NOUN
ajlm-1398	22	48	of	of	ADP
ajlm-1398	22	49	diabetes.3	diabetes.3	PROPN
ajlm-1398	22	50	chronic	chronic	ADJ
ajlm-1398	22	51	kidney	kidney	NOUN
ajlm-1398	22	52	disease	disease	NOUN
ajlm-1398	22	53	affects	affect	VERB
ajlm-1398	22	54	about	about	ADV
ajlm-1398	22	55	half	half	DET
ajlm-1398	22	56	a	a	DET
ajlm-1398	22	57	million	million	NUM
ajlm-1398	22	58	people	people	NOUN
ajlm-1398	22	59	globally	globally	ADV
ajlm-1398	22	60	,	,	PUNCT
ajlm-1398	22	61	and	and	CCONJ
ajlm-1398	22	62	people	people	NOUN
ajlm-1398	22	63	with	with	ADP
ajlm-1398	22	64	ckd	ckd	PROPN
ajlm-1398	22	65	are	be	AUX
ajlm-1398	22	66	at	at	ADP
ajlm-1398	22	67	a	a	DET
ajlm-1398	22	68	high	high	ADJ
ajlm-1398	22	69	risk	risk	NOUN
ajlm-1398	22	70	of	of	ADP
ajlm-1398	22	71	developing	develop	VERB
ajlm-1398	22	72	stroke	stroke	NOUN
ajlm-1398	22	73	and	and	CCONJ
ajlm-1398	22	74	cardiovascular	cardiovascular	ADJ
ajlm-1398	22	75	disease	disease	NOUN
ajlm-1398	22	76	.	.	PUNCT
ajlm-1398	23	1	chronic	chronic	ADJ
ajlm-1398	23	2	kidney	kidney	NOUN
ajlm-1398	23	3	disease	disease	NOUN
ajlm-1398	23	4	patients	patient	NOUN
ajlm-1398	23	5	are	be	AUX
ajlm-1398	23	6	most	most	ADV
ajlm-1398	23	7	likely	likely	ADJ
ajlm-1398	23	8	to	to	PART
ajlm-1398	23	9	die	die	VERB
ajlm-1398	23	10	from	from	ADP
ajlm-1398	23	11	cardiovascular	cardiovascular	ADJ
ajlm-1398	23	12	disease	disease	NOUN
ajlm-1398	23	13	than	than	ADP
ajlm-1398	23	14	progress	progress	NOUN
ajlm-1398	23	15	to	to	PART
ajlm-1398	23	16	end	end	VERB
ajlm-1398	23	17	-	-	PUNCT
ajlm-1398	23	18	stage	stage	NOUN
ajlm-1398	23	19	renal	renal	ADJ
ajlm-1398	23	20	failure.4	failure.4	PROPN
ajlm-1398	23	21	in	in	ADP
ajlm-1398	23	22	south	south	PROPN
ajlm-1398	23	23	africa	africa	PROPN
ajlm-1398	23	24	,	,	PUNCT
ajlm-1398	23	25	diabetic	diabetic	ADJ
ajlm-1398	23	26	nephropathy	nephropathy	NOUN
ajlm-1398	23	27	is	be	AUX
ajlm-1398	23	28	diagnosed	diagnose	VERB
ajlm-1398	23	29	clinically	clinically	ADV
ajlm-1398	23	30	using	use	VERB
ajlm-1398	23	31	a	a	DET
ajlm-1398	23	32	digital	digital	ADJ
ajlm-1398	23	33	community	community	NOUN
ajlm-1398	23	34	analyser	analyser	NOUN
ajlm-1398	23	35	vantage	vantage	NOUN
ajlm-1398	23	36	instrument	instrument	NOUN
ajlm-1398	23	37	that	that	PRON
ajlm-1398	23	38	measures	measure	VERB
ajlm-1398	23	39	the	the	DET
ajlm-1398	23	40	amount	amount	NOUN
ajlm-1398	23	41	of	of	ADP
ajlm-1398	23	42	albumin	albumin	NOUN
ajlm-1398	23	43	and	and	CCONJ
ajlm-1398	23	44	creatinine	creatinine	NOUN
ajlm-1398	23	45	,	,	PUNCT
ajlm-1398	23	46	as	as	ADV
ajlm-1398	23	47	well	well	ADV
ajlm-1398	23	48	as	as	ADP
ajlm-1398	23	49	the	the	DET
ajlm-1398	23	50	ratio	ratio	NOUN
ajlm-1398	23	51	of	of	ADP
ajlm-1398	23	52	albumin	albumin	NOUN
ajlm-1398	23	53	to	to	ADP
ajlm-1398	23	54	creatinine	creatinine	NOUN
ajlm-1398	23	55	(	(	PUNCT
ajlm-1398	23	56	a	a	X
ajlm-1398	23	57	/	/	SYM
ajlm-1398	23	58	c	c	NOUN
ajlm-1398	23	59	)	)	PUNCT
ajlm-1398	23	60	in	in	ADP
ajlm-1398	23	61	urine	urine	NOUN
ajlm-1398	23	62	.	.	PUNCT
ajlm-1398	24	1	the	the	DET
ajlm-1398	24	2	diagnostic	diagnostic	ADJ
ajlm-1398	24	3	criteria	criterion	NOUN
ajlm-1398	24	4	based	base	VERB
ajlm-1398	24	5	on	on	ADP
ajlm-1398	24	6	the	the	DET
ajlm-1398	24	7	a	a	NOUN
ajlm-1398	24	8	/	/	SYM
ajlm-1398	24	9	c	c	NOUN
ajlm-1398	24	10	ratio	ratio	NOUN
ajlm-1398	24	11	are	be	AUX
ajlm-1398	24	12	as	as	SCONJ
ajlm-1398	24	13	follows	follow	VERB
ajlm-1398	24	14	:	:	PUNCT
ajlm-1398	24	15	normal	normal	ADJ
ajlm-1398	24	16	range	range	VERB
ajlm-1398	24	17	≤	≤	NUM
ajlm-1398	24	18	3.5	3.5	NUM
ajlm-1398	24	19	mg	mg	NUM
ajlm-1398	24	20	/	/	SYM
ajlm-1398	24	21	mmol	mmol	NOUN
ajlm-1398	24	22	(	(	PUNCT
ajlm-1398	24	23	female	female	NOUN
ajlm-1398	24	24	)	)	PUNCT
ajlm-1398	24	25	and	and	CCONJ
ajlm-1398	24	26	≤	≤	NUM
ajlm-1398	24	27	2.5	2.5	NUM
ajlm-1398	24	28	mg	mg	NUM
ajlm-1398	24	29	/	/	SYM
ajlm-1398	24	30	mmol	mmol	NOUN
ajlm-1398	24	31	(	(	PUNCT
ajlm-1398	24	32	male	male	NOUN
ajlm-1398	24	33	)	)	PUNCT
ajlm-1398	24	34	;	;	PUNCT
ajlm-1398	24	35	microalbumin	microalbumin	NOUN
ajlm-1398	24	36	range	range	VERB
ajlm-1398	24	37	2.6	2.6	NUM
ajlm-1398	24	38	mg	mg	NOUN
ajlm-1398	24	39	/	/	SYM
ajlm-1398	24	40	mmol	mmol	NOUN
ajlm-1398	24	41	–	–	PUNCT
ajlm-1398	24	42	25.0	25.0	NUM
ajlm-1398	24	43	mg	mg	NUM
ajlm-1398	24	44	/	/	SYM
ajlm-1398	24	45	mmol	mmol	NOUN
ajlm-1398	24	46	(	(	PUNCT
ajlm-1398	24	47	female	female	NOUN
ajlm-1398	24	48	)	)	PUNCT
ajlm-1398	24	49	and	and	CCONJ
ajlm-1398	24	50	3.6	3.6	NUM
ajlm-1398	24	51	mg	mg	NUM
ajlm-1398	24	52	/	/	SYM
ajlm-1398	24	53	mmol	mmol	NOUN
ajlm-1398	24	54	–	–	PUNCT
ajlm-1398	24	55	35.0	35.0	NUM
ajlm-1398	24	56	mg	mg	NOUN
ajlm-1398	24	57	/	/	SYM
ajlm-1398	24	58	mmol	mmol	NOUN
ajlm-1398	24	59	(	(	PUNCT
ajlm-1398	24	60	male	male	NOUN
ajlm-1398	24	61	)	)	PUNCT
ajlm-1398	24	62	;	;	PUNCT
ajlm-1398	24	63	macroalbumin	macroalbumin	NOUN
ajlm-1398	24	64	range	range	NOUN
ajlm-1398	24	65	26.0	26.0	NUM
ajlm-1398	24	66	mg	mg	NOUN
ajlm-1398	24	67	/	/	SYM
ajlm-1398	24	68	mmol	mmol	NOUN
ajlm-1398	24	69	–	–	PUNCT
ajlm-1398	24	70	100.0	100.0	NUM
ajlm-1398	24	71	mg	mg	NUM
ajlm-1398	24	72	/	/	SYM
ajlm-1398	24	73	mmol	mmol	NOUN
ajlm-1398	24	74	(	(	PUNCT
ajlm-1398	24	75	female	female	NOUN
ajlm-1398	24	76	)	)	PUNCT
ajlm-1398	24	77	and	and	CCONJ
ajlm-1398	24	78	36.0	36.0	NUM
ajlm-1398	24	79	mg	mg	NUM
ajlm-1398	24	80	/	/	SYM
ajlm-1398	24	81	mmol	mmol	NOUN
ajlm-1398	24	82	–	–	PUNCT
ajlm-1398	24	83	100.0	100.0	NUM
ajlm-1398	24	84	mg	mg	NUM
ajlm-1398	24	85	/	/	SYM
ajlm-1398	24	86	mmol	mmol	NOUN
ajlm-1398	24	87	(	(	PUNCT
ajlm-1398	24	88	male).5	male).5	PROPN
ajlm-1398	24	89	although	although	SCONJ
ajlm-1398	24	90	the	the	DET
ajlm-1398	24	91	a	a	NOUN
ajlm-1398	24	92	/	/	SYM
ajlm-1398	24	93	c	c	NOUN
ajlm-1398	24	94	ratio	ratio	NOUN
ajlm-1398	24	95	is	be	AUX
ajlm-1398	24	96	a	a	DET
ajlm-1398	24	97	good	good	ADJ
ajlm-1398	24	98	indicator	indicator	NOUN
ajlm-1398	24	99	of	of	ADP
ajlm-1398	24	100	ckd	ckd	PROPN
ajlm-1398	24	101	,	,	PUNCT
ajlm-1398	24	102	the	the	DET
ajlm-1398	24	103	detected	detect	VERB
ajlm-1398	24	104	value	value	NOUN
ajlm-1398	24	105	needs	need	VERB
ajlm-1398	24	106	to	to	PART
ajlm-1398	24	107	be	be	AUX
ajlm-1398	24	108	sustained	sustain	VERB
ajlm-1398	24	109	in	in	ADP
ajlm-1398	24	110	the	the	DET
ajlm-1398	24	111	patient	patient	NOUN
ajlm-1398	24	112	over	over	ADP
ajlm-1398	24	113	3	3	NUM
ajlm-1398	24	114	months	month	NOUN
ajlm-1398	24	115	to	to	PART
ajlm-1398	24	116	accurately	accurately	ADV
ajlm-1398	24	117	diagnose	diagnose	VERB
ajlm-1398	24	118	ckd.6	ckd.6	NOUN
ajlm-1398	24	119	it	it	PRON
ajlm-1398	24	120	also	also	ADV
ajlm-1398	24	121	lacks	lack	VERB
ajlm-1398	24	122	specificity	specificity	NOUN
ajlm-1398	24	123	and	and	CCONJ
ajlm-1398	24	124	sensitivity	sensitivity	NOUN
ajlm-1398	24	125	during	during	ADP
ajlm-1398	24	126	a	a	DET
ajlm-1398	24	127	progressive	progressive	ADJ
ajlm-1398	24	128	decline	decline	NOUN
ajlm-1398	24	129	in	in	ADP
ajlm-1398	24	130	renal	renal	ADJ
ajlm-1398	24	131	function	function	NOUN
ajlm-1398	24	132	and	and	CCONJ
ajlm-1398	24	133	can	can	AUX
ajlm-1398	24	134	give	give	VERB
ajlm-1398	24	135	false	false	ADJ
ajlm-1398	24	136	results	result	NOUN
ajlm-1398	24	137	,	,	PUNCT
ajlm-1398	24	138	where	where	SCONJ
ajlm-1398	24	139	patients	patient	NOUN
ajlm-1398	24	140	with	with	ADP
ajlm-1398	24	141	ckd	ckd	PROPN
ajlm-1398	24	142	could	could	AUX
ajlm-1398	24	143	appear	appear	VERB
ajlm-1398	24	144	normal.7	normal.7	ADJ
ajlm-1398	24	145	the	the	DET
ajlm-1398	24	146	glomerular	glomerular	ADJ
ajlm-1398	24	147	filtration	filtration	NOUN
ajlm-1398	24	148	rate	rate	NOUN
ajlm-1398	24	149	(	(	PUNCT
ajlm-1398	24	150	gfr	gfr	NOUN
ajlm-1398	24	151	)	)	PUNCT
ajlm-1398	24	152	is	be	AUX
ajlm-1398	24	153	an	an	DET
ajlm-1398	24	154	important	important	ADJ
ajlm-1398	24	155	marker	marker	NOUN
ajlm-1398	24	156	in	in	ADP
ajlm-1398	24	157	the	the	DET
ajlm-1398	24	158	assessment	assessment	NOUN
ajlm-1398	24	159	of	of	ADP
ajlm-1398	24	160	kidney	kidney	NOUN
ajlm-1398	24	161	function	function	NOUN
ajlm-1398	24	162	.	.	PUNCT
ajlm-1398	25	1	it	it	PRON
ajlm-1398	25	2	can	can	AUX
ajlm-1398	25	3	be	be	AUX
ajlm-1398	25	4	calculated	calculate	VERB
ajlm-1398	25	5	using	use	VERB
ajlm-1398	25	6	the	the	DET
ajlm-1398	25	7	ckd	ckd	PROPN
ajlm-1398	25	8	epidemiology	epidemiology	NOUN
ajlm-1398	25	9	collaboration	collaboration	NOUN
ajlm-1398	25	10	formula	formula	NOUN
ajlm-1398	25	11	and	and	CCONJ
ajlm-1398	25	12	the	the	DET
ajlm-1398	25	13	modification	modification	NOUN
ajlm-1398	25	14	of	of	ADP
ajlm-1398	25	15	diet	diet	NOUN
ajlm-1398	25	16	in	in	ADP
ajlm-1398	25	17	renal	renal	ADJ
ajlm-1398	25	18	disease	disease	NOUN
ajlm-1398	25	19	equation	equation	NOUN
ajlm-1398	25	20	.	.	PUNCT
ajlm-1398	26	1	the	the	DET
ajlm-1398	26	2	modification	modification	NOUN
ajlm-1398	26	3	of	of	ADP
ajlm-1398	26	4	diet	diet	NOUN
ajlm-1398	26	5	in	in	ADP
ajlm-1398	26	6	renal	renal	ADJ
ajlm-1398	26	7	disease	disease	NOUN
ajlm-1398	26	8	equation	equation	NOUN
ajlm-1398	26	9	estimates	estimate	VERB
ajlm-1398	26	10	the	the	DET
ajlm-1398	26	11	gfr	gfr	PROPN
ajlm-1398	26	12	(	(	PUNCT
ajlm-1398	26	13	egfr	egfr	PROPN
ajlm-1398	26	14	)	)	PUNCT
ajlm-1398	26	15	based	base	VERB
ajlm-1398	26	16	on	on	ADP
ajlm-1398	26	17	age	age	NOUN
ajlm-1398	26	18	,	,	PUNCT
ajlm-1398	26	19	sex	sex	NOUN
ajlm-1398	26	20	and	and	CCONJ
ajlm-1398	26	21	serum	serum	NOUN
ajlm-1398	26	22	creatinine	creatinine	NOUN
ajlm-1398	26	23	(	(	PUNCT
ajlm-1398	26	24	scr).7,8	scr).7,8	NOUN
ajlm-1398	26	25	renal	renal	ADJ
ajlm-1398	26	26	decline	decline	NOUN
ajlm-1398	26	27	in	in	ADP
ajlm-1398	26	28	ckd	ckd	PROPN
ajlm-1398	26	29	is	be	AUX
ajlm-1398	26	30	classified	classify	VERB
ajlm-1398	26	31	into	into	ADP
ajlm-1398	26	32	five	five	NUM
ajlm-1398	26	33	stages	stage	NOUN
ajlm-1398	26	34	,	,	PUNCT
ajlm-1398	26	35	which	which	PRON
ajlm-1398	26	36	indicate	indicate	VERB
ajlm-1398	26	37	the	the	DET
ajlm-1398	26	38	progression	progression	NOUN
ajlm-1398	26	39	of	of	ADP
ajlm-1398	26	40	the	the	DET
ajlm-1398	26	41	disease	disease	NOUN
ajlm-1398	26	42	.	.	PUNCT
ajlm-1398	27	1	these	these	DET
ajlm-1398	27	2	stages	stage	NOUN
ajlm-1398	27	3	are	be	AUX
ajlm-1398	27	4	based	base	VERB
ajlm-1398	27	5	on	on	ADP
ajlm-1398	27	6	the	the	DET
ajlm-1398	27	7	gfr	gfr	NOUN
ajlm-1398	27	8	and	and	CCONJ
ajlm-1398	27	9	include	include	VERB
ajlm-1398	27	10	stage	stage	NOUN
ajlm-1398	27	11	1	1	NUM
ajlm-1398	27	12	(	(	PUNCT
ajlm-1398	27	13	≥	≥	NUM
ajlm-1398	27	14	90	90	NUM
ajlm-1398	27	15	ml	ml	NOUN
ajlm-1398	27	16	/	/	SYM
ajlm-1398	27	17	min	min	NOUN
ajlm-1398	27	18	per	per	ADP
ajlm-1398	27	19	1.73	1.73	NUM
ajlm-1398	27	20	m2	m2	NOUN
ajlm-1398	27	21	)	)	PUNCT
ajlm-1398	27	22	,	,	PUNCT
ajlm-1398	27	23	stage	stage	NOUN
ajlm-1398	27	24	2	2	NUM
ajlm-1398	27	25	(	(	PUNCT
ajlm-1398	27	26	60	60	NUM
ajlm-1398	27	27	ml	ml	NOUN
ajlm-1398	27	28	/	/	SYM
ajlm-1398	27	29	min	min	NOUN
ajlm-1398	27	30	–	–	PUNCT
ajlm-1398	27	31	89	89	NUM
ajlm-1398	27	32	ml	ml	NOUN
ajlm-1398	27	33	/	/	SYM
ajlm-1398	27	34	min	min	NOUN
ajlm-1398	27	35	per	per	ADP
ajlm-1398	27	36	1.73	1.73	NUM
ajlm-1398	27	37	m2	m2	NOUN
ajlm-1398	27	38	)	)	PUNCT
ajlm-1398	27	39	,	,	PUNCT
ajlm-1398	27	40	stage	stage	NOUN
ajlm-1398	27	41	3	3	NUM
ajlm-1398	27	42	(	(	PUNCT
ajlm-1398	27	43	30	30	NUM
ajlm-1398	27	44	ml	ml	NOUN
ajlm-1398	27	45	/	/	SYM
ajlm-1398	27	46	min	min	NOUN
ajlm-1398	27	47	–	–	PUNCT
ajlm-1398	27	48	59	59	NUM
ajlm-1398	27	49	ml	ml	NOUN
ajlm-1398	27	50	/	/	SYM
ajlm-1398	27	51	min	min	NOUN
ajlm-1398	27	52	per	per	ADP
ajlm-1398	27	53	1.73	1.73	NUM
ajlm-1398	27	54	m2	m2	NOUN
ajlm-1398	27	55	)	)	PUNCT
ajlm-1398	27	56	,	,	PUNCT
ajlm-1398	27	57	stage	stage	NOUN
ajlm-1398	27	58	4	4	NUM
ajlm-1398	27	59	(	(	PUNCT
ajlm-1398	27	60	15	15	NUM
ajlm-1398	27	61	ml	ml	NOUN
ajlm-1398	27	62	/	/	SYM
ajlm-1398	27	63	min	min	NOUN
ajlm-1398	27	64	–	–	PUNCT
ajlm-1398	27	65	29	29	NUM
ajlm-1398	27	66	ml	ml	NOUN
ajlm-1398	27	67	/	/	SYM
ajlm-1398	27	68	min	min	NOUN
ajlm-1398	27	69	per	per	ADP
ajlm-1398	27	70	1.73	1.73	NUM
ajlm-1398	27	71	m2	m2	NOUN
ajlm-1398	27	72	)	)	PUNCT
ajlm-1398	27	73	and	and	CCONJ
ajlm-1398	27	74	stage	stage	NOUN
ajlm-1398	27	75	5	5	NUM
ajlm-1398	27	76	(	(	PUNCT
ajlm-1398	27	77	<	<	X
ajlm-1398	27	78	15	15	NUM
ajlm-1398	27	79	ml	ml	NOUN
ajlm-1398	27	80	/	/	SYM
ajlm-1398	27	81	min	min	NOUN
ajlm-1398	27	82	per	per	ADP
ajlm-1398	27	83	1.73	1.73	NUM
ajlm-1398	27	84	m2).9	m2).9	NOUN
ajlm-1398	27	85	the	the	DET
ajlm-1398	27	86	assessment	assessment	NOUN
ajlm-1398	27	87	of	of	ADP
ajlm-1398	27	88	gfr	gfr	NOUN
ajlm-1398	27	89	using	use	VERB
ajlm-1398	27	90	scr	scr	NOUN
ajlm-1398	27	91	concentrations	concentration	NOUN
ajlm-1398	27	92	gives	give	VERB
ajlm-1398	27	93	inconclusive	inconclusive	ADJ
ajlm-1398	27	94	results	result	NOUN
ajlm-1398	27	95	in	in	ADP
ajlm-1398	27	96	the	the	DET
ajlm-1398	27	97	early	early	ADJ
ajlm-1398	27	98	stages	stage	NOUN
ajlm-1398	27	99	of	of	ADP
ajlm-1398	27	100	renal	renal	ADJ
ajlm-1398	27	101	decline	decline	NOUN
ajlm-1398	27	102	and	and	CCONJ
ajlm-1398	27	103	lacks	lack	VERB
ajlm-1398	27	104	sensitivity	sensitivity	NOUN
ajlm-1398	27	105	because	because	SCONJ
ajlm-1398	27	106	scr	scr	NOUN
ajlm-1398	27	107	only	only	ADV
ajlm-1398	27	108	becomes	become	VERB
ajlm-1398	27	109	detectable	detectable	ADJ
ajlm-1398	27	110	after	after	SCONJ
ajlm-1398	27	111	renal	renal	ADJ
ajlm-1398	27	112	decline	decline	NOUN
ajlm-1398	27	113	has	have	AUX
ajlm-1398	27	114	progressed	progress	VERB
ajlm-1398	27	115	significantly	significantly	ADV
ajlm-1398	27	116	.	.	PUNCT
ajlm-1398	28	1	the	the	DET
ajlm-1398	28	2	ckd	ckd	PROPN
ajlm-1398	28	3	epidemiology	epidemiology	NOUN
ajlm-1398	28	4	collaboration	collaboration	NOUN
ajlm-1398	28	5	formula	formula	NOUN
ajlm-1398	28	6	provides	provide	VERB
ajlm-1398	28	7	a	a	DET
ajlm-1398	28	8	good	good	ADJ
ajlm-1398	28	9	indicator	indicator	NOUN
ajlm-1398	28	10	of	of	ADP
ajlm-1398	28	11	the	the	DET
ajlm-1398	28	12	egfr	egfr	NOUN
ajlm-1398	28	13	in	in	ADP
ajlm-1398	28	14	the	the	DET
ajlm-1398	28	15	early	early	ADJ
ajlm-1398	28	16	stages	stage	NOUN
ajlm-1398	28	17	of	of	ADP
ajlm-1398	28	18	ckd	ckd	PROPN
ajlm-1398	28	19	(	(	PUNCT
ajlm-1398	28	20	>	>	X
ajlm-1398	28	21	90	90	NUM
ajlm-1398	28	22	ml	ml	NOUN
ajlm-1398	28	23	/	/	SYM
ajlm-1398	28	24	min	min	NOUN
ajlm-1398	28	25	per	per	ADP
ajlm-1398	28	26	1.73	1.73	NUM
ajlm-1398	28	27	m2	m2	NOUN
ajlm-1398	28	28	)	)	PUNCT
ajlm-1398	28	29	;	;	PUNCT
ajlm-1398	28	30	however	however	ADV
ajlm-1398	28	31	,	,	PUNCT
ajlm-1398	28	32	it	it	PRON
ajlm-1398	28	33	also	also	ADV
ajlm-1398	28	34	underestimates	underestimate	VERB
ajlm-1398	28	35	the	the	DET
ajlm-1398	28	36	gfr	gfr	NOUN
ajlm-1398	28	37	in	in	ADP
ajlm-1398	28	38	diabetic	diabetic	ADJ
ajlm-1398	28	39	patients.10	patients.10	NOUN
ajlm-1398	28	40	similarly	similarly	ADV
ajlm-1398	28	41	,	,	PUNCT
ajlm-1398	28	42	although	although	SCONJ
ajlm-1398	28	43	the	the	DET
ajlm-1398	28	44	modification	modification	NOUN
ajlm-1398	28	45	of	of	ADP
ajlm-1398	28	46	diet	diet	NOUN
ajlm-1398	28	47	in	in	ADP
ajlm-1398	28	48	renal	renal	ADJ
ajlm-1398	28	49	disease	disease	NOUN
ajlm-1398	28	50	equation	equation	NOUN
ajlm-1398	28	51	provides	provide	VERB
ajlm-1398	28	52	reliable	reliable	ADJ
ajlm-1398	28	53	results	result	NOUN
ajlm-1398	28	54	for	for	ADP
ajlm-1398	28	55	patients	patient	NOUN
ajlm-1398	28	56	with	with	ADP
ajlm-1398	28	57	ckd	ckd	PROPN
ajlm-1398	28	58	,	,	PUNCT
ajlm-1398	28	59	it	it	PRON
ajlm-1398	28	60	may	may	AUX
ajlm-1398	28	61	give	give	VERB
ajlm-1398	28	62	false	false	ADJ
ajlm-1398	28	63	positives	positive	NOUN
ajlm-1398	28	64	for	for	ADP
ajlm-1398	28	65	healthy	healthy	ADJ
ajlm-1398	28	66	patients.8	patients.8	PROPN
ajlm-1398	28	67	measuring	measure	VERB
ajlm-1398	28	68	the	the	DET
ajlm-1398	28	69	concentration	concentration	NOUN
ajlm-1398	28	70	of	of	ADP
ajlm-1398	28	71	amino	amino	ADJ
ajlm-1398	28	72	acids	acid	NOUN
ajlm-1398	28	73	in	in	ADP
ajlm-1398	28	74	the	the	DET
ajlm-1398	28	75	body	body	NOUN
ajlm-1398	28	76	is	be	AUX
ajlm-1398	28	77	important	important	ADJ
ajlm-1398	28	78	in	in	ADP
ajlm-1398	28	79	the	the	DET
ajlm-1398	28	80	diagnosis	diagnosis	NOUN
ajlm-1398	28	81	and	and	CCONJ
ajlm-1398	28	82	management	management	NOUN
ajlm-1398	28	83	of	of	ADP
ajlm-1398	28	84	several	several	ADJ
ajlm-1398	28	85	metabolic	metabolic	NOUN
ajlm-1398	28	86	abnormalities	abnormality	NOUN
ajlm-1398	28	87	.	.	PUNCT
ajlm-1398	29	1	amino	amino	NOUN
ajlm-1398	29	2	acid	acid	NOUN
ajlm-1398	29	3	concentrations	concentration	NOUN
ajlm-1398	29	4	can	can	AUX
ajlm-1398	29	5	be	be	AUX
ajlm-1398	29	6	used	use	VERB
ajlm-1398	29	7	to	to	PART
ajlm-1398	29	8	determine	determine	VERB
ajlm-1398	29	9	the	the	DET
ajlm-1398	29	10	status	status	NOUN
ajlm-1398	29	11	of	of	ADP
ajlm-1398	29	12	patients	patient	NOUN
ajlm-1398	29	13	’	'	PUNCT
ajlm-1398	29	14	nutrition	nutrition	NOUN
ajlm-1398	29	15	,	,	PUNCT
ajlm-1398	29	16	renal	renal	ADJ
ajlm-1398	29	17	function	function	NOUN
ajlm-1398	29	18	and	and	CCONJ
ajlm-1398	29	19	tissue	tissue	NOUN
ajlm-1398	29	20	injury.11	injury.11	VERB
ajlm-1398	29	21	the	the	DET
ajlm-1398	29	22	metabolism	metabolism	NOUN
ajlm-1398	29	23	and	and	CCONJ
ajlm-1398	29	24	excretion	excretion	NOUN
ajlm-1398	29	25	of	of	ADP
ajlm-1398	29	26	amino	amino	ADJ
ajlm-1398	29	27	acids	acid	NOUN
ajlm-1398	29	28	such	such	ADJ
ajlm-1398	29	29	as	as	ADP
ajlm-1398	29	30	phenylalanine	phenylalanine	NOUN
ajlm-1398	29	31	and	and	CCONJ
ajlm-1398	29	32	tyrosine	tyrosine	NOUN
ajlm-1398	29	33	have	have	AUX
ajlm-1398	29	34	been	be	AUX
ajlm-1398	29	35	reported	report	VERB
ajlm-1398	29	36	to	to	PART
ajlm-1398	29	37	undergo	undergo	VERB
ajlm-1398	29	38	considerable	considerable	ADJ
ajlm-1398	29	39	changes	change	NOUN
ajlm-1398	29	40	in	in	ADP
ajlm-1398	29	41	patients	patient	NOUN
ajlm-1398	29	42	with	with	ADP
ajlm-1398	29	43	ckd.12	ckd.12	NOUN
ajlm-1398	29	44	urine	urine	NOUN
ajlm-1398	29	45	is	be	AUX
ajlm-1398	29	46	the	the	DET
ajlm-1398	29	47	most	most	ADV
ajlm-1398	29	48	preferred	prefer	VERB
ajlm-1398	29	49	biofluid	biofluid	NOUN
ajlm-1398	29	50	in	in	ADP
ajlm-1398	29	51	metabolomics	metabolomic	NOUN
ajlm-1398	29	52	due	due	ADP
ajlm-1398	29	53	to	to	ADP
ajlm-1398	29	54	its	its	PRON
ajlm-1398	29	55	ease	ease	NOUN
ajlm-1398	29	56	of	of	ADP
ajlm-1398	29	57	collection	collection	NOUN
ajlm-1398	29	58	in	in	ADP
ajlm-1398	29	59	large	large	ADJ
ajlm-1398	29	60	volumes	volume	NOUN
ajlm-1398	29	61	and	and	CCONJ
ajlm-1398	29	62	its	its	PRON
ajlm-1398	29	63	lesser	less	ADJ
ajlm-1398	29	64	complexity	complexity	NOUN
ajlm-1398	29	65	compared	compare	VERB
ajlm-1398	29	66	to	to	ADP
ajlm-1398	29	67	other	other	ADJ
ajlm-1398	29	68	body	body	NOUN
ajlm-1398	29	69	fluids	fluid	NOUN
ajlm-1398	29	70	such	such	ADJ
ajlm-1398	29	71	as	as	ADP
ajlm-1398	29	72	blood.13,14	blood.13,14	ADJ
ajlm-1398	29	73	liquid	liquid	ADJ
ajlm-1398	29	74	chromatography	chromatography	NOUN
ajlm-1398	29	75	tandem	tandem	PROPN
ajlm-1398	29	76	mass	mass	PROPN
ajlm-1398	29	77	spectrometry	spectrometry	NOUN
ajlm-1398	29	78	eliminates	eliminate	VERB
ajlm-1398	29	79	lengthy	lengthy	ADJ
ajlm-1398	29	80	sample	sample	NOUN
ajlm-1398	29	81	preparations	preparation	NOUN
ajlm-1398	29	82	as	as	SCONJ
ajlm-1398	29	83	amino	amino	NOUN
ajlm-1398	29	84	acids	acid	NOUN
ajlm-1398	29	85	can	can	AUX
ajlm-1398	29	86	be	be	AUX
ajlm-1398	29	87	analysed	analyse	VERB
ajlm-1398	29	88	without	without	ADP
ajlm-1398	29	89	the	the	DET
ajlm-1398	29	90	need	need	NOUN
ajlm-1398	29	91	for	for	ADP
ajlm-1398	29	92	derivatisation.11	derivatisation.11	NOUN
ajlm-1398	29	93	the	the	DET
ajlm-1398	29	94	advantages	advantage	NOUN
ajlm-1398	29	95	of	of	ADP
ajlm-1398	29	96	using	use	VERB
ajlm-1398	29	97	this	this	DET
ajlm-1398	29	98	technique	technique	NOUN
ajlm-1398	29	99	include	include	VERB
ajlm-1398	29	100	high	high	ADJ
ajlm-1398	29	101	sensitivity	sensitivity	NOUN
ajlm-1398	29	102	,	,	PUNCT
ajlm-1398	29	103	specificity	specificity	NOUN
ajlm-1398	29	104	,	,	PUNCT
ajlm-1398	29	105	and	and	CCONJ
ajlm-1398	29	106	throughput.15	throughput.15	VERB
ajlm-1398	29	107	this	this	DET
ajlm-1398	29	108	technique	technique	NOUN
ajlm-1398	29	109	is	be	AUX
ajlm-1398	29	110	based	base	VERB
ajlm-1398	29	111	on	on	ADP
ajlm-1398	29	112	the	the	DET
ajlm-1398	29	113	structural	structural	ADJ
ajlm-1398	29	114	characteristics	characteristic	NOUN
ajlm-1398	29	115	of	of	ADP
ajlm-1398	29	116	analytes	analyte	NOUN
ajlm-1398	29	117	obtained	obtain	VERB
ajlm-1398	29	118	by	by	ADP
ajlm-1398	29	119	fragmentation	fragmentation	NOUN
ajlm-1398	29	120	through	through	ADP
ajlm-1398	29	121	collision	collision	NOUN
ajlm-1398	29	122	,	,	PUNCT
ajlm-1398	29	123	and	and	CCONJ
ajlm-1398	29	124	it	it	PRON
ajlm-1398	29	125	is	be	AUX
ajlm-1398	29	126	a	a	DET
ajlm-1398	29	127	powerful	powerful	ADJ
ajlm-1398	29	128	technique	technique	NOUN
ajlm-1398	29	129	for	for	ADP
ajlm-1398	29	130	quantitation.16	quantitation.16	PROPN
ajlm-1398	29	131	this	this	DET
ajlm-1398	29	132	study	study	NOUN
ajlm-1398	29	133	aimed	aim	VERB
ajlm-1398	29	134	to	to	PART
ajlm-1398	29	135	assess	assess	VERB
ajlm-1398	29	136	the	the	DET
ajlm-1398	29	137	relationship	relationship	NOUN
ajlm-1398	29	138	between	between	ADP
ajlm-1398	29	139	urinary	urinary	ADJ
ajlm-1398	29	140	amino	amino	NOUN
ajlm-1398	29	141	acid	acid	NOUN
ajlm-1398	29	142	concentration	concentration	NOUN
ajlm-1398	29	143	ratios	ratio	NOUN
ajlm-1398	29	144	and	and	CCONJ
ajlm-1398	29	145	renal	renal	ADJ
ajlm-1398	29	146	function	function	NOUN
ajlm-1398	29	147	decline	decline	NOUN
ajlm-1398	29	148	as	as	SCONJ
ajlm-1398	29	149	predicted	predict	VERB
ajlm-1398	29	150	by	by	ADP
ajlm-1398	29	151	the	the	DET
ajlm-1398	29	152	egfr	egfr	NOUN
ajlm-1398	29	153	in	in	ADP
ajlm-1398	29	154	diabetic	diabetic	ADJ
ajlm-1398	29	155	and	and	CCONJ
ajlm-1398	29	156	non	non	ADJ
ajlm-1398	29	157	-	-	ADJ
ajlm-1398	29	158	diabetic	diabetic	ADJ
ajlm-1398	29	159	patients	patient	NOUN
ajlm-1398	29	160	using	use	VERB
ajlm-1398	29	161	liquid	liquid	ADJ
ajlm-1398	29	162	chromatography	chromatography	NOUN
ajlm-1398	29	163	tandem	tandem	PROPN
ajlm-1398	29	164	mass	mass	PROPN
ajlm-1398	29	165	spectrometry	spectrometry	NOUN
ajlm-1398	29	166	.	.	PUNCT
ajlm-1398	30	1	methods	method	NOUN
ajlm-1398	30	2	ethical	ethical	ADJ
ajlm-1398	30	3	considerations	consideration	NOUN
ajlm-1398	30	4	ethical	ethical	ADJ
ajlm-1398	30	5	clearance	clearance	NOUN
ajlm-1398	30	6	was	be	AUX
ajlm-1398	30	7	obtained	obtain	VERB
ajlm-1398	30	8	from	from	ADP
ajlm-1398	30	9	the	the	DET
ajlm-1398	30	10	human	human	ADJ
ajlm-1398	30	11	and	and	CCONJ
ajlm-1398	30	12	animal	animal	NOUN
ajlm-1398	30	13	rights	right	NOUN
ajlm-1398	30	14	chris	chris	PROPN
ajlm-1398	30	15	hani	hani	PROPN
ajlm-1398	30	16	baragwanath	baragwanath	PROPN
ajlm-1398	30	17	academic	academic	PROPN
ajlm-1398	30	18	hospital	hospital	PROPN
ajlm-1398	30	19	medical	medical	PROPN
ajlm-1398	30	20	advisory	advisory	PROPN
ajlm-1398	30	21	committee	committee	NOUN
ajlm-1398	30	22	and	and	CCONJ
ajlm-1398	30	23	the	the	DET
ajlm-1398	30	24	university	university	NOUN
ajlm-1398	30	25	of	of	ADP
ajlm-1398	30	26	the	the	DET
ajlm-1398	30	27	witwatersrand	witwatersrand	NOUN
ajlm-1398	30	28	human	human	PROPN
ajlm-1398	30	29	research	research	PROPN
ajlm-1398	30	30	ethics	ethic	NOUN
ajlm-1398	30	31	committee	committee	PROPN
ajlm-1398	30	32	(	(	PUNCT
ajlm-1398	30	33	reference	reference	NOUN
ajlm-1398	30	34	number	number	NOUN
ajlm-1398	30	35	:	:	PUNCT
ajlm-1398	30	36	m180798	m180798	NOUN
ajlm-1398	30	37	)	)	PUNCT
ajlm-1398	30	38	.	.	PUNCT
ajlm-1398	31	1	a	a	DET
ajlm-1398	31	2	brief	brief	ADJ
ajlm-1398	31	3	explanation	explanation	NOUN
ajlm-1398	31	4	of	of	ADP
ajlm-1398	31	5	the	the	DET
ajlm-1398	31	6	study	study	NOUN
ajlm-1398	31	7	was	be	AUX
ajlm-1398	31	8	communicated	communicate	VERB
ajlm-1398	31	9	to	to	ADP
ajlm-1398	31	10	the	the	DET
ajlm-1398	31	11	participants	participant	NOUN
ajlm-1398	31	12	,	,	PUNCT
ajlm-1398	31	13	who	who	PRON
ajlm-1398	31	14	then	then	ADV
ajlm-1398	31	15	provided	provide	VERB
ajlm-1398	31	16	written	write	VERB
ajlm-1398	31	17	informed	inform	VERB
ajlm-1398	31	18	consent	consent	NOUN
ajlm-1398	31	19	to	to	PART
ajlm-1398	31	20	allow	allow	VERB
ajlm-1398	31	21	the	the	DET
ajlm-1398	31	22	collection	collection	NOUN
ajlm-1398	31	23	and	and	CCONJ
ajlm-1398	31	24	analysis	analysis	NOUN
ajlm-1398	31	25	of	of	ADP
ajlm-1398	31	26	their	their	PRON
ajlm-1398	31	27	urine	urine	NOUN
ajlm-1398	31	28	samples	sample	NOUN
ajlm-1398	31	29	and	and	CCONJ
ajlm-1398	31	30	medical	medical	ADJ
ajlm-1398	31	31	records	record	NOUN
ajlm-1398	31	32	.	.	PUNCT
ajlm-1398	32	1	medical	medical	ADJ
ajlm-1398	32	2	practice	practice	NOUN
ajlm-1398	32	3	and	and	CCONJ
ajlm-1398	32	4	ethical	ethical	ADJ
ajlm-1398	32	5	guidelines	guideline	NOUN
ajlm-1398	32	6	were	be	AUX
ajlm-1398	32	7	followed	follow	VERB
ajlm-1398	32	8	to	to	PART
ajlm-1398	32	9	ensure	ensure	VERB
ajlm-1398	32	10	the	the	DET
ajlm-1398	32	11	confidentiality	confidentiality	NOUN
ajlm-1398	32	12	of	of	ADP
ajlm-1398	32	13	the	the	DET
ajlm-1398	32	14	results	result	NOUN
ajlm-1398	32	15	obtained	obtain	VERB
ajlm-1398	32	16	in	in	ADP
ajlm-1398	32	17	this	this	DET
ajlm-1398	32	18	study	study	NOUN
ajlm-1398	32	19	.	.	PUNCT
ajlm-1398	33	1	samples	sample	NOUN
ajlm-1398	33	2	were	be	AUX
ajlm-1398	33	3	coded	code	VERB
ajlm-1398	33	4	to	to	PART
ajlm-1398	33	5	preserve	preserve	VERB
ajlm-1398	33	6	anonymity	anonymity	NOUN
ajlm-1398	33	7	.	.	PUNCT
ajlm-1398	34	1	study	study	NOUN
ajlm-1398	34	2	design	design	NOUN
ajlm-1398	34	3	and	and	CCONJ
ajlm-1398	34	4	sampling	sample	VERB
ajlm-1398	34	5	a	a	DET
ajlm-1398	34	6	total	total	NOUN
ajlm-1398	34	7	of	of	ADP
ajlm-1398	34	8	187	187	NUM
ajlm-1398	34	9	spot	spot	NOUN
ajlm-1398	34	10	urine	urine	NOUN
ajlm-1398	34	11	specimens	specimen	NOUN
ajlm-1398	34	12	were	be	AUX
ajlm-1398	34	13	collected	collect	VERB
ajlm-1398	34	14	from	from	ADP
ajlm-1398	34	15	study	study	NOUN
ajlm-1398	34	16	participants	participant	NOUN
ajlm-1398	34	17	between	between	ADP
ajlm-1398	34	18	february	february	PROPN
ajlm-1398	34	19	2019	2019	NUM
ajlm-1398	34	20	and	and	CCONJ
ajlm-1398	34	21	april	april	PROPN
ajlm-1398	34	22	2019	2019	NUM
ajlm-1398	34	23	at	at	ADP
ajlm-1398	34	24	the	the	DET
ajlm-1398	34	25	chris	chris	PROPN
ajlm-1398	34	26	hani	hani	PROPN
ajlm-1398	34	27	baragwanath	baragwanath	PROPN
ajlm-1398	34	28	academic	academic	PROPN
ajlm-1398	34	29	hospital	hospital	NOUN
ajlm-1398	34	30	located	locate	VERB
ajlm-1398	34	31	in	in	ADP
ajlm-1398	34	32	soweto	soweto	PROPN
ajlm-1398	34	33	,	,	PUNCT
ajlm-1398	34	34	johannesburg	johannesburg	PROPN
ajlm-1398	34	35	,	,	PUNCT
ajlm-1398	34	36	south	south	PROPN
ajlm-1398	34	37	africa	africa	PROPN
ajlm-1398	34	38	.	.	PUNCT
ajlm-1398	35	1	this	this	PRON
ajlm-1398	35	2	is	be	AUX
ajlm-1398	35	3	the	the	DET
ajlm-1398	35	4	biggest	big	ADJ
ajlm-1398	35	5	hospital	hospital	NOUN
ajlm-1398	35	6	in	in	ADP
ajlm-1398	35	7	africa	africa	PROPN
ajlm-1398	35	8	and	and	CCONJ
ajlm-1398	35	9	serves	serve	VERB
ajlm-1398	35	10	a	a	DET
ajlm-1398	35	11	large	large	ADJ
ajlm-1398	35	12	community	community	NOUN
ajlm-1398	35	13	from	from	ADP
ajlm-1398	35	14	urban	urban	ADJ
ajlm-1398	35	15	to	to	ADP
ajlm-1398	35	16	rural	rural	ADJ
ajlm-1398	35	17	areas	area	NOUN
ajlm-1398	35	18	;	;	PUNCT
ajlm-1398	35	19	it	it	PRON
ajlm-1398	35	20	sees	see	VERB
ajlm-1398	35	21	hundreds	hundred	NOUN
ajlm-1398	35	22	to	to	PART
ajlm-1398	35	23	thousands	thousand	NOUN
ajlm-1398	35	24	of	of	ADP
ajlm-1398	35	25	patients	patient	NOUN
ajlm-1398	35	26	annually	annually	ADV
ajlm-1398	35	27	.	.	PUNCT
ajlm-1398	36	1	data	datum	NOUN
ajlm-1398	36	2	on	on	ADP
ajlm-1398	36	3	ethnicity	ethnicity	NOUN
ajlm-1398	36	4	,	,	PUNCT
ajlm-1398	36	5	age	age	NOUN
ajlm-1398	36	6	,	,	PUNCT
ajlm-1398	36	7	egfr	egfr	NOUN
ajlm-1398	36	8	,	,	PUNCT
ajlm-1398	36	9	glycated	glycate	VERB
ajlm-1398	36	10	haemoglobin	haemoglobin	NOUN
ajlm-1398	36	11	(	(	PUNCT
ajlm-1398	36	12	hba1c	hba1c	PROPN
ajlm-1398	36	13	)	)	PUNCT
ajlm-1398	36	14	,	,	PUNCT
ajlm-1398	36	15	scr	scr	NOUN
ajlm-1398	36	16	,	,	PUNCT
ajlm-1398	36	17	urinary	urinary	ADJ
ajlm-1398	36	18	creatinine	creatinine	NOUN
ajlm-1398	36	19	,	,	PUNCT
ajlm-1398	36	20	albumin	albumin	NOUN
ajlm-1398	36	21	,	,	PUNCT
ajlm-1398	36	22	a	a	PRON
ajlm-1398	36	23	/	/	SYM
ajlm-1398	36	24	c	c	NOUN
ajlm-1398	36	25	and	and	CCONJ
ajlm-1398	36	26	gender	gender	NOUN
ajlm-1398	36	27	were	be	AUX
ajlm-1398	36	28	obtained	obtain	VERB
ajlm-1398	36	29	from	from	ADP
ajlm-1398	36	30	participants	participant	NOUN
ajlm-1398	36	31	’	'	PUNCT
ajlm-1398	36	32	medical	medical	ADJ
ajlm-1398	36	33	records	record	NOUN
ajlm-1398	36	34	.	.	PUNCT
ajlm-1398	37	1	samples	sample	NOUN
ajlm-1398	37	2	from	from	ADP
ajlm-1398	37	3	36	36	NUM
ajlm-1398	37	4	participants	participant	NOUN
ajlm-1398	37	5	were	be	AUX
ajlm-1398	37	6	excluded	exclude	VERB
ajlm-1398	37	7	from	from	ADP
ajlm-1398	37	8	the	the	DET
ajlm-1398	37	9	analysis	analysis	NOUN
ajlm-1398	37	10	because	because	SCONJ
ajlm-1398	37	11	of	of	ADP
ajlm-1398	37	12	missing	miss	VERB
ajlm-1398	37	13	data	datum	NOUN
ajlm-1398	37	14	(	(	PUNCT
ajlm-1398	37	15	33	33	NUM
ajlm-1398	37	16	medical	medical	ADJ
ajlm-1398	37	17	records	record	NOUN
ajlm-1398	37	18	without	without	ADP
ajlm-1398	37	19	egfr	egfr	ADJ
ajlm-1398	37	20	data	datum	NOUN
ajlm-1398	37	21	and	and	CCONJ
ajlm-1398	37	22	3	3	NUM
ajlm-1398	37	23	without	without	ADP
ajlm-1398	37	24	hba1c	hba1c	PROPN
ajlm-1398	37	25	data	datum	NOUN
ajlm-1398	37	26	)	)	PUNCT
ajlm-1398	37	27	.	.	PUNCT
ajlm-1398	38	1	all	all	DET
ajlm-1398	38	2	participants	participant	NOUN
ajlm-1398	38	3	with	with	ADP
ajlm-1398	38	4	complete	complete	ADJ
ajlm-1398	38	5	medical	medical	ADJ
ajlm-1398	38	6	data	datum	NOUN
ajlm-1398	38	7	(	(	PUNCT
ajlm-1398	38	8	n	n	NOUN
ajlm-1398	38	9	=	=	SYM
ajlm-1398	38	10	151	151	NUM
ajlm-1398	38	11	)	)	PUNCT
ajlm-1398	38	12	were	be	AUX
ajlm-1398	38	13	of	of	ADP
ajlm-1398	38	14	african	african	ADJ
ajlm-1398	38	15	descent	descent	NOUN
ajlm-1398	38	16	,	,	PUNCT
ajlm-1398	38	17	including	include	VERB
ajlm-1398	38	18	women	woman	NOUN
ajlm-1398	38	19	(	(	PUNCT
ajlm-1398	38	20	n	n	NOUN
ajlm-1398	38	21	=	=	SYM
ajlm-1398	38	22	104	104	NUM
ajlm-1398	38	23	)	)	PUNCT
ajlm-1398	38	24	and	and	CCONJ
ajlm-1398	38	25	men	man	NOUN
ajlm-1398	38	26	(	(	PUNCT
ajlm-1398	38	27	n	n	NOUN
ajlm-1398	38	28	=	=	SYM
ajlm-1398	38	29	47	47	NUM
ajlm-1398	38	30	)	)	PUNCT
ajlm-1398	38	31	between	between	ADP
ajlm-1398	38	32	the	the	DET
ajlm-1398	38	33	ages	age	NOUN
ajlm-1398	38	34	of	of	ADP
ajlm-1398	38	35	18	18	NUM
ajlm-1398	38	36	years	year	NOUN
ajlm-1398	38	37	and	and	CCONJ
ajlm-1398	38	38	90	90	NUM
ajlm-1398	38	39	years	year	NOUN
ajlm-1398	38	40	.	.	PUNCT
ajlm-1398	39	1	urine	urine	NOUN
ajlm-1398	39	2	samples	sample	NOUN
ajlm-1398	39	3	were	be	AUX
ajlm-1398	39	4	divided	divide	VERB
ajlm-1398	39	5	into	into	ADP
ajlm-1398	39	6	two	two	NUM
ajlm-1398	39	7	groups	group	NOUN
ajlm-1398	39	8	based	base	VERB
ajlm-1398	39	9	on	on	ADP
ajlm-1398	39	10	hba1c	hba1c	NOUN
ajlm-1398	39	11	:	:	PUNCT
ajlm-1398	39	12	people	people	NOUN
ajlm-1398	39	13	with	with	ADP
ajlm-1398	39	14	diabetes	diabetes	NOUN
ajlm-1398	39	15	(	(	PUNCT
ajlm-1398	39	16	n	n	NOUN
ajlm-1398	39	17	=	=	SYM
ajlm-1398	39	18	129	129	NUM
ajlm-1398	39	19	;	;	PUNCT
ajlm-1398	39	20	hba1c	hba1c	X
ajlm-1398	39	21	>	>	X
ajlm-1398	39	22	6.4	6.4	NUM
ajlm-1398	39	23	%	%	NOUN
ajlm-1398	39	24	)	)	PUNCT
ajlm-1398	39	25	and	and	CCONJ
ajlm-1398	39	26	people	people	NOUN
ajlm-1398	39	27	without	without	ADP
ajlm-1398	39	28	diabetes	diabetes	NOUN
ajlm-1398	39	29	(	(	PUNCT
ajlm-1398	39	30	n	n	NOUN
ajlm-1398	39	31	=	=	SYM
ajlm-1398	39	32	22	22	NUM
ajlm-1398	39	33	;	;	PUNCT
ajlm-1398	39	34	hba1c	hba1c	NOUN
ajlm-1398	39	35	≤	≤	ADV
ajlm-1398	39	36	6.4	6.4	NUM
ajlm-1398	39	37	%	%	NOUN
ajlm-1398	39	38	)	)	PUNCT
ajlm-1398	39	39	.	.	PUNCT
ajlm-1398	40	1	these	these	DET
ajlm-1398	40	2	groups	group	NOUN
ajlm-1398	40	3	were	be	AUX
ajlm-1398	40	4	further	far	ADV
ajlm-1398	40	5	divided	divide	VERB
ajlm-1398	40	6	into	into	ADP
ajlm-1398	40	7	sub	sub	NOUN
ajlm-1398	40	8	-	-	NOUN
ajlm-1398	40	9	groups	group	NOUN
ajlm-1398	40	10	based	base	VERB
ajlm-1398	40	11	on	on	ADP
ajlm-1398	40	12	the	the	DET
ajlm-1398	40	13	stage	stage	NOUN
ajlm-1398	40	14	of	of	ADP
ajlm-1398	40	15	ckd	ckd	PROPN
ajlm-1398	40	16	as	as	SCONJ
ajlm-1398	40	17	follows	follow	VERB
ajlm-1398	40	18	:	:	PUNCT
ajlm-1398	40	19	63	63	NUM
ajlm-1398	40	20	people	people	NOUN
ajlm-1398	40	21	with	with	ADP
ajlm-1398	40	22	diabetes	diabetes	NOUN
ajlm-1398	40	23	and	and	CCONJ
ajlm-1398	40	24	9	9	NUM
ajlm-1398	40	25	without	without	ADP
ajlm-1398	40	26	diabetes	diabetes	NOUN
ajlm-1398	40	27	were	be	AUX
ajlm-1398	40	28	categorised	categorise	VERB
ajlm-1398	40	29	as	as	ADP
ajlm-1398	40	30	being	be	AUX
ajlm-1398	40	31	in	in	ADP
ajlm-1398	40	32	stage	stage	NOUN
ajlm-1398	40	33	1	1	NUM
ajlm-1398	40	34	(	(	PUNCT
ajlm-1398	40	35	≥	≥	NUM
ajlm-1398	40	36	90	90	NUM
ajlm-1398	40	37	ml	ml	NOUN
ajlm-1398	40	38	/	/	SYM
ajlm-1398	40	39	min	min	NOUN
ajlm-1398	40	40	per	per	ADP
ajlm-1398	40	41	1.73	1.73	NUM
ajlm-1398	40	42	m2	m2	NOUN
ajlm-1398	40	43	)	)	PUNCT
ajlm-1398	40	44	,	,	PUNCT
ajlm-1398	40	45	43	43	NUM
ajlm-1398	40	46	people	people	NOUN
ajlm-1398	40	47	with	with	ADP
ajlm-1398	40	48	diabetes	diabetes	NOUN
ajlm-1398	40	49	and	and	CCONJ
ajlm-1398	40	50	10	10	NUM
ajlm-1398	40	51	without	without	ADP
ajlm-1398	40	52	diabetes	diabetes	NOUN
ajlm-1398	40	53	were	be	AUX
ajlm-1398	40	54	classified	classify	VERB
ajlm-1398	40	55	as	as	ADP
ajlm-1398	40	56	being	be	AUX
ajlm-1398	40	57	in	in	ADP
ajlm-1398	40	58	stage	stage	NOUN
ajlm-1398	40	59	2	2	NUM
ajlm-1398	40	60	(	(	PUNCT
ajlm-1398	40	61	60	60	NUM
ajlm-1398	40	62	ml	ml	NOUN
ajlm-1398	40	63	/	/	SYM
ajlm-1398	40	64	min	min	NOUN
ajlm-1398	40	65	–	–	PUNCT
ajlm-1398	40	66	89	89	NUM
ajlm-1398	40	67	ml	ml	NOUN
ajlm-1398	40	68	/	/	SYM
ajlm-1398	40	69	min	min	NOUN
ajlm-1398	40	70	per	per	ADP
ajlm-1398	40	71	1.73	1.73	NUM
ajlm-1398	40	72	m2	m2	NOUN
ajlm-1398	40	73	)	)	PUNCT
ajlm-1398	40	74	,	,	PUNCT
ajlm-1398	40	75	15	15	NUM
ajlm-1398	40	76	people	people	NOUN
ajlm-1398	40	77	with	with	ADP
ajlm-1398	40	78	diabetes	diabetes	NOUN
ajlm-1398	40	79	and	and	CCONJ
ajlm-1398	40	80	3	3	NUM
ajlm-1398	40	81	without	without	ADP
ajlm-1398	40	82	diabetes	diabetes	NOUN
ajlm-1398	40	83	were	be	AUX
ajlm-1398	40	84	classified	classify	VERB
ajlm-1398	40	85	as	as	ADP
ajlm-1398	40	86	being	be	AUX
ajlm-1398	40	87	in	in	ADP
ajlm-1398	40	88	stage	stage	NOUN
ajlm-1398	40	89	3	3	NUM
ajlm-1398	40	90	(	(	PUNCT
ajlm-1398	40	91	30	30	NUM
ajlm-1398	40	92	ml	ml	NOUN
ajlm-1398	40	93	/	/	SYM
ajlm-1398	40	94	min	min	NOUN
ajlm-1398	40	95	–	–	PUNCT
ajlm-1398	40	96	59	59	NUM
ajlm-1398	40	97	ml	ml	NOUN
ajlm-1398	40	98	/	/	SYM
ajlm-1398	40	99	min	min	NOUN
ajlm-1398	40	100	per	per	ADP
ajlm-1398	40	101	1.73	1.73	NUM
ajlm-1398	40	102	m2	m2	NOUN
ajlm-1398	40	103	)	)	PUNCT
ajlm-1398	40	104	,	,	PUNCT
ajlm-1398	40	105	7	7	NUM
ajlm-1398	40	106	people	people	NOUN
ajlm-1398	40	107	with	with	ADP
ajlm-1398	40	108	diabetes	diabetes	NOUN
ajlm-1398	40	109	were	be	AUX
ajlm-1398	40	110	classified	classify	VERB
ajlm-1398	40	111	as	as	ADP
ajlm-1398	40	112	being	be	AUX
ajlm-1398	40	113	in	in	ADP
ajlm-1398	40	114	stage	stage	NOUN
ajlm-1398	40	115	4	4	NUM
ajlm-1398	40	116	(	(	PUNCT
ajlm-1398	40	117	15	15	NUM
ajlm-1398	40	118	ml	ml	NOUN
ajlm-1398	40	119	/	/	SYM
ajlm-1398	40	120	min	min	NOUN
ajlm-1398	40	121	–	–	PUNCT
ajlm-1398	40	122	29	29	NUM
ajlm-1398	40	123	ml	ml	NOUN
ajlm-1398	40	124	/	/	SYM
ajlm-1398	40	125	min	min	NOUN
ajlm-1398	40	126	per	per	ADP
ajlm-1398	40	127	1.73	1.73	NUM
ajlm-1398	40	128	m2	m2	NOUN
ajlm-1398	40	129	)	)	PUNCT
ajlm-1398	40	130	,	,	PUNCT
ajlm-1398	40	131	and	and	CCONJ
ajlm-1398	40	132	1	1	NUM
ajlm-1398	40	133	participant	participant	NOUN
ajlm-1398	40	134	was	be	AUX
ajlm-1398	40	135	categorised	categorise	VERB
ajlm-1398	40	136	as	as	ADP
ajlm-1398	40	137	being	be	AUX
ajlm-1398	40	138	in	in	ADP
ajlm-1398	40	139	stage	stage	NOUN
ajlm-1398	40	140	5	5	NUM
ajlm-1398	40	141	(	(	PUNCT
ajlm-1398	40	142	<	<	X
ajlm-1398	40	143	15	15	NUM
ajlm-1398	40	144	ml	ml	NOUN
ajlm-1398	40	145	/	/	SYM
ajlm-1398	40	146	min	min	NOUN
ajlm-1398	40	147	per	per	ADP
ajlm-1398	40	148	1.73	1.73	NUM
ajlm-1398	40	149	m2	m2	NOUN
ajlm-1398	40	150	)	)	PUNCT
ajlm-1398	40	151	.	.	PUNCT
ajlm-1398	41	1	the	the	DET
ajlm-1398	41	2	amino	amino	ADJ
ajlm-1398	41	3	acids	acid	NOUN
ajlm-1398	41	4	arginine	arginine	NOUN
ajlm-1398	41	5	,	,	PUNCT
ajlm-1398	41	6	citrulline	citrulline	NOUN
ajlm-1398	41	7	,	,	PUNCT
ajlm-1398	41	8	isoleucine	isoleucine	NOUN
ajlm-1398	41	9	,	,	PUNCT
ajlm-1398	41	10	ornithine	ornithine	NOUN
ajlm-1398	41	11	,	,	PUNCT
ajlm-1398	41	12	phenylalanine	phenylalanine	NOUN
ajlm-1398	41	13	,	,	PUNCT
ajlm-1398	41	14	and	and	CCONJ
ajlm-1398	41	15	tyrosine	tyrosine	NOUN
ajlm-1398	41	16	were	be	AUX
ajlm-1398	41	17	quantitatively	quantitatively	ADV
ajlm-1398	41	18	analysed	analyse	VERB
ajlm-1398	41	19	in	in	ADP
ajlm-1398	41	20	each	each	DET
ajlm-1398	41	21	sample	sample	NOUN
ajlm-1398	41	22	.	.	PUNCT
ajlm-1398	42	1	using	use	VERB
ajlm-1398	42	2	the	the	DET
ajlm-1398	42	3	modification	modification	NOUN
ajlm-1398	42	4	of	of	ADP
ajlm-1398	42	5	diet	diet	NOUN
ajlm-1398	42	6	in	in	ADP
ajlm-1398	42	7	renal	renal	ADJ
ajlm-1398	42	8	disease	disease	NOUN
ajlm-1398	42	9	equation	equation	NOUN
ajlm-1398	42	10	,	,	PUNCT
ajlm-1398	42	11	the	the	DET
ajlm-1398	42	12	egfr	egfr	NOUN
ajlm-1398	42	13	was	be	AUX
ajlm-1398	42	14	calculated	calculate	VERB
ajlm-1398	42	15	to	to	PART
ajlm-1398	42	16	assess	assess	VERB
ajlm-1398	42	17	the	the	DET
ajlm-1398	42	18	degree	degree	NOUN
ajlm-1398	42	19	of	of	ADP
ajlm-1398	42	20	kidney	kidney	NOUN
ajlm-1398	42	21	function	function	NOUN
ajlm-1398	42	22	.	.	PUNCT
ajlm-1398	43	1	urine	urine	NOUN
ajlm-1398	43	2	samples	sample	NOUN
ajlm-1398	43	3	were	be	AUX
ajlm-1398	43	4	collected	collect	VERB
ajlm-1398	43	5	into	into	ADP
ajlm-1398	43	6	20	20	NUM
ajlm-1398	43	7	ml	ml	NOUN
ajlm-1398	43	8	sterile	sterile	ADJ
ajlm-1398	43	9	polypropylene	polypropylene	NOUN
ajlm-1398	43	10	screw	screw	NOUN
ajlm-1398	43	11	-	-	PUNCT
ajlm-1398	43	12	top	top	NOUN
ajlm-1398	43	13	containers	container	NOUN
ajlm-1398	43	14	and	and	CCONJ
ajlm-1398	43	15	placed	place	VERB
ajlm-1398	43	16	on	on	ADP
ajlm-1398	43	17	wet	wet	ADJ
ajlm-1398	43	18	ice	ice	NOUN
ajlm-1398	43	19	in	in	ADP
ajlm-1398	43	20	polystyrene	polystyrene	NOUN
ajlm-1398	43	21	containers	container	NOUN
ajlm-1398	43	22	before	before	ADP
ajlm-1398	43	23	transportation	transportation	NOUN
ajlm-1398	43	24	to	to	ADP
ajlm-1398	43	25	the	the	DET
ajlm-1398	43	26	national	national	PROPN
ajlm-1398	43	27	institute	institute	PROPN
ajlm-1398	43	28	of	of	ADP
ajlm-1398	43	29	occupational	occupational	PROPN
ajlm-1398	43	30	health	health	PROPN
ajlm-1398	43	31	biobank	biobank	NOUN
ajlm-1398	43	32	for	for	ADP
ajlm-1398	43	33	long	long	ADJ
ajlm-1398	43	34	-	-	PUNCT
ajlm-1398	43	35	term	term	NOUN
ajlm-1398	43	36	storage	storage	NOUN
ajlm-1398	43	37	at	at	ADP
ajlm-1398	43	38	−20	−20	PROPN
ajlm-1398	43	39	°	°	ADP
ajlm-1398	43	40	c	c	NOUN
ajlm-1398	43	41	.	.	PUNCT
ajlm-1398	44	1	before	before	ADP
ajlm-1398	44	2	analysis	analysis	NOUN
ajlm-1398	44	3	,	,	PUNCT
ajlm-1398	44	4	the	the	DET
ajlm-1398	44	5	samples	sample	NOUN
ajlm-1398	44	6	were	be	AUX
ajlm-1398	44	7	transported	transport	VERB
ajlm-1398	44	8	to	to	ADP
ajlm-1398	44	9	the	the	DET
ajlm-1398	44	10	university	university	NOUN
ajlm-1398	44	11	of	of	ADP
ajlm-1398	44	12	the	the	DET
ajlm-1398	44	13	witwatersrand	witwatersrand	NOUN
ajlm-1398	44	14	school	school	PROPN
ajlm-1398	44	15	of	of	ADP
ajlm-1398	44	16	chemistry	chemistry	NOUN
ajlm-1398	44	17	mass	mass	PROPN
ajlm-1398	44	18	spectrometry	spectrometry	NOUN
ajlm-1398	44	19	laboratory	laboratory	NOUN
ajlm-1398	44	20	,	,	PUNCT
ajlm-1398	44	21	where	where	SCONJ
ajlm-1398	44	22	they	they	PRON
ajlm-1398	44	23	were	be	AUX
ajlm-1398	44	24	briefly	briefly	ADV
ajlm-1398	44	25	stored	store	VERB
ajlm-1398	44	26	at	at	ADP
ajlm-1398	44	27	−20	−20	PROPN
ajlm-1398	44	28	°	°	ADP
ajlm-1398	44	29	c	c	NOUN
ajlm-1398	44	30	for	for	ADP
ajlm-1398	44	31	a	a	DET
ajlm-1398	44	32	few	few	ADJ
ajlm-1398	44	33	days	day	NOUN
ajlm-1398	44	34	before	before	ADP
ajlm-1398	44	35	analysis	analysis	NOUN
ajlm-1398	44	36	.	.	PUNCT
ajlm-1398	45	1	chemicals	chemical	NOUN
ajlm-1398	45	2	and	and	CCONJ
ajlm-1398	45	3	materials	material	NOUN
ajlm-1398	45	4	all	all	DET
ajlm-1398	45	5	amino	amino	ADJ
ajlm-1398	45	6	acids	acid	NOUN
ajlm-1398	45	7	(	(	PUNCT
ajlm-1398	45	8	purity	purity	NOUN
ajlm-1398	45	9	≥	≥	NOUN
ajlm-1398	45	10	98.0	98.0	NUM
ajlm-1398	45	11	%	%	NOUN
ajlm-1398	45	12	)	)	PUNCT
ajlm-1398	45	13	,	,	PUNCT
ajlm-1398	45	14	as	as	ADV
ajlm-1398	45	15	well	well	ADV
ajlm-1398	45	16	as	as	ADP
ajlm-1398	45	17	the	the	DET
ajlm-1398	45	18	formic	formic	ADJ
ajlm-1398	45	19	acid	acid	NOUN
ajlm-1398	45	20	(	(	PUNCT
ajlm-1398	45	21	purity	purity	NOUN
ajlm-1398	45	22	≥	≥	NOUN
ajlm-1398	45	23	98.0	98.0	NUM
ajlm-1398	45	24	%	%	NOUN
ajlm-1398	45	25	)	)	PUNCT
ajlm-1398	45	26	,	,	PUNCT
ajlm-1398	45	27	sigmatrix	sigmatrix	VERB
ajlm-1398	45	28	urine	urine	NOUN
ajlm-1398	45	29	diluent	diluent	NOUN
ajlm-1398	45	30	(	(	PUNCT
ajlm-1398	45	31	purity	purity	NOUN
ajlm-1398	45	32	≥	≥	NOUN
ajlm-1398	45	33	98.0	98.0	NUM
ajlm-1398	45	34	%	%	NOUN
ajlm-1398	45	35	)	)	PUNCT
ajlm-1398	45	36	and	and	CCONJ
ajlm-1398	45	37	hplc	hplc	NOUN
ajlm-1398	45	38	-	-	PUNCT
ajlm-1398	45	39	grade	grade	NOUN
ajlm-1398	45	40	acetonitrile	acetonitrile	NOUN
ajlm-1398	45	41	(	(	PUNCT
ajlm-1398	45	42	≥	≥	NUM
ajlm-1398	45	43	99.9	99.9	NUM
ajlm-1398	45	44	%	%	NOUN
ajlm-1398	45	45	)	)	PUNCT
ajlm-1398	45	46	,	,	PUNCT
ajlm-1398	45	47	were	be	AUX
ajlm-1398	45	48	obtained	obtain	VERB
ajlm-1398	45	49	from	from	ADP
ajlm-1398	45	50	sigma	sigma	PROPN
ajlm-1398	45	51	-	-	PUNCT
ajlm-1398	45	52	aldrich	aldrich	PROPN
ajlm-1398	45	53	(	(	PUNCT
ajlm-1398	45	54	johannesburg	johannesburg	PROPN
ajlm-1398	45	55	,	,	PUNCT
ajlm-1398	45	56	south	south	PROPN
ajlm-1398	45	57	africa	africa	PROPN
ajlm-1398	45	58	)	)	PUNCT
ajlm-1398	45	59	.	.	PUNCT
ajlm-1398	46	1	deionised	deionise	VERB
ajlm-1398	46	2	water	water	NOUN
ajlm-1398	46	3	,	,	PUNCT
ajlm-1398	46	4	which	which	PRON
ajlm-1398	46	5	was	be	AUX
ajlm-1398	46	6	used	use	VERB
ajlm-1398	46	7	as	as	ADP
ajlm-1398	46	8	a	a	DET
ajlm-1398	46	9	solvent	solvent	NOUN
ajlm-1398	46	10	for	for	ADP
ajlm-1398	46	11	dilution	dilution	NOUN
ajlm-1398	46	12	of	of	ADP
ajlm-1398	46	13	analytes	analyte	NOUN
ajlm-1398	46	14	,	,	PUNCT
ajlm-1398	46	15	was	be	AUX
ajlm-1398	46	16	purified	purify	VERB
ajlm-1398	46	17	using	use	VERB
ajlm-1398	46	18	a	a	DET
ajlm-1398	46	19	direct	direct	ADJ
ajlm-1398	46	20	-	-	PUNCT
ajlm-1398	46	21	q	q	NOUN
ajlm-1398	46	22	®	®	NOUN
ajlm-1398	46	23	3	3	NUM
ajlm-1398	46	24	uv	uv	PROPN
ajlm-1398	46	25	millipore	millipore	PROPN
ajlm-1398	46	26	system	system	NOUN
ajlm-1398	46	27	(	(	PUNCT
ajlm-1398	46	28	molsheim	molsheim	PROPN
ajlm-1398	46	29	,	,	PUNCT
ajlm-1398	46	30	france	france	PROPN
ajlm-1398	46	31	)	)	PUNCT
ajlm-1398	46	32	.	.	PUNCT
ajlm-1398	47	1	a	a	DET
ajlm-1398	47	2	stock	stock	NOUN
ajlm-1398	47	3	solution	solution	NOUN
ajlm-1398	47	4	of	of	ADP
ajlm-1398	47	5	each	each	DET
ajlm-1398	47	6	amino	amino	NOUN
ajlm-1398	47	7	acid	acid	NOUN
ajlm-1398	47	8	(	(	PUNCT
ajlm-1398	47	9	100	100	NUM
ajlm-1398	47	10	mg	mg	NUM
ajlm-1398	47	11	/	/	SYM
ajlm-1398	47	12	l	l	NOUN
ajlm-1398	47	13	)	)	PUNCT
ajlm-1398	47	14	was	be	AUX
ajlm-1398	47	15	prepared	prepare	VERB
ajlm-1398	47	16	by	by	ADP
ajlm-1398	47	17	weighing	weigh	VERB
ajlm-1398	47	18	10	10	NUM
ajlm-1398	47	19	mg	mg	NOUN
ajlm-1398	47	20	of	of	ADP
ajlm-1398	47	21	the	the	DET
ajlm-1398	47	22	amino	amino	NOUN
ajlm-1398	47	23	acid	acid	NOUN
ajlm-1398	47	24	which	which	PRON
ajlm-1398	47	25	was	be	AUX
ajlm-1398	47	26	then	then	ADV
ajlm-1398	47	27	dissolved	dissolve	VERB
ajlm-1398	47	28	to	to	ADP
ajlm-1398	47	29	a	a	DET
ajlm-1398	47	30	final	final	ADJ
ajlm-1398	47	31	volume	volume	NOUN
ajlm-1398	47	32	with	with	ADP
ajlm-1398	47	33	millipore	millipore	PROPN
ajlm-1398	47	34	h2o	h2o	PROPN
ajlm-1398	47	35	in	in	ADP
ajlm-1398	47	36	a	a	DET
ajlm-1398	47	37	100	100	NUM
ajlm-1398	47	38	ml	ml	NOUN
ajlm-1398	47	39	volumetric	volumetric	ADJ
ajlm-1398	47	40	flask	flask	NOUN
ajlm-1398	47	41	.	.	PUNCT
ajlm-1398	48	1	from	from	ADP
ajlm-1398	48	2	the	the	DET
ajlm-1398	48	3	stock	stock	NOUN
ajlm-1398	48	4	solution	solution	NOUN
ajlm-1398	48	5	,	,	PUNCT
ajlm-1398	48	6	10	10	NUM
ajlm-1398	48	7	calibration	calibration	NOUN
ajlm-1398	48	8	points	point	NOUN
ajlm-1398	48	9	(	(	PUNCT
ajlm-1398	48	10	0.01	0.01	NUM
ajlm-1398	48	11	mg	mg	PROPN
ajlm-1398	48	12	/	/	SYM
ajlm-1398	48	13	l	l	NOUN
ajlm-1398	48	14	,	,	PUNCT
ajlm-1398	48	15	0.05	0.05	NUM
ajlm-1398	48	16	mg	mg	PROPN
ajlm-1398	48	17	/	/	SYM
ajlm-1398	48	18	l	l	NOUN
ajlm-1398	48	19	,	,	PUNCT
ajlm-1398	48	20	0.10	0.10	NUM
ajlm-1398	48	21	mg	mg	PROPN
ajlm-1398	48	22	/	/	SYM
ajlm-1398	48	23	l	l	NOUN
ajlm-1398	48	24	,	,	PUNCT
ajlm-1398	48	25	0.30	0.30	NUM
ajlm-1398	48	26	mg	mg	PROPN
ajlm-1398	48	27	/	/	SYM
ajlm-1398	48	28	l	l	NOUN
ajlm-1398	48	29	,	,	PUNCT
ajlm-1398	48	30	0.50	0.50	NUM
ajlm-1398	48	31	mg	mg	PROPN
ajlm-1398	48	32	/	/	SYM
ajlm-1398	48	33	l	l	NOUN
ajlm-1398	48	34	,	,	PUNCT
ajlm-1398	48	35	1.00	1.00	NUM
ajlm-1398	48	36	mg	mg	PROPN
ajlm-1398	48	37	/	/	SYM
ajlm-1398	48	38	l	l	NOUN
ajlm-1398	48	39	,	,	PUNCT
ajlm-1398	48	40	2.00	2.00	NUM
ajlm-1398	48	41	mg	mg	NUM
ajlm-1398	48	42	/	/	SYM
ajlm-1398	48	43	l	l	NOUN
ajlm-1398	48	44	,	,	PUNCT
ajlm-1398	48	45	3.00	3.00	NUM
ajlm-1398	48	46	mg	mg	NOUN
ajlm-1398	48	47	/	/	SYM
ajlm-1398	48	48	l	l	NOUN
ajlm-1398	48	49	,	,	PUNCT
ajlm-1398	48	50	4.00	4.00	NUM
ajlm-1398	48	51	mg	mg	NOUN
ajlm-1398	48	52	/	/	SYM
ajlm-1398	48	53	l	l	NOUN
ajlm-1398	48	54	,	,	PUNCT
ajlm-1398	48	55	and	and	CCONJ
ajlm-1398	48	56	5.00	5.00	NUM
ajlm-1398	48	57	mg	mg	NUM
ajlm-1398	48	58	/	/	SYM
ajlm-1398	48	59	l	l	NOUN
ajlm-1398	48	60	)	)	PUNCT
ajlm-1398	48	61	were	be	AUX
ajlm-1398	48	62	prepared	prepare	VERB
ajlm-1398	48	63	by	by	ADP
ajlm-1398	48	64	diluting	dilute	VERB
ajlm-1398	48	65	appropriate	appropriate	ADJ
ajlm-1398	48	66	volumes	volume	NOUN
ajlm-1398	48	67	of	of	ADP
ajlm-1398	48	68	stock	stock	NOUN
ajlm-1398	48	69	solution	solution	NOUN
ajlm-1398	48	70	in	in	ADP
ajlm-1398	48	71	a	a	DET
ajlm-1398	48	72	urine	urine	NOUN
ajlm-1398	48	73	diluent	diluent	NOUN
ajlm-1398	48	74	–	–	PUNCT
ajlm-1398	48	75	h2o	h2o	PROPN
ajlm-1398	48	76	(	(	PUNCT
ajlm-1398	48	77	1:5	1:5	NUM
ajlm-1398	48	78	ratio	ratio	NOUN
ajlm-1398	48	79	)	)	PUNCT
ajlm-1398	48	80	mixture	mixture	NOUN
ajlm-1398	48	81	.	.	PUNCT
ajlm-1398	49	1	the	the	DET
ajlm-1398	49	2	urine	urine	NOUN
ajlm-1398	49	3	diluent	diluent	NOUN
ajlm-1398	49	4	was	be	AUX
ajlm-1398	49	5	used	use	VERB
ajlm-1398	49	6	as	as	ADP
ajlm-1398	49	7	a	a	DET
ajlm-1398	49	8	blank	blank	ADJ
ajlm-1398	49	9	matrix	matrix	NOUN
ajlm-1398	49	10	to	to	PART
ajlm-1398	49	11	mimic	mimic	VERB
ajlm-1398	49	12	human	human	ADJ
ajlm-1398	49	13	urine	urine	NOUN
ajlm-1398	49	14	.	.	PUNCT
ajlm-1398	50	1	quantitative	quantitative	ADJ
ajlm-1398	50	2	analysis	analysis	NOUN
ajlm-1398	50	3	frozen	frozen	ADJ
ajlm-1398	50	4	urine	urine	NOUN
ajlm-1398	50	5	samples	sample	NOUN
ajlm-1398	50	6	were	be	AUX
ajlm-1398	50	7	thawed	thaw	VERB
ajlm-1398	50	8	for	for	ADP
ajlm-1398	50	9	30	30	NUM
ajlm-1398	50	10	min	min	NOUN
ajlm-1398	50	11	,	,	PUNCT
ajlm-1398	50	12	then	then	ADV
ajlm-1398	50	13	1	1	NUM
ajlm-1398	50	14	ml	ml	NOUN
ajlm-1398	50	15	of	of	ADP
ajlm-1398	50	16	the	the	DET
ajlm-1398	50	17	urine	urine	NOUN
ajlm-1398	50	18	was	be	AUX
ajlm-1398	50	19	transferred	transfer	VERB
ajlm-1398	50	20	into	into	ADP
ajlm-1398	50	21	a	a	DET
ajlm-1398	50	22	2	2	NUM
ajlm-1398	50	23	ml	ml	NOUN
ajlm-1398	50	24	centrifuge	centrifuge	NOUN
ajlm-1398	50	25	tube	tube	NOUN
ajlm-1398	50	26	and	and	CCONJ
ajlm-1398	50	27	diluted	dilute	VERB
ajlm-1398	50	28	with	with	ADP
ajlm-1398	50	29	1	1	NUM
ajlm-1398	50	30	ml	ml	NOUN
ajlm-1398	50	31	of	of	ADP
ajlm-1398	50	32	millipore	millipore	PROPN
ajlm-1398	50	33	h2o	h2o	PROPN
ajlm-1398	50	34	,	,	PUNCT
ajlm-1398	50	35	and	and	CCONJ
ajlm-1398	50	36	centrifuged	centrifuge	VERB
ajlm-1398	50	37	at	at	ADP
ajlm-1398	50	38	3000	3000	NUM
ajlm-1398	50	39	g	g	NOUN
ajlm-1398	50	40	for	for	ADP
ajlm-1398	50	41	10	10	NUM
ajlm-1398	50	42	min	min	NOUN
ajlm-1398	50	43	.	.	PROPN
ajlm-1398	50	44	afterwards	afterwards	ADV
ajlm-1398	50	45	,	,	PUNCT
ajlm-1398	50	46	0.2	0.2	NUM
ajlm-1398	50	47	ml	ml	NOUN
ajlm-1398	50	48	of	of	ADP
ajlm-1398	50	49	the	the	DET
ajlm-1398	50	50	supernatant	supernatant	NOUN
ajlm-1398	50	51	was	be	AUX
ajlm-1398	50	52	transferred	transfer	VERB
ajlm-1398	50	53	into	into	ADP
ajlm-1398	50	54	a	a	DET
ajlm-1398	50	55	2	2	NUM
ajlm-1398	50	56	ml	ml	NOUN
ajlm-1398	50	57	ultra	ultra	ADJ
ajlm-1398	50	58	-	-	ADJ
ajlm-1398	50	59	high	high	ADJ
ajlm-1398	50	60	performance	performance	NOUN
ajlm-1398	50	61	liquid	liquid	NOUN
ajlm-1398	50	62	chromatography	chromatography	NOUN
ajlm-1398	50	63	(	(	PUNCT
ajlm-1398	50	64	uhplc	uhplc	PROPN
ajlm-1398	50	65	)	)	PUNCT
ajlm-1398	50	66	vial	vial	ADJ
ajlm-1398	50	67	and	and	CCONJ
ajlm-1398	50	68	0.8	0.8	NUM
ajlm-1398	50	69	ml	ml	NOUN
ajlm-1398	50	70	of	of	ADP
ajlm-1398	50	71	millipore	millipore	PROPN
ajlm-1398	50	72	h2o	h2o	PROPN
ajlm-1398	50	73	was	be	AUX
ajlm-1398	50	74	added	add	VERB
ajlm-1398	50	75	to	to	PART
ajlm-1398	50	76	make	make	VERB
ajlm-1398	50	77	up	up	ADP
ajlm-1398	50	78	the	the	DET
ajlm-1398	50	79	final	final	ADJ
ajlm-1398	50	80	volume	volume	NOUN
ajlm-1398	50	81	to	to	ADP
ajlm-1398	50	82	1	1	NUM
ajlm-1398	50	83	ml	ml	NOUN
ajlm-1398	50	84	.	.	NOUN
ajlm-1398	50	85	standards	standard	NOUN
ajlm-1398	50	86	and	and	CCONJ
ajlm-1398	50	87	samples	sample	NOUN
ajlm-1398	50	88	were	be	AUX
ajlm-1398	50	89	analysed	analyse	VERB
ajlm-1398	50	90	on	on	ADP
ajlm-1398	50	91	a	a	DET
ajlm-1398	50	92	ymc	ymc	NOUN
ajlm-1398	50	93	-	-	PUNCT
ajlm-1398	50	94	triart	triart	PROPN
ajlm-1398	50	95	c18	c18	NOUN
ajlm-1398	51	1	uhplc	uhplc	PROPN
ajlm-1398	51	2	column	column	NOUN
ajlm-1398	51	3	(	(	PUNCT
ajlm-1398	51	4	1.9	1.9	NUM
ajlm-1398	51	5	µm	µm	ADP
ajlm-1398	51	6	beads	bead	NOUN
ajlm-1398	51	7	,	,	PUNCT
ajlm-1398	51	8	pore	pore	ADJ
ajlm-1398	51	9	size	size	NOUN
ajlm-1398	51	10	120	120	NUM
ajlm-1398	51	11	å	å	NOUN
ajlm-1398	51	12	,	,	PUNCT
ajlm-1398	51	13	2	2	NUM
ajlm-1398	51	14	mm	mm	NOUN
ajlm-1398	51	15	i	i	NOUN
ajlm-1398	51	16	d	d	PROPN
ajlm-1398	51	17	×	×	NOUN
ajlm-1398	51	18	150	150	NUM
ajlm-1398	51	19	mm	mm	NOUN
ajlm-1398	51	20	length	length	NOUN
ajlm-1398	51	21	)	)	PUNCT
ajlm-1398	51	22	(	(	PUNCT
ajlm-1398	51	23	analytical	analytical	ADJ
ajlm-1398	51	24	science	science	NOUN
ajlm-1398	51	25	technology	technology	PROPN
ajlm-1398	51	26	pty	pty	PROPN
ajlm-1398	51	27	ltd	ltd	PROPN
ajlm-1398	51	28	,	,	PUNCT
ajlm-1398	51	29	cape	cape	NOUN
ajlm-1398	51	30	town	town	NOUN
ajlm-1398	51	31	,	,	PUNCT
ajlm-1398	51	32	south	south	PROPN
ajlm-1398	51	33	africa	africa	PROPN
ajlm-1398	51	34	)	)	PUNCT
ajlm-1398	51	35	.	.	PUNCT
ajlm-1398	52	1	all	all	DET
ajlm-1398	52	2	analyses	analysis	NOUN
ajlm-1398	52	3	were	be	AUX
ajlm-1398	52	4	conducted	conduct	VERB
ajlm-1398	52	5	in	in	ADP
ajlm-1398	52	6	triplicate	triplicate	NOUN
ajlm-1398	52	7	with	with	ADP
ajlm-1398	52	8	quality	quality	NOUN
ajlm-1398	52	9	control	control	NOUN
ajlm-1398	52	10	samples	sample	NOUN
ajlm-1398	52	11	(	(	PUNCT
ajlm-1398	52	12	lowest	low	ADJ
ajlm-1398	52	13	limit	limit	NOUN
ajlm-1398	52	14	of	of	ADP
ajlm-1398	52	15	quantitation	quantitation	NOUN
ajlm-1398	52	16	[	[	X
ajlm-1398	52	17	lloq]1	lloq]1	NOUN
ajlm-1398	52	18	[	[	X
ajlm-1398	52	19	0.1	0.1	NUM
ajlm-1398	52	20	mg	mg	PROPN
ajlm-1398	52	21	/	/	SYM
ajlm-1398	52	22	l	l	NOUN
ajlm-1398	52	23	]	]	X
ajlm-1398	52	24	,	,	PUNCT
ajlm-1398	52	25	lloq3	lloq3	NOUN
ajlm-1398	53	1	[	[	X
ajlm-1398	53	2	0.5	0.5	NUM
ajlm-1398	53	3	mg	mg	PROPN
ajlm-1398	53	4	/	/	SYM
ajlm-1398	53	5	l	l	NOUN
ajlm-1398	53	6	]	]	PUNCT
ajlm-1398	53	7	and	and	CCONJ
ajlm-1398	53	8	upper	upper	ADJ
ajlm-1398	53	9	limit	limit	NOUN
ajlm-1398	53	10	of	of	ADP
ajlm-1398	53	11	quantitation	quantitation	NOUN
ajlm-1398	53	12	[	[	X
ajlm-1398	53	13	uloq	uloq	X
ajlm-1398	53	14	]	]	X
ajlm-1398	54	1	[	[	X
ajlm-1398	54	2	4	4	NUM
ajlm-1398	54	3	mg	mg	NUM
ajlm-1398	54	4	/	/	SYM
ajlm-1398	54	5	l	l	NOUN
ajlm-1398	54	6	]	]	PUNCT
ajlm-1398	54	7	)	)	PUNCT
ajlm-1398	54	8	,	,	PUNCT
ajlm-1398	54	9	which	which	PRON
ajlm-1398	54	10	were	be	AUX
ajlm-1398	54	11	analysed	analyse	VERB
ajlm-1398	54	12	in	in	ADP
ajlm-1398	54	13	the	the	DET
ajlm-1398	54	14	same	same	ADJ
ajlm-1398	54	15	way	way	NOUN
ajlm-1398	54	16	as	as	SCONJ
ajlm-1398	54	17	the	the	DET
ajlm-1398	54	18	urine	urine	NOUN
ajlm-1398	54	19	samples	sample	VERB
ajlm-1398	54	20	above	above	ADV
ajlm-1398	54	21	and	and	CCONJ
ajlm-1398	54	22	were	be	AUX
ajlm-1398	54	23	used	use	VERB
ajlm-1398	54	24	to	to	PART
ajlm-1398	54	25	assess	assess	VERB
ajlm-1398	54	26	the	the	DET
ajlm-1398	54	27	performance	performance	NOUN
ajlm-1398	54	28	(	(	PUNCT
ajlm-1398	54	29	linearity	linearity	NOUN
ajlm-1398	54	30	,	,	PUNCT
ajlm-1398	54	31	accuracy	accuracy	NOUN
ajlm-1398	54	32	,	,	PUNCT
ajlm-1398	54	33	precision	precision	NOUN
ajlm-1398	54	34	,	,	PUNCT
ajlm-1398	54	35	and	and	CCONJ
ajlm-1398	54	36	percentage	percentage	NOUN
ajlm-1398	54	37	recovery	recovery	NOUN
ajlm-1398	54	38	)	)	PUNCT
ajlm-1398	54	39	of	of	ADP
ajlm-1398	54	40	the	the	DET
ajlm-1398	54	41	method	method	NOUN
ajlm-1398	54	42	.	.	PUNCT
ajlm-1398	55	1	the	the	DET
ajlm-1398	55	2	thermo	thermo	NOUN
ajlm-1398	55	3	scientifictm	scientifictm	NOUN
ajlm-1398	55	4	ultimatetm	ultimatetm	NOUN
ajlm-1398	55	5	3000	3000	NUM
ajlm-1398	55	6	uhplc	uhplc	NOUN
ajlm-1398	55	7	system	system	NOUN
ajlm-1398	55	8	coupled	couple	VERB
ajlm-1398	55	9	to	to	ADP
ajlm-1398	55	10	a	a	DET
ajlm-1398	55	11	bruker	bruker	ADJ
ajlm-1398	55	12	compact	compact	ADJ
ajlm-1398	55	13	qq	qq	ADJ
ajlm-1398	55	14	-	-	NOUN
ajlm-1398	55	15	time	time	NOUN
ajlm-1398	55	16	-	-	PUNCT
ajlm-1398	55	17	of	of	ADP
ajlm-1398	55	18	-	-	PUNCT
ajlm-1398	55	19	flight	flight	NOUN
ajlm-1398	55	20	high	high	ADJ
ajlm-1398	55	21	-	-	PUNCT
ajlm-1398	55	22	resolution	resolution	NOUN
ajlm-1398	55	23	mass	mass	NOUN
ajlm-1398	55	24	spectrometer	spectrometer	NOUN
ajlm-1398	55	25	(	(	PUNCT
ajlm-1398	55	26	bruker	bruker	PROPN
ajlm-1398	55	27	daltonics	daltonic	NOUN
ajlm-1398	55	28	,	,	PUNCT
ajlm-1398	55	29	bremen	breman	NOUN
ajlm-1398	55	30	,	,	PUNCT
ajlm-1398	55	31	germany	germany	PROPN
ajlm-1398	55	32	)	)	PUNCT
ajlm-1398	55	33	was	be	AUX
ajlm-1398	55	34	used	use	VERB
ajlm-1398	55	35	for	for	ADP
ajlm-1398	55	36	the	the	DET
ajlm-1398	55	37	analysis	analysis	NOUN
ajlm-1398	55	38	.	.	PUNCT
ajlm-1398	56	1	the	the	DET
ajlm-1398	56	2	samples	sample	NOUN
ajlm-1398	56	3	and	and	CCONJ
ajlm-1398	56	4	standards	standard	NOUN
ajlm-1398	56	5	were	be	AUX
ajlm-1398	56	6	placed	place	VERB
ajlm-1398	56	7	in	in	ADP
ajlm-1398	56	8	an	an	DET
ajlm-1398	56	9	autosampler	autosampler	NOUN
ajlm-1398	56	10	set	set	VERB
ajlm-1398	56	11	at	at	ADP
ajlm-1398	56	12	5	5	NUM
ajlm-1398	56	13	°	°	NOUN
ajlm-1398	56	14	c	c	NOUN
ajlm-1398	56	15	.	.	PUNCT
ajlm-1398	57	1	a	a	DET
ajlm-1398	57	2	two	two	NUM
ajlm-1398	57	3	-	-	PUNCT
ajlm-1398	57	4	buffer	buffer	NOUN
ajlm-1398	57	5	system	system	NOUN
ajlm-1398	57	6	was	be	AUX
ajlm-1398	57	7	employed	employ	VERB
ajlm-1398	57	8	,	,	PUNCT
ajlm-1398	57	9	utilising	utilise	VERB
ajlm-1398	57	10	formic	formic	ADJ
ajlm-1398	57	11	acid	acid	NOUN
ajlm-1398	57	12	as	as	ADP
ajlm-1398	57	13	the	the	DET
ajlm-1398	57	14	ion	ion	NOUN
ajlm-1398	57	15	-	-	PUNCT
ajlm-1398	57	16	pairing	pair	VERB
ajlm-1398	57	17	agent	agent	NOUN
ajlm-1398	57	18	;	;	PUNCT
ajlm-1398	57	19	solvent	solvent	NOUN
ajlm-1398	57	20	a	a	DET
ajlm-1398	57	21	consisted	consist	VERB
ajlm-1398	57	22	of	of	ADP
ajlm-1398	57	23	0.1	0.1	NUM
ajlm-1398	57	24	%	%	NOUN
ajlm-1398	57	25	formic	formic	ADJ
ajlm-1398	57	26	acid	acid	NOUN
ajlm-1398	57	27	in	in	ADP
ajlm-1398	57	28	h2o	h2o	PROPN
ajlm-1398	57	29	(	(	PUNCT
ajlm-1398	57	30	volume	volume	NOUN
ajlm-1398	57	31	per	per	ADP
ajlm-1398	57	32	volume	volume	NOUN
ajlm-1398	57	33	)	)	PUNCT
ajlm-1398	57	34	,	,	PUNCT
ajlm-1398	57	35	and	and	CCONJ
ajlm-1398	57	36	solvent	solvent	PROPN
ajlm-1398	57	37	b	b	PROPN
ajlm-1398	57	38	comprised	comprise	VERB
ajlm-1398	57	39	0.1	0.1	NUM
ajlm-1398	57	40	%	%	NOUN
ajlm-1398	57	41	formic	formic	ADJ
ajlm-1398	57	42	acid	acid	NOUN
ajlm-1398	57	43	in	in	ADP
ajlm-1398	57	44	acetonitrile	acetonitrile	NOUN
ajlm-1398	57	45	(	(	PUNCT
ajlm-1398	57	46	volume	volume	NOUN
ajlm-1398	57	47	per	per	ADP
ajlm-1398	57	48	volume	volume	NOUN
ajlm-1398	57	49	)	)	PUNCT
ajlm-1398	57	50	.	.	PUNCT
ajlm-1398	58	1	twenty	twenty	NUM
ajlm-1398	58	2	µl	µl	NOUN
ajlm-1398	58	3	of	of	ADP
ajlm-1398	58	4	the	the	DET
ajlm-1398	58	5	sample	sample	NOUN
ajlm-1398	58	6	was	be	AUX
ajlm-1398	58	7	injected	inject	VERB
ajlm-1398	58	8	into	into	ADP
ajlm-1398	58	9	the	the	DET
ajlm-1398	58	10	c18	c18	NOUN
ajlm-1398	58	11	uhplc	uhplc	VERB
ajlm-1398	58	12	column	column	NOUN
ajlm-1398	58	13	and	and	CCONJ
ajlm-1398	58	14	eluted	elute	VERB
ajlm-1398	58	15	using	use	VERB
ajlm-1398	58	16	a	a	DET
ajlm-1398	58	17	gradient	gradient	ADJ
ajlm-1398	58	18	elution	elution	NOUN
ajlm-1398	58	19	technique	technique	NOUN
ajlm-1398	58	20	,	,	PUNCT
ajlm-1398	58	21	starting	start	VERB
ajlm-1398	58	22	from	from	ADP
ajlm-1398	58	23	an	an	DET
ajlm-1398	58	24	h2o	h2o	NOUN
ajlm-1398	58	25	:	:	PUNCT
ajlm-1398	58	26	acetonitrile	acetonitrile	ADJ
ajlm-1398	58	27	ratio	ratio	NOUN
ajlm-1398	58	28	of	of	ADP
ajlm-1398	58	29	95:5	95:5	NUM
ajlm-1398	58	30	%	%	NOUN
ajlm-1398	58	31	to	to	ADP
ajlm-1398	58	32	5:95	5:95	NUM
ajlm-1398	58	33	%	%	NOUN
ajlm-1398	58	34	in	in	ADP
ajlm-1398	58	35	10	10	NUM
ajlm-1398	58	36	min	min	NOUN
ajlm-1398	58	37	;	;	PUNCT
ajlm-1398	58	38	the	the	DET
ajlm-1398	58	39	standards	standard	NOUN
ajlm-1398	58	40	and	and	CCONJ
ajlm-1398	58	41	samples	sample	NOUN
ajlm-1398	58	42	were	be	AUX
ajlm-1398	58	43	injected	inject	VERB
ajlm-1398	58	44	three	three	NUM
ajlm-1398	58	45	times	time	NOUN
ajlm-1398	58	46	.	.	PUNCT
ajlm-1398	59	1	mass	mass	ADJ
ajlm-1398	59	2	spectrometry	spectrometry	NOUN
ajlm-1398	59	3	parameters	parameter	NOUN
ajlm-1398	59	4	the	the	DET
ajlm-1398	59	5	electrospray	electrospray	NOUN
ajlm-1398	59	6	ionisation	ionisation	NOUN
ajlm-1398	59	7	source	source	NOUN
ajlm-1398	59	8	was	be	AUX
ajlm-1398	59	9	operated	operate	VERB
ajlm-1398	59	10	in	in	ADP
ajlm-1398	59	11	the	the	DET
ajlm-1398	59	12	positive	positive	ADJ
ajlm-1398	59	13	ionisation	ionisation	NOUN
ajlm-1398	59	14	mode	mode	NOUN
ajlm-1398	59	15	at	at	ADP
ajlm-1398	59	16	a	a	DET
ajlm-1398	59	17	temperature	temperature	NOUN
ajlm-1398	59	18	of	of	ADP
ajlm-1398	59	19	250	250	NUM
ajlm-1398	59	20	°	°	NOUN
ajlm-1398	59	21	c	c	NOUN
ajlm-1398	59	22	.	.	PUNCT
ajlm-1398	60	1	the	the	DET
ajlm-1398	60	2	dry	dry	ADJ
ajlm-1398	60	3	gas	gas	NOUN
ajlm-1398	60	4	(	(	PUNCT
ajlm-1398	60	5	n2	n2	NOUN
ajlm-1398	60	6	)	)	PUNCT
ajlm-1398	60	7	flow	flow	NOUN
ajlm-1398	60	8	rate	rate	NOUN
ajlm-1398	60	9	was	be	AUX
ajlm-1398	60	10	set	set	VERB
ajlm-1398	60	11	at	at	ADP
ajlm-1398	60	12	9.0	9.0	NUM
ajlm-1398	60	13	l	l	NOUN
ajlm-1398	60	14	/	/	SYM
ajlm-1398	60	15	min	min	PROPN
ajlm-1398	60	16	,	,	PUNCT
ajlm-1398	60	17	the	the	DET
ajlm-1398	60	18	nebuliser	nebuliser	NOUN
ajlm-1398	60	19	gas	gas	NOUN
ajlm-1398	60	20	(	(	PUNCT
ajlm-1398	60	21	n2	n2	NOUN
ajlm-1398	60	22	)	)	PUNCT
ajlm-1398	60	23	pressure	pressure	NOUN
ajlm-1398	60	24	was	be	AUX
ajlm-1398	60	25	set	set	VERB
ajlm-1398	60	26	to	to	ADP
ajlm-1398	60	27	1.8	1.8	NUM
ajlm-1398	60	28	bars	bar	NOUN
ajlm-1398	60	29	,	,	PUNCT
ajlm-1398	60	30	the	the	DET
ajlm-1398	60	31	capillary	capillary	ADJ
ajlm-1398	60	32	voltage	voltage	NOUN
ajlm-1398	60	33	was	be	AUX
ajlm-1398	60	34	4500	4500	NUM
ajlm-1398	60	35	v	v	NOUN
ajlm-1398	60	36	,	,	PUNCT
ajlm-1398	60	37	the	the	DET
ajlm-1398	60	38	end	end	NOUN
ajlm-1398	60	39	plate	plate	NOUN
ajlm-1398	60	40	offset	offset	NOUN
ajlm-1398	60	41	was	be	AUX
ajlm-1398	60	42	-500	-500	NUM
ajlm-1398	60	43	v	v	NOUN
ajlm-1398	60	44	,	,	PUNCT
ajlm-1398	60	45	and	and	CCONJ
ajlm-1398	60	46	the	the	DET
ajlm-1398	60	47	charging	charge	VERB
ajlm-1398	60	48	voltage	voltage	NOUN
ajlm-1398	60	49	was	be	AUX
ajlm-1398	60	50	2000	2000	NUM
ajlm-1398	60	51	v.	v.	ADP
ajlm-1398	60	52	in	in	ADP
ajlm-1398	60	53	the	the	DET
ajlm-1398	60	54	quadrupole	quadrupole	NOUN
ajlm-1398	60	55	,	,	PUNCT
ajlm-1398	60	56	a	a	DET
ajlm-1398	60	57	multiple	multiple	ADJ
ajlm-1398	60	58	reaction	reaction	NOUN
ajlm-1398	60	59	monitoring	monitoring	NOUN
ajlm-1398	60	60	method	method	NOUN
ajlm-1398	60	61	was	be	AUX
ajlm-1398	60	62	applied	apply	VERB
ajlm-1398	60	63	with	with	ADP
ajlm-1398	60	64	a	a	DET
ajlm-1398	60	65	mass	mass	ADJ
ajlm-1398	60	66	range	range	NOUN
ajlm-1398	60	67	of	of	ADP
ajlm-1398	60	68	50	50	NUM
ajlm-1398	60	69	mass	mass	NOUN
ajlm-1398	60	70	-	-	PUNCT
ajlm-1398	60	71	to	to	ADP
ajlm-1398	60	72	-	-	PUNCT
ajlm-1398	60	73	charge	charge	NOUN
ajlm-1398	60	74	ratio	ratio	NOUN
ajlm-1398	60	75	(	(	PUNCT
ajlm-1398	60	76	m	m	PROPN
ajlm-1398	60	77	/	/	SYM
ajlm-1398	60	78	z	z	NOUN
ajlm-1398	60	79	)	)	PUNCT
ajlm-1398	60	80	to	to	ADP
ajlm-1398	60	81	1300	1300	NUM
ajlm-1398	60	82	m	m	NOUN
ajlm-1398	60	83	/	/	SYM
ajlm-1398	60	84	z	z	NOUN
ajlm-1398	60	85	to	to	PART
ajlm-1398	60	86	fragment	fragment	VERB
ajlm-1398	60	87	arginine	arginine	NOUN
ajlm-1398	60	88	(	(	PUNCT
ajlm-1398	60	89	175	175	NUM
ajlm-1398	60	90	m	m	PROPN
ajlm-1398	60	91	/	/	SYM
ajlm-1398	60	92	z	z	NOUN
ajlm-1398	60	93	)	)	PUNCT
ajlm-1398	60	94	,	,	PUNCT
ajlm-1398	60	95	citrulline	citrulline	NOUN
ajlm-1398	60	96	(	(	PUNCT
ajlm-1398	60	97	176	176	NUM
ajlm-1398	60	98	m	m	PROPN
ajlm-1398	60	99	/	/	SYM
ajlm-1398	60	100	z	z	NOUN
ajlm-1398	60	101	)	)	PUNCT
ajlm-1398	60	102	,	,	PUNCT
ajlm-1398	60	103	isoleucine	isoleucine	NOUN
ajlm-1398	60	104	(	(	PUNCT
ajlm-1398	60	105	132	132	NUM
ajlm-1398	60	106	m	m	NOUN
ajlm-1398	60	107	/	/	SYM
ajlm-1398	60	108	z	z	NOUN
ajlm-1398	60	109	)	)	PUNCT
ajlm-1398	60	110	,	,	PUNCT
ajlm-1398	60	111	ornithine	ornithine	NOUN
ajlm-1398	60	112	(	(	PUNCT
ajlm-1398	60	113	133	133	NUM
ajlm-1398	60	114	m	m	PROPN
ajlm-1398	60	115	/	/	SYM
ajlm-1398	60	116	z	z	NOUN
ajlm-1398	60	117	)	)	PUNCT
ajlm-1398	60	118	,	,	PUNCT
ajlm-1398	60	119	phenylalanine	phenylalanine	NOUN
ajlm-1398	60	120	(	(	PUNCT
ajlm-1398	60	121	166	166	NUM
ajlm-1398	60	122	m	m	PROPN
ajlm-1398	60	123	/	/	SYM
ajlm-1398	60	124	z	z	NOUN
ajlm-1398	60	125	)	)	PUNCT
ajlm-1398	60	126	,	,	PUNCT
ajlm-1398	60	127	and	and	CCONJ
ajlm-1398	60	128	tyrosine	tyrosine	NOUN
ajlm-1398	60	129	(	(	PUNCT
ajlm-1398	60	130	182	182	NUM
ajlm-1398	60	131	m	m	NOUN
ajlm-1398	60	132	/	/	SYM
ajlm-1398	60	133	z	z	NOUN
ajlm-1398	60	134	)	)	PUNCT
ajlm-1398	60	135	at	at	ADP
ajlm-1398	60	136	26.00	26.00	NUM
ajlm-1398	60	137	,	,	PUNCT
ajlm-1398	60	138	14.00	14.00	NUM
ajlm-1398	60	139	,	,	PUNCT
ajlm-1398	60	140	22.00	22.00	NUM
ajlm-1398	60	141	,	,	PUNCT
ajlm-1398	60	142	12.00	12.00	NUM
ajlm-1398	60	143	,	,	PUNCT
ajlm-1398	60	144	15.00	15.00	NUM
ajlm-1398	60	145	and	and	CCONJ
ajlm-1398	60	146	12.00	12.00	NUM
ajlm-1398	60	147	ev	ev	ADP
ajlm-1398	60	148	collision	collision	NOUN
ajlm-1398	60	149	energies	energy	NOUN
ajlm-1398	60	150	.	.	PUNCT
ajlm-1398	61	1	the	the	DET
ajlm-1398	61	2	time	time	NOUN
ajlm-1398	61	3	-	-	PUNCT
ajlm-1398	61	4	of	of	ADP
ajlm-1398	61	5	-	-	PUNCT
ajlm-1398	61	6	flight	flight	NOUN
ajlm-1398	61	7	detector	detector	NOUN
ajlm-1398	61	8	voltage	voltage	NOUN
ajlm-1398	61	9	was	be	AUX
ajlm-1398	61	10	set	set	VERB
ajlm-1398	61	11	at	at	ADP
ajlm-1398	61	12	2242.9	2242.9	NUM
ajlm-1398	61	13	v.	v.	ADP
ajlm-1398	61	14	data	datum	NOUN
ajlm-1398	61	15	analysis	analysis	NOUN
ajlm-1398	61	16	all	all	DET
ajlm-1398	61	17	data	datum	NOUN
ajlm-1398	61	18	processing	processing	NOUN
ajlm-1398	61	19	was	be	AUX
ajlm-1398	61	20	done	do	VERB
ajlm-1398	61	21	on	on	ADP
ajlm-1398	61	22	the	the	DET
ajlm-1398	61	23	bruker	bruker	NOUN
ajlm-1398	61	24	quantanalysis	quantanalysis	NOUN
ajlm-1398	61	25	software	software	NOUN
ajlm-1398	61	26	(	(	PUNCT
ajlm-1398	61	27	bruker	bruker	PROPN
ajlm-1398	61	28	daltonics	daltonic	NOUN
ajlm-1398	61	29	,	,	PUNCT
ajlm-1398	61	30	bremen	breman	NOUN
ajlm-1398	61	31	,	,	PUNCT
ajlm-1398	61	32	germany	germany	PROPN
ajlm-1398	61	33	)	)	PUNCT
ajlm-1398	61	34	to	to	PART
ajlm-1398	61	35	determine	determine	VERB
ajlm-1398	61	36	the	the	DET
ajlm-1398	61	37	concentration	concentration	NOUN
ajlm-1398	61	38	of	of	ADP
ajlm-1398	61	39	amino	amino	ADJ
ajlm-1398	61	40	acids	acid	NOUN
ajlm-1398	61	41	.	.	PUNCT
ajlm-1398	62	1	the	the	DET
ajlm-1398	62	2	dilution	dilution	NOUN
ajlm-1398	62	3	factor	factor	NOUN
ajlm-1398	62	4	of	of	ADP
ajlm-1398	62	5	10	10	NUM
ajlm-1398	62	6	was	be	AUX
ajlm-1398	62	7	used	use	VERB
ajlm-1398	62	8	to	to	PART
ajlm-1398	62	9	determine	determine	VERB
ajlm-1398	62	10	the	the	DET
ajlm-1398	62	11	actual	actual	ADJ
ajlm-1398	62	12	concentration	concentration	NOUN
ajlm-1398	62	13	of	of	ADP
ajlm-1398	62	14	amino	amino	ADJ
ajlm-1398	62	15	acids	acid	NOUN
ajlm-1398	62	16	in	in	ADP
ajlm-1398	62	17	the	the	DET
ajlm-1398	62	18	urine	urine	NOUN
ajlm-1398	62	19	samples	sample	NOUN
ajlm-1398	62	20	.	.	PUNCT
ajlm-1398	63	1	the	the	DET
ajlm-1398	63	2	lloq	lloq	NOUN
ajlm-1398	63	3	was	be	AUX
ajlm-1398	63	4	determined	determine	VERB
ajlm-1398	63	5	for	for	ADP
ajlm-1398	63	6	each	each	DET
ajlm-1398	63	7	amino	amino	NOUN
ajlm-1398	63	8	acid	acid	NOUN
ajlm-1398	63	9	and	and	CCONJ
ajlm-1398	63	10	found	find	VERB
ajlm-1398	63	11	to	to	PART
ajlm-1398	63	12	be	be	AUX
ajlm-1398	63	13	within	within	ADP
ajlm-1398	63	14	the	the	DET
ajlm-1398	63	15	range	range	NOUN
ajlm-1398	63	16	of	of	ADP
ajlm-1398	63	17	0.52	0.52	NUM
ajlm-1398	63	18	mg	mg	PROPN
ajlm-1398	63	19	/	/	SYM
ajlm-1398	63	20	l	l	NOUN
ajlm-1398	63	21	to	to	ADP
ajlm-1398	63	22	0.58	0.58	NUM
ajlm-1398	63	23	mg	mg	PROPN
ajlm-1398	63	24	/	/	SYM
ajlm-1398	63	25	l	l	NOUN
ajlm-1398	63	26	for	for	ADP
ajlm-1398	63	27	arginine	arginine	NOUN
ajlm-1398	63	28	,	,	PUNCT
ajlm-1398	63	29	citrulline	citrulline	NOUN
ajlm-1398	63	30	,	,	PUNCT
ajlm-1398	63	31	and	and	CCONJ
ajlm-1398	63	32	ornithine	ornithine	NOUN
ajlm-1398	63	33	and	and	CCONJ
ajlm-1398	63	34	0.12	0.12	NUM
ajlm-1398	63	35	mg	mg	PROPN
ajlm-1398	63	36	/	/	SYM
ajlm-1398	63	37	l	l	NOUN
ajlm-1398	63	38	to	to	ADP
ajlm-1398	63	39	0.19	0.19	NUM
ajlm-1398	63	40	mg	mg	PROPN
ajlm-1398	63	41	/	/	SYM
ajlm-1398	63	42	l	l	NOUN
ajlm-1398	63	43	for	for	ADP
ajlm-1398	63	44	isoleucine	isoleucine	NOUN
ajlm-1398	63	45	,	,	PUNCT
ajlm-1398	63	46	phenylalanine	phenylalanine	NOUN
ajlm-1398	63	47	,	,	PUNCT
ajlm-1398	63	48	and	and	CCONJ
ajlm-1398	63	49	tyrosine	tyrosine	NOUN
ajlm-1398	63	50	(	(	PUNCT
ajlm-1398	63	51	table	table	NOUN
ajlm-1398	63	52	1	1	NUM
ajlm-1398	63	53	)	)	PUNCT
ajlm-1398	63	54	.	.	PUNCT
ajlm-1398	64	1	statistical	statistical	ADJ
ajlm-1398	64	2	data	datum	NOUN
ajlm-1398	64	3	analysis	analysis	NOUN
ajlm-1398	64	4	was	be	AUX
ajlm-1398	64	5	carried	carry	VERB
ajlm-1398	64	6	out	out	ADP
ajlm-1398	64	7	in	in	ADP
ajlm-1398	64	8	microsoft	microsoft	PROPN
ajlm-1398	64	9	excel	excel	PROPN
ajlm-1398	64	10	version	version	NOUN
ajlm-1398	64	11	2101	2101	NUM
ajlm-1398	64	12	(	(	PUNCT
ajlm-1398	64	13	microsoft	microsoft	PROPN
ajlm-1398	64	14	corporation	corporation	PROPN
ajlm-1398	64	15	,	,	PUNCT
ajlm-1398	64	16	redmond	redmond	PROPN
ajlm-1398	64	17	,	,	PUNCT
ajlm-1398	64	18	washington	washington	PROPN
ajlm-1398	64	19	,	,	PUNCT
ajlm-1398	64	20	united	united	PROPN
ajlm-1398	64	21	states	states	PROPN
ajlm-1398	64	22	)	)	PUNCT
ajlm-1398	64	23	.	.	PUNCT
ajlm-1398	65	1	mean	mean	VERB
ajlm-1398	65	2	and	and	CCONJ
ajlm-1398	65	3	standard	standard	ADJ
ajlm-1398	65	4	deviation	deviation	NOUN
ajlm-1398	65	5	values	value	NOUN
ajlm-1398	65	6	were	be	AUX
ajlm-1398	65	7	obtained	obtain	VERB
ajlm-1398	65	8	using	use	VERB
ajlm-1398	65	9	descriptive	descriptive	ADJ
ajlm-1398	65	10	statistics	statistic	NOUN
ajlm-1398	65	11	,	,	PUNCT
ajlm-1398	65	12	significant	significant	ADJ
ajlm-1398	65	13	differences	difference	NOUN
ajlm-1398	65	14	in	in	ADP
ajlm-1398	65	15	variables	variable	NOUN
ajlm-1398	65	16	between	between	ADP
ajlm-1398	65	17	diabetic	diabetic	ADJ
ajlm-1398	65	18	and	and	CCONJ
ajlm-1398	65	19	non	non	ADJ
ajlm-1398	65	20	-	-	ADJ
ajlm-1398	65	21	diabetic	diabetic	ADJ
ajlm-1398	65	22	patients	patient	NOUN
ajlm-1398	65	23	were	be	AUX
ajlm-1398	65	24	assessed	assess	VERB
ajlm-1398	65	25	using	use	VERB
ajlm-1398	65	26	analysis	analysis	NOUN
ajlm-1398	65	27	of	of	ADP
ajlm-1398	65	28	variance	variance	NOUN
ajlm-1398	65	29	,	,	PUNCT
ajlm-1398	65	30	and	and	CCONJ
ajlm-1398	65	31	linear	linear	ADJ
ajlm-1398	65	32	correlations	correlation	NOUN
ajlm-1398	65	33	between	between	ADP
ajlm-1398	65	34	biochemical	biochemical	ADJ
ajlm-1398	65	35	and	and	CCONJ
ajlm-1398	65	36	analytical	analytical	ADJ
ajlm-1398	65	37	data	datum	NOUN
ajlm-1398	65	38	were	be	AUX
ajlm-1398	65	39	determined	determine	VERB
ajlm-1398	65	40	using	use	VERB
ajlm-1398	65	41	pearson	pearson	PROPN
ajlm-1398	65	42	’s	’s	PART
ajlm-1398	65	43	correlation	correlation	NOUN
ajlm-1398	65	44	coefficient	coefficient	NOUN
ajlm-1398	65	45	(	(	PUNCT
ajlm-1398	65	46	r	r	NOUN
ajlm-1398	65	47	)	)	PUNCT
ajlm-1398	65	48	.	.	PUNCT
ajlm-1398	66	1	a	a	DET
ajlm-1398	66	2	p	p	NOUN
ajlm-1398	66	3	-	-	PUNCT
ajlm-1398	66	4	value	value	NOUN
ajlm-1398	66	5	0.05	0.05	NUM
ajlm-1398	66	6	or	or	CCONJ
ajlm-1398	66	7	less	less	ADJ
ajlm-1398	66	8	was	be	AUX
ajlm-1398	66	9	considered	consider	VERB
ajlm-1398	66	10	significant	significant	ADJ
ajlm-1398	66	11	.	.	PUNCT
ajlm-1398	67	1	table	table	NOUN
ajlm-1398	67	2	1	1	NUM
ajlm-1398	67	3	:	:	PUNCT
ajlm-1398	67	4	 	 	SPACE
ajlm-1398	67	5	analytical	analytical	ADJ
ajlm-1398	67	6	method	method	NOUN
ajlm-1398	67	7	performance	performance	NOUN
ajlm-1398	67	8	characteristics	characteristic	NOUN
ajlm-1398	67	9	of	of	ADP
ajlm-1398	67	10	three	three	NUM
ajlm-1398	67	11	spiked	spiked	ADJ
ajlm-1398	67	12	blank	blank	ADJ
ajlm-1398	67	13	matrices	matrix	NOUN
ajlm-1398	67	14	with	with	ADP
ajlm-1398	67	15	amino	amino	NOUN
ajlm-1398	67	16	acid	acid	NOUN
ajlm-1398	67	17	standards	standard	NOUN
ajlm-1398	67	18	at	at	ADP
ajlm-1398	67	19	different	different	ADJ
ajlm-1398	67	20	concentrations	concentration	NOUN
ajlm-1398	67	21	,	,	PUNCT
ajlm-1398	67	22	johannesburg	johannesburg	PROPN
ajlm-1398	67	23	,	,	PUNCT
ajlm-1398	67	24	south	south	PROPN
ajlm-1398	67	25	africa	africa	PROPN
ajlm-1398	67	26	,	,	PUNCT
ajlm-1398	67	27	november	november	PROPN
ajlm-1398	67	28	2019	2019	NUM
ajlm-1398	67	29	to	to	ADP
ajlm-1398	67	30	january	january	PROPN
ajlm-1398	67	31	2021	2021	NUM
ajlm-1398	67	32	.	.	PUNCT
ajlm-1398	68	1	results	result	VERB
ajlm-1398	68	2	all	all	DET
ajlm-1398	68	3	amino	amino	ADJ
ajlm-1398	68	4	acids	acid	NOUN
ajlm-1398	68	5	were	be	AUX
ajlm-1398	68	6	well	well	ADV
ajlm-1398	68	7	separated	separate	VERB
ajlm-1398	68	8	on	on	ADP
ajlm-1398	68	9	the	the	DET
ajlm-1398	68	10	c18	c18	NOUN
ajlm-1398	68	11	column	column	NOUN
ajlm-1398	68	12	and	and	CCONJ
ajlm-1398	68	13	gave	give	VERB
ajlm-1398	68	14	different	different	ADJ
ajlm-1398	68	15	fragment	fragment	ADJ
ajlm-1398	68	16	ions	ion	NOUN
ajlm-1398	68	17	and	and	CCONJ
ajlm-1398	68	18	retention	retention	NOUN
ajlm-1398	68	19	times	time	NOUN
ajlm-1398	68	20	(	(	PUNCT
ajlm-1398	68	21	arginine	arginine	NOUN
ajlm-1398	68	22	,	,	PUNCT
ajlm-1398	68	23	0.81	0.81	NUM
ajlm-1398	68	24	min	min	NOUN
ajlm-1398	68	25	;	;	PUNCT
ajlm-1398	68	26	citrulline	citrulline	NOUN
ajlm-1398	68	27	,	,	PUNCT
ajlm-1398	68	28	0.90	0.90	NUM
ajlm-1398	68	29	min	min	NOUN
ajlm-1398	68	30	;	;	PUNCT
ajlm-1398	68	31	isoleucine	isoleucine	NOUN
ajlm-1398	68	32	,	,	PUNCT
ajlm-1398	68	33	2.10	2.10	NUM
ajlm-1398	68	34	min	min	NOUN
ajlm-1398	68	35	;	;	PUNCT
ajlm-1398	68	36	ornithine	ornithine	NOUN
ajlm-1398	68	37	,	,	PUNCT
ajlm-1398	68	38	0.74	0.74	NUM
ajlm-1398	68	39	min	min	NOUN
ajlm-1398	68	40	;	;	PUNCT
ajlm-1398	68	41	phenylalanine	phenylalanine	NOUN
ajlm-1398	68	42	,	,	PUNCT
ajlm-1398	68	43	4.44	4.44	NUM
ajlm-1398	68	44	min	min	NOUN
ajlm-1398	68	45	and	and	CCONJ
ajlm-1398	68	46	tyrosine	tyrosine	NOUN
ajlm-1398	68	47	,	,	PUNCT
ajlm-1398	68	48	2.96	2.96	NUM
ajlm-1398	68	49	min	min	NOUN
ajlm-1398	68	50	)	)	PUNCT
ajlm-1398	68	51	,	,	PUNCT
ajlm-1398	68	52	indicating	indicate	VERB
ajlm-1398	68	53	good	good	ADJ
ajlm-1398	68	54	selectivity	selectivity	NOUN
ajlm-1398	68	55	(	(	PUNCT
ajlm-1398	68	56	figure	figure	NOUN
ajlm-1398	68	57	1	1	NUM
ajlm-1398	68	58	)	)	PUNCT
ajlm-1398	68	59	.	.	PUNCT
ajlm-1398	69	1	figure	figure	NOUN
ajlm-1398	69	2	1	1	NUM
ajlm-1398	69	3	:	:	PUNCT
ajlm-1398	69	4	chromatogram	chromatogram	PROPN
ajlm-1398	69	5	showing	showing	NOUN
ajlm-1398	69	6	(	(	PUNCT
ajlm-1398	69	7	a	a	X
ajlm-1398	69	8	)	)	PUNCT
ajlm-1398	69	9	the	the	DET
ajlm-1398	69	10	uhplc	uhplc	PROPN
ajlm-1398	69	11	baseline	baseline	PROPN
ajlm-1398	69	12	separation	separation	NOUN
ajlm-1398	69	13	of	of	ADP
ajlm-1398	69	14	arginine	arginine	NOUN
ajlm-1398	69	15	,	,	PUNCT
ajlm-1398	69	16	citrulline	citrulline	NOUN
ajlm-1398	69	17	,	,	PUNCT
ajlm-1398	69	18	isoleucine	isoleucine	NOUN
ajlm-1398	69	19	,	,	PUNCT
ajlm-1398	69	20	ornithine	ornithine	NOUN
ajlm-1398	69	21	,	,	PUNCT
ajlm-1398	69	22	phenylalanine	phenylalanine	NOUN
ajlm-1398	69	23	and	and	CCONJ
ajlm-1398	69	24	tyrosine	tyrosine	NOUN
ajlm-1398	69	25	;	;	PUNCT
ajlm-1398	69	26	and	and	CCONJ
ajlm-1398	69	27	(	(	PUNCT
ajlm-1398	69	28	b	b	X
ajlm-1398	69	29	)	)	PUNCT
ajlm-1398	69	30	the	the	DET
ajlm-1398	69	31	mass	mass	NOUN
ajlm-1398	69	32	spectrum	spectrum	NOUN
ajlm-1398	69	33	with	with	ADP
ajlm-1398	69	34	retention	retention	NOUN
ajlm-1398	69	35	times	time	NOUN
ajlm-1398	69	36	and	and	CCONJ
ajlm-1398	69	37	collision	collision	VERB
ajlm-1398	69	38	energy	energy	NOUN
ajlm-1398	69	39	required	require	VERB
ajlm-1398	69	40	to	to	PART
ajlm-1398	69	41	fragment	fragment	VERB
ajlm-1398	69	42	each	each	DET
ajlm-1398	69	43	amino	amino	NOUN
ajlm-1398	69	44	acid	acid	NOUN
ajlm-1398	69	45	to	to	PART
ajlm-1398	69	46	give	give	VERB
ajlm-1398	69	47	the	the	DET
ajlm-1398	69	48	fragment	fragment	ADJ
ajlm-1398	69	49	ions	ion	NOUN
ajlm-1398	69	50	(	(	PUNCT
ajlm-1398	69	51	quant	quant	ADJ
ajlm-1398	69	52	masses	masse	NOUN
ajlm-1398	69	53	)	)	PUNCT
ajlm-1398	69	54	.	.	PUNCT
ajlm-1398	70	1	data	datum	NOUN
ajlm-1398	70	2	analysed	analyse	VERB
ajlm-1398	70	3	between	between	ADP
ajlm-1398	70	4	november	november	PROPN
ajlm-1398	70	5	2019	2019	NUM
ajlm-1398	70	6	and	and	CCONJ
ajlm-1398	70	7	january	january	PROPN
ajlm-1398	70	8	2021	2021	NUM
ajlm-1398	70	9	,	,	PUNCT
ajlm-1398	70	10	johannesburg	johannesburg	PROPN
ajlm-1398	70	11	,	,	PUNCT
ajlm-1398	70	12	south	south	PROPN
ajlm-1398	70	13	africa	africa	PROPN
ajlm-1398	70	14	.	.	PUNCT
ajlm-1398	71	1	in	in	ADP
ajlm-1398	71	2	diabetic	diabetic	ADJ
ajlm-1398	71	3	patients	patient	NOUN
ajlm-1398	71	4	,	,	PUNCT
ajlm-1398	71	5	the	the	DET
ajlm-1398	71	6	ornithine	ornithine	NOUN
ajlm-1398	71	7	/	/	SYM
ajlm-1398	71	8	arginine	arginine	NOUN
ajlm-1398	71	9	and	and	CCONJ
ajlm-1398	71	10	tyrosine	tyrosine	NOUN
ajlm-1398	71	11	/	/	SYM
ajlm-1398	71	12	phenylalanine	phenylalanine	NOUN
ajlm-1398	71	13	ratios	ratio	NOUN
ajlm-1398	71	14	increased	increase	VERB
ajlm-1398	71	15	as	as	SCONJ
ajlm-1398	71	16	the	the	DET
ajlm-1398	71	17	egfr	egfr	NOUN
ajlm-1398	71	18	decreased	decrease	VERB
ajlm-1398	71	19	(	(	PUNCT
ajlm-1398	71	20	table	table	NOUN
ajlm-1398	71	21	2	2	NUM
ajlm-1398	71	22	)	)	PUNCT
ajlm-1398	71	23	.	.	PUNCT
ajlm-1398	72	1	this	this	DET
ajlm-1398	72	2	relationship	relationship	NOUN
ajlm-1398	72	3	was	be	AUX
ajlm-1398	72	4	confirmed	confirm	VERB
ajlm-1398	72	5	by	by	ADP
ajlm-1398	72	6	strong	strong	ADJ
ajlm-1398	72	7	negative	negative	ADJ
ajlm-1398	72	8	correlations	correlation	NOUN
ajlm-1398	72	9	(	(	PUNCT
ajlm-1398	72	10	r	r	NOUN
ajlm-1398	72	11	=	=	PUNCT
ajlm-1398	72	12	–	–	PUNCT
ajlm-1398	72	13	0.81	0.81	NUM
ajlm-1398	72	14	;	;	PUNCT
ajlm-1398	72	15	p	p	X
ajlm-1398	72	16	=	=	PROPN
ajlm-1398	72	17	0.19	0.19	NUM
ajlm-1398	72	18	and	and	CCONJ
ajlm-1398	72	19	r	r	NOUN
ajlm-1398	72	20	=	=	PUNCT
ajlm-1398	72	21	–	–	PUNCT
ajlm-1398	72	22	0.96	0.96	NUM
ajlm-1398	72	23	;	;	PUNCT
ajlm-1398	72	24	p	p	X
ajlm-1398	72	25	=	=	NOUN
ajlm-1398	72	26	0.04	0.04	NUM
ajlm-1398	72	27	)	)	PUNCT
ajlm-1398	72	28	between	between	ADP
ajlm-1398	72	29	the	the	DET
ajlm-1398	72	30	amino	amino	NOUN
ajlm-1398	72	31	acid	acid	NOUN
ajlm-1398	72	32	concentration	concentration	NOUN
ajlm-1398	72	33	ratios	ratio	NOUN
ajlm-1398	72	34	and	and	CCONJ
ajlm-1398	72	35	the	the	DET
ajlm-1398	72	36	egfr	egfr	NOUN
ajlm-1398	72	37	.	.	PUNCT
ajlm-1398	73	1	conversely	conversely	ADV
ajlm-1398	73	2	,	,	PUNCT
ajlm-1398	73	3	the	the	DET
ajlm-1398	73	4	arginine	arginine	NOUN
ajlm-1398	73	5	/	/	SYM
ajlm-1398	73	6	citrulline	citrulline	NOUN
ajlm-1398	73	7	ratio	ratio	NOUN
ajlm-1398	73	8	decreased	decrease	VERB
ajlm-1398	73	9	with	with	ADP
ajlm-1398	73	10	decreasing	decrease	VERB
ajlm-1398	73	11	egfr	egfr	NOUN
ajlm-1398	73	12	,	,	PUNCT
ajlm-1398	73	13	and	and	CCONJ
ajlm-1398	73	14	this	this	PRON
ajlm-1398	73	15	was	be	AUX
ajlm-1398	73	16	supported	support	VERB
ajlm-1398	73	17	by	by	ADP
ajlm-1398	73	18	a	a	DET
ajlm-1398	73	19	statistically	statistically	ADV
ajlm-1398	73	20	significant	significant	ADJ
ajlm-1398	73	21	positive	positive	ADJ
ajlm-1398	73	22	correlation	correlation	NOUN
ajlm-1398	73	23	(	(	PUNCT
ajlm-1398	73	24	r	r	NOUN
ajlm-1398	73	25	=	=	SYM
ajlm-1398	73	26	0.71	0.71	NUM
ajlm-1398	73	27	;	;	PUNCT
ajlm-1398	73	28	p	p	X
ajlm-1398	73	29	=	=	NOUN
ajlm-1398	73	30	0.29	0.29	NUM
ajlm-1398	73	31	)	)	PUNCT
ajlm-1398	73	32	.	.	PUNCT
ajlm-1398	74	1	the	the	DET
ajlm-1398	74	2	concentrations	concentration	NOUN
ajlm-1398	74	3	of	of	ADP
ajlm-1398	74	4	ornithine	ornithine	NOUN
ajlm-1398	74	5	,	,	PUNCT
ajlm-1398	74	6	isoleucine	isoleucine	NOUN
ajlm-1398	74	7	,	,	PUNCT
ajlm-1398	74	8	tyrosine	tyrosine	NOUN
ajlm-1398	74	9	and	and	CCONJ
ajlm-1398	74	10	phenylalanine	phenylalanine	NOUN
ajlm-1398	74	11	decreased	decrease	VERB
ajlm-1398	74	12	with	with	ADP
ajlm-1398	74	13	decreasing	decrease	VERB
ajlm-1398	74	14	renal	renal	ADJ
ajlm-1398	74	15	function	function	NOUN
ajlm-1398	74	16	and	and	CCONJ
ajlm-1398	74	17	this	this	PRON
ajlm-1398	74	18	was	be	AUX
ajlm-1398	74	19	confirmed	confirm	VERB
ajlm-1398	74	20	by	by	ADP
ajlm-1398	74	21	statistically	statistically	ADV
ajlm-1398	74	22	significant	significant	ADJ
ajlm-1398	74	23	correlations	correlation	NOUN
ajlm-1398	74	24	(	(	PUNCT
ajlm-1398	74	25	[	[	X
ajlm-1398	74	26	r	r	X
ajlm-1398	74	27	=	=	SYM
ajlm-1398	74	28	0.83	0.83	NUM
ajlm-1398	74	29	;	;	PUNCT
ajlm-1398	74	30	p	p	X
ajlm-1398	74	31	=	=	PROPN
ajlm-1398	74	32	0.17	0.17	NUM
ajlm-1398	74	33	]	]	PUNCT
ajlm-1398	74	34	,	,	PUNCT
ajlm-1398	75	1	[	[	X
ajlm-1398	75	2	r	r	X
ajlm-1398	75	3	=	=	SYM
ajlm-1398	75	4	0.94	0.94	NUM
ajlm-1398	75	5	;	;	PUNCT
ajlm-1398	75	6	p	p	X
ajlm-1398	76	1	=	=	PROPN
ajlm-1398	76	2	0.06	0.06	NUM
ajlm-1398	76	3	]	]	PUNCT
ajlm-1398	76	4	,	,	PUNCT
ajlm-1398	76	5	[	[	X
ajlm-1398	76	6	r	r	X
ajlm-1398	76	7	=	=	SYM
ajlm-1398	76	8	0.94	0.94	NUM
ajlm-1398	76	9	;	;	PUNCT
ajlm-1398	77	1	p	p	X
ajlm-1398	77	2	=	=	PROPN
ajlm-1398	77	3	0.06	0.06	NUM
ajlm-1398	77	4	]	]	PUNCT
ajlm-1398	77	5	and	and	CCONJ
ajlm-1398	78	1	[	[	X
ajlm-1398	78	2	r	r	X
ajlm-1398	78	3	=	=	SYM
ajlm-1398	78	4	1.00	1.00	NUM
ajlm-1398	78	5	;	;	PUNCT
ajlm-1398	78	6	p	p	X
ajlm-1398	78	7	=	=	NOUN
ajlm-1398	78	8	0.004	0.004	NUM
ajlm-1398	78	9	]	]	NUM
ajlm-1398	78	10	)	)	PUNCT
ajlm-1398	78	11	.	.	PUNCT
ajlm-1398	79	1	the	the	DET
ajlm-1398	79	2	amino	amino	NOUN
ajlm-1398	79	3	acid	acid	NOUN
ajlm-1398	79	4	concentrations	concentration	NOUN
ajlm-1398	79	5	demonstrated	demonstrate	VERB
ajlm-1398	79	6	statistically	statistically	ADV
ajlm-1398	79	7	significant	significant	ADJ
ajlm-1398	79	8	positive	positive	ADJ
ajlm-1398	79	9	correlations	correlation	NOUN
ajlm-1398	79	10	to	to	ADP
ajlm-1398	79	11	hba1c	hba1c	PROPN
ajlm-1398	79	12	coefficient	coefficient	NOUN
ajlm-1398	79	13	(	(	PUNCT
ajlm-1398	79	14	r	r	NOUN
ajlm-1398	79	15	)	)	PUNCT
ajlm-1398	79	16	and	and	CCONJ
ajlm-1398	79	17	correlated	correlate	VERB
ajlm-1398	79	18	negatively	negatively	ADV
ajlm-1398	79	19	with	with	ADP
ajlm-1398	79	20	urinary	urinary	ADJ
ajlm-1398	79	21	creatinine	creatinine	NOUN
ajlm-1398	79	22	and	and	CCONJ
ajlm-1398	79	23	age	age	NOUN
ajlm-1398	79	24	.	.	PUNCT
ajlm-1398	80	1	there	there	PRON
ajlm-1398	80	2	was	be	VERB
ajlm-1398	80	3	no	no	DET
ajlm-1398	80	4	significant	significant	ADJ
ajlm-1398	80	5	correlation	correlation	NOUN
ajlm-1398	80	6	between	between	ADP
ajlm-1398	80	7	the	the	DET
ajlm-1398	80	8	amino	amino	NOUN
ajlm-1398	80	9	acid	acid	NOUN
ajlm-1398	80	10	concentrations	concentration	NOUN
ajlm-1398	80	11	and	and	CCONJ
ajlm-1398	80	12	a	a	DET
ajlm-1398	80	13	/	/	SYM
ajlm-1398	80	14	c	c	NOUN
ajlm-1398	80	15	ratio	ratio	NOUN
ajlm-1398	80	16	,	,	PUNCT
ajlm-1398	80	17	albumin	albumin	NOUN
ajlm-1398	80	18	,	,	PUNCT
ajlm-1398	80	19	or	or	CCONJ
ajlm-1398	80	20	scr	scr	NOUN
ajlm-1398	80	21	.	.	PROPN
ajlm-1398	81	1	haemoglobin	haemoglobin	PROPN
ajlm-1398	81	2	a1c	a1c	PROPN
ajlm-1398	81	3	correlated	correlate	VERB
ajlm-1398	81	4	strongly	strongly	ADV
ajlm-1398	81	5	with	with	ADP
ajlm-1398	81	6	concentrations	concentration	NOUN
ajlm-1398	81	7	of	of	ADP
ajlm-1398	81	8	citrulline	citrulline	NOUN
ajlm-1398	81	9	(	(	PUNCT
ajlm-1398	81	10	r	r	NOUN
ajlm-1398	81	11	=	=	NOUN
ajlm-1398	81	12	0.76	0.76	NUM
ajlm-1398	81	13	)	)	PUNCT
ajlm-1398	81	14	,	,	PUNCT
ajlm-1398	81	15	isoleucine	isoleucine	NOUN
ajlm-1398	81	16	(	(	PUNCT
ajlm-1398	81	17	r	r	NOUN
ajlm-1398	81	18	=	=	PUNCT
ajlm-1398	81	19	–	–	PUNCT
ajlm-1398	81	20	0.83	0.83	NUM
ajlm-1398	81	21	)	)	PUNCT
ajlm-1398	81	22	and	and	CCONJ
ajlm-1398	81	23	ornithine	ornithine	NOUN
ajlm-1398	81	24	(	(	PUNCT
ajlm-1398	81	25	r	r	NOUN
ajlm-1398	81	26	=	=	PUNCT
ajlm-1398	81	27	–	–	PUNCT
ajlm-1398	81	28	0.86	0.86	NUM
ajlm-1398	81	29	)	)	PUNCT
ajlm-1398	81	30	,	,	PUNCT
ajlm-1398	81	31	while	while	SCONJ
ajlm-1398	81	32	age	age	NOUN
ajlm-1398	81	33	correlated	correlate	VERB
ajlm-1398	81	34	negatively	negatively	ADV
ajlm-1398	81	35	with	with	ADP
ajlm-1398	81	36	the	the	DET
ajlm-1398	81	37	concentrations	concentration	NOUN
ajlm-1398	81	38	of	of	ADP
ajlm-1398	81	39	isoleucine	isoleucine	NOUN
ajlm-1398	81	40	(	(	PUNCT
ajlm-1398	81	41	r	r	NOUN
ajlm-1398	81	42	=	=	PUNCT
ajlm-1398	81	43	–	–	PUNCT
ajlm-1398	81	44	0.98	0.98	NUM
ajlm-1398	81	45	)	)	PUNCT
ajlm-1398	81	46	,	,	PUNCT
ajlm-1398	81	47	ornithine	ornithine	NOUN
ajlm-1398	81	48	(	(	PUNCT
ajlm-1398	81	49	r	r	NOUN
ajlm-1398	81	50	=	=	PUNCT
ajlm-1398	81	51	–	–	PUNCT
ajlm-1398	81	52	0.95	0.95	NUM
ajlm-1398	81	53	)	)	PUNCT
ajlm-1398	81	54	,	,	PUNCT
ajlm-1398	81	55	phenylalanine	phenylalanine	NOUN
ajlm-1398	81	56	(	(	PUNCT
ajlm-1398	81	57	r	r	NOUN
ajlm-1398	81	58	=	=	PUNCT
ajlm-1398	81	59	–	–	PUNCT
ajlm-1398	81	60	0.83	0.83	NUM
ajlm-1398	81	61	)	)	PUNCT
ajlm-1398	81	62	and	and	CCONJ
ajlm-1398	81	63	tyrosine	tyrosine	NOUN
ajlm-1398	81	64	(	(	PUNCT
ajlm-1398	81	65	r	r	NOUN
ajlm-1398	81	66	=	=	PUNCT
ajlm-1398	81	67	–	–	PUNCT
ajlm-1398	81	68	0.80	0.80	NUM
ajlm-1398	81	69	)	)	PUNCT
ajlm-1398	81	70	.	.	PUNCT
ajlm-1398	82	1	table	table	NOUN
ajlm-1398	82	2	2	2	NUM
ajlm-1398	82	3	:	:	PUNCT
ajlm-1398	82	4	 	 	SPACE
ajlm-1398	82	5	correlation	correlation	NOUN
ajlm-1398	82	6	between	between	ADP
ajlm-1398	82	7	the	the	DET
ajlm-1398	82	8	amino	amino	NOUN
ajlm-1398	82	9	acid	acid	NOUN
ajlm-1398	82	10	concentrations	concentration	NOUN
ajlm-1398	82	11	and	and	CCONJ
ajlm-1398	82	12	ratios	ratio	NOUN
ajlm-1398	82	13	and	and	CCONJ
ajlm-1398	82	14	clinical	clinical	ADJ
ajlm-1398	82	15	data	datum	NOUN
ajlm-1398	82	16	of	of	ADP
ajlm-1398	82	17	patients	patient	NOUN
ajlm-1398	82	18	with	with	ADP
ajlm-1398	82	19	diabetes	diabetes	NOUN
ajlm-1398	82	20	,	,	PUNCT
ajlm-1398	82	21	johannesburg	johannesburg	PROPN
ajlm-1398	82	22	,	,	PUNCT
ajlm-1398	82	23	south	south	PROPN
ajlm-1398	82	24	africa	africa	PROPN
ajlm-1398	82	25	,	,	PUNCT
ajlm-1398	82	26	november	november	PROPN
ajlm-1398	82	27	2019	2019	NUM
ajlm-1398	82	28	to	to	ADP
ajlm-1398	82	29	january	january	PROPN
ajlm-1398	82	30	2021	2021	NUM
ajlm-1398	82	31	.	.	PUNCT
ajlm-1398	83	1	the	the	DET
ajlm-1398	83	2	trends	trend	NOUN
ajlm-1398	83	3	observed	observe	VERB
ajlm-1398	83	4	between	between	ADP
ajlm-1398	83	5	amino	amino	NOUN
ajlm-1398	83	6	acid	acid	NOUN
ajlm-1398	83	7	concentrations	concentration	NOUN
ajlm-1398	83	8	and	and	CCONJ
ajlm-1398	83	9	ratios	ratio	NOUN
ajlm-1398	83	10	with	with	ADP
ajlm-1398	83	11	clinical	clinical	ADJ
ajlm-1398	83	12	parameters	parameter	NOUN
ajlm-1398	83	13	for	for	ADP
ajlm-1398	83	14	non	non	ADJ
ajlm-1398	83	15	-	-	ADJ
ajlm-1398	83	16	diabetic	diabetic	ADJ
ajlm-1398	83	17	patients	patient	NOUN
ajlm-1398	83	18	are	be	AUX
ajlm-1398	83	19	within	within	ADP
ajlm-1398	83	20	the	the	DET
ajlm-1398	83	21	normal	normal	ADJ
ajlm-1398	83	22	range	range	NOUN
ajlm-1398	83	23	for	for	ADP
ajlm-1398	83	24	hba1c	hba1c	PROPN
ajlm-1398	83	25	and	and	CCONJ
ajlm-1398	83	26	egfr	egfr	NOUN
ajlm-1398	83	27	,	,	PUNCT
ajlm-1398	83	28	and	and	CCONJ
ajlm-1398	83	29	hence	hence	ADV
ajlm-1398	83	30	do	do	AUX
ajlm-1398	83	31	not	not	PART
ajlm-1398	83	32	show	show	VERB
ajlm-1398	83	33	disease	disease	NOUN
ajlm-1398	83	34	progression	progression	NOUN
ajlm-1398	83	35	(	(	PUNCT
ajlm-1398	83	36	table	table	NOUN
ajlm-1398	83	37	3	3	NUM
ajlm-1398	83	38	)	)	PUNCT
ajlm-1398	83	39	.	.	PUNCT
ajlm-1398	84	1	serum	serum	PROPN
ajlm-1398	84	2	creatinine	creatinine	PROPN
ajlm-1398	84	3	correlated	correlate	VERB
ajlm-1398	84	4	significantly	significantly	ADV
ajlm-1398	84	5	(	(	PUNCT
ajlm-1398	84	6	p	p	X
ajlm-1398	84	7	=	=	NOUN
ajlm-1398	84	8	0.45	0.45	NUM
ajlm-1398	84	9	)	)	PUNCT
ajlm-1398	84	10	with	with	ADP
ajlm-1398	84	11	isoleucine	isoleucine	NOUN
ajlm-1398	84	12	concentration	concentration	NOUN
ajlm-1398	84	13	(	(	PUNCT
ajlm-1398	84	14	r	r	NOUN
ajlm-1398	84	15	=	=	NOUN
ajlm-1398	84	16	0.76	0.76	NUM
ajlm-1398	84	17	)	)	PUNCT
ajlm-1398	84	18	and	and	CCONJ
ajlm-1398	84	19	citrulline	citrulline	NOUN
ajlm-1398	84	20	/	/	SYM
ajlm-1398	84	21	ornithine	ornithine	NOUN
ajlm-1398	84	22	ratios	ratio	NOUN
ajlm-1398	84	23	(	(	PUNCT
ajlm-1398	84	24	r	r	NOUN
ajlm-1398	84	25	=	=	SYM
ajlm-1398	84	26	0.81	0.81	NUM
ajlm-1398	84	27	,	,	PUNCT
ajlm-1398	84	28	p	p	X
ajlm-1398	84	29	=	=	NOUN
ajlm-1398	84	30	0.40	0.40	NUM
ajlm-1398	84	31	)	)	PUNCT
ajlm-1398	84	32	in	in	ADP
ajlm-1398	84	33	non	non	ADJ
ajlm-1398	84	34	-	-	ADJ
ajlm-1398	84	35	diabetic	diabetic	ADJ
ajlm-1398	84	36	patients	patient	NOUN
ajlm-1398	84	37	.	.	PUNCT
ajlm-1398	85	1	the	the	DET
ajlm-1398	85	2	tyrosine	tyrosine	NOUN
ajlm-1398	85	3	/	/	SYM
ajlm-1398	85	4	phenylalanine	phenylalanine	NOUN
ajlm-1398	85	5	ratios	ratio	NOUN
ajlm-1398	85	6	(	(	PUNCT
ajlm-1398	85	7	r	r	NOUN
ajlm-1398	85	8	=	=	SYM
ajlm-1398	85	9	0.85	0.85	NUM
ajlm-1398	85	10	)	)	PUNCT
ajlm-1398	85	11	,	,	PUNCT
ajlm-1398	85	12	as	as	ADV
ajlm-1398	85	13	well	well	ADV
ajlm-1398	85	14	as	as	ADP
ajlm-1398	85	15	the	the	DET
ajlm-1398	85	16	concentrations	concentration	NOUN
ajlm-1398	85	17	of	of	ADP
ajlm-1398	85	18	tyrosine	tyrosine	NOUN
ajlm-1398	85	19	(	(	PUNCT
ajlm-1398	85	20	r	r	NOUN
ajlm-1398	85	21	=	=	NOUN
ajlm-1398	85	22	0.76	0.76	NUM
ajlm-1398	85	23	)	)	PUNCT
ajlm-1398	85	24	and	and	CCONJ
ajlm-1398	85	25	ornithine	ornithine	NOUN
ajlm-1398	85	26	(	(	PUNCT
ajlm-1398	85	27	r	r	NOUN
ajlm-1398	85	28	=	=	SYM
ajlm-1398	85	29	0.83	0.83	NUM
ajlm-1398	85	30	)	)	PUNCT
ajlm-1398	85	31	,	,	PUNCT
ajlm-1398	85	32	decreased	decrease	VERB
ajlm-1398	85	33	with	with	ADP
ajlm-1398	85	34	decreasing	decrease	VERB
ajlm-1398	85	35	egfr	egfr	NOUN
ajlm-1398	85	36	,	,	PUNCT
ajlm-1398	85	37	while	while	SCONJ
ajlm-1398	85	38	the	the	DET
ajlm-1398	85	39	concentrations	concentration	NOUN
ajlm-1398	85	40	of	of	ADP
ajlm-1398	85	41	citrulline	citrulline	NOUN
ajlm-1398	85	42	(	(	PUNCT
ajlm-1398	85	43	r	r	NOUN
ajlm-1398	85	44	=	=	PUNCT
ajlm-1398	85	45	–	–	PUNCT
ajlm-1398	85	46	0.94	0.94	NUM
ajlm-1398	85	47	)	)	PUNCT
ajlm-1398	85	48	and	and	CCONJ
ajlm-1398	85	49	isoleucine	isoleucine	NOUN
ajlm-1398	85	50	(	(	PUNCT
ajlm-1398	85	51	r	r	NOUN
ajlm-1398	85	52	=	=	PUNCT
ajlm-1398	85	53	–	–	PUNCT
ajlm-1398	85	54	0.91	0.91	NUM
ajlm-1398	85	55	)	)	PUNCT
ajlm-1398	85	56	increased	increase	VERB
ajlm-1398	85	57	with	with	ADP
ajlm-1398	85	58	decreasing	decrease	VERB
ajlm-1398	85	59	egfr	egfr	NOUN
ajlm-1398	85	60	(	(	PUNCT
ajlm-1398	85	61	table	table	NOUN
ajlm-1398	85	62	3	3	NUM
ajlm-1398	85	63	)	)	PUNCT
ajlm-1398	85	64	.	.	PUNCT
ajlm-1398	86	1	table	table	NOUN
ajlm-1398	86	2	3	3	NUM
ajlm-1398	86	3	:	:	PUNCT
ajlm-1398	86	4	 	 	SPACE
ajlm-1398	86	5	correlation	correlation	NOUN
ajlm-1398	86	6	between	between	ADP
ajlm-1398	86	7	the	the	DET
ajlm-1398	86	8	amino	amino	NOUN
ajlm-1398	86	9	acid	acid	NOUN
ajlm-1398	86	10	concentrations	concentration	NOUN
ajlm-1398	86	11	and	and	CCONJ
ajlm-1398	86	12	ratios	ratio	NOUN
ajlm-1398	86	13	and	and	CCONJ
ajlm-1398	86	14	clinical	clinical	ADJ
ajlm-1398	86	15	data	datum	NOUN
ajlm-1398	86	16	of	of	ADP
ajlm-1398	86	17	non	non	ADJ
ajlm-1398	86	18	-	-	ADJ
ajlm-1398	86	19	diabetic	diabetic	ADJ
ajlm-1398	86	20	patients	patient	NOUN
ajlm-1398	86	21	,	,	PUNCT
ajlm-1398	86	22	johannesburg	johannesburg	PROPN
ajlm-1398	86	23	,	,	PUNCT
ajlm-1398	86	24	south	south	PROPN
ajlm-1398	86	25	africa	africa	PROPN
ajlm-1398	86	26	,	,	PUNCT
ajlm-1398	86	27	november	november	PROPN
ajlm-1398	86	28	2019	2019	NUM
ajlm-1398	86	29	to	to	ADP
ajlm-1398	86	30	january	january	PROPN
ajlm-1398	86	31	2021	2021	NUM
ajlm-1398	86	32	.	.	PUNCT
ajlm-1398	87	1	the	the	DET
ajlm-1398	87	2	citrulline	citrulline	NOUN
ajlm-1398	87	3	/	/	SYM
ajlm-1398	87	4	ornithine	ornithine	NOUN
ajlm-1398	87	5	ratios	ratio	NOUN
ajlm-1398	87	6	(	(	PUNCT
ajlm-1398	87	7	p	p	X
ajlm-1398	87	8	=	=	NOUN
ajlm-1398	87	9	0.01	0.01	NUM
ajlm-1398	87	10	)	)	PUNCT
ajlm-1398	87	11	,	,	PUNCT
ajlm-1398	87	12	as	as	ADV
ajlm-1398	87	13	well	well	ADV
ajlm-1398	87	14	as	as	ADP
ajlm-1398	87	15	the	the	DET
ajlm-1398	87	16	concentrations	concentration	NOUN
ajlm-1398	87	17	of	of	ADP
ajlm-1398	87	18	citrulline	citrulline	NOUN
ajlm-1398	87	19	(	(	PUNCT
ajlm-1398	87	20	p	p	X
ajlm-1398	87	21	<	<	X
ajlm-1398	87	22	0.001	0.001	NUM
ajlm-1398	87	23	)	)	PUNCT
ajlm-1398	87	24	and	and	CCONJ
ajlm-1398	87	25	isoleucine	isoleucine	NOUN
ajlm-1398	87	26	(	(	PUNCT
ajlm-1398	87	27	p	p	X
ajlm-1398	87	28	=	=	NOUN
ajlm-1398	87	29	0.04	0.04	NUM
ajlm-1398	87	30	)	)	PUNCT
ajlm-1398	87	31	,	,	PUNCT
ajlm-1398	87	32	were	be	AUX
ajlm-1398	87	33	significantly	significantly	ADV
ajlm-1398	87	34	higher	high	ADJ
ajlm-1398	87	35	in	in	ADP
ajlm-1398	87	36	the	the	DET
ajlm-1398	87	37	diabetic	diabetic	ADJ
ajlm-1398	87	38	group	group	NOUN
ajlm-1398	87	39	compared	compare	VERB
ajlm-1398	87	40	to	to	ADP
ajlm-1398	87	41	the	the	DET
ajlm-1398	87	42	non	non	ADJ
ajlm-1398	87	43	-	-	ADJ
ajlm-1398	87	44	diabetic	diabetic	ADJ
ajlm-1398	87	45	group	group	NOUN
ajlm-1398	87	46	in	in	ADP
ajlm-1398	87	47	stage	stage	NOUN
ajlm-1398	87	48	1	1	NUM
ajlm-1398	87	49	of	of	ADP
ajlm-1398	87	50	ckd	ckd	PROPN
ajlm-1398	87	51	(	(	PUNCT
ajlm-1398	87	52	table	table	NOUN
ajlm-1398	87	53	4	4	NUM
ajlm-1398	87	54	)	)	PUNCT
ajlm-1398	87	55	.	.	PUNCT
ajlm-1398	88	1	similarly	similarly	ADV
ajlm-1398	88	2	,	,	PUNCT
ajlm-1398	88	3	the	the	DET
ajlm-1398	88	4	ornithine	ornithine	NOUN
ajlm-1398	88	5	/	/	SYM
ajlm-1398	88	6	arginine	arginine	NOUN
ajlm-1398	88	7	ratios	ratio	NOUN
ajlm-1398	88	8	(	(	PUNCT
ajlm-1398	88	9	p	p	X
ajlm-1398	88	10	=	=	NOUN
ajlm-1398	88	11	0.02	0.02	NUM
ajlm-1398	88	12	)	)	PUNCT
ajlm-1398	88	13	and	and	CCONJ
ajlm-1398	88	14	citrulline	citrulline	NOUN
ajlm-1398	88	15	concentrations	concentration	NOUN
ajlm-1398	88	16	(	(	PUNCT
ajlm-1398	88	17	p	p	X
ajlm-1398	88	18	=	=	NOUN
ajlm-1398	88	19	0.03	0.03	NUM
ajlm-1398	88	20	)	)	PUNCT
ajlm-1398	88	21	were	be	AUX
ajlm-1398	88	22	significantly	significantly	ADV
ajlm-1398	88	23	higher	high	ADJ
ajlm-1398	88	24	in	in	ADP
ajlm-1398	88	25	the	the	DET
ajlm-1398	88	26	diabetic	diabetic	ADJ
ajlm-1398	88	27	group	group	NOUN
ajlm-1398	88	28	compared	compare	VERB
ajlm-1398	88	29	to	to	ADP
ajlm-1398	88	30	the	the	DET
ajlm-1398	88	31	non	non	ADJ
ajlm-1398	88	32	-	-	ADJ
ajlm-1398	88	33	diabetic	diabetic	ADJ
ajlm-1398	88	34	group	group	NOUN
ajlm-1398	88	35	in	in	ADP
ajlm-1398	88	36	stage	stage	NOUN
ajlm-1398	88	37	3	3	NUM
ajlm-1398	88	38	.	.	PUNCT
ajlm-1398	89	1	in	in	ADP
ajlm-1398	89	2	stage	stage	NOUN
ajlm-1398	89	3	4	4	NUM
ajlm-1398	89	4	,	,	PUNCT
ajlm-1398	89	5	the	the	DET
ajlm-1398	89	6	tyrosine	tyrosine	NOUN
ajlm-1398	89	7	/	/	SYM
ajlm-1398	89	8	phenylalanine	phenylalanine	NOUN
ajlm-1398	89	9	ratios	ratio	NOUN
ajlm-1398	89	10	were	be	AUX
ajlm-1398	89	11	significantly	significantly	ADV
ajlm-1398	89	12	(	(	PUNCT
ajlm-1398	89	13	p	p	X
ajlm-1398	89	14	=	=	NOUN
ajlm-1398	89	15	0.03	0.03	NUM
ajlm-1398	89	16	)	)	PUNCT
ajlm-1398	89	17	higher	high	ADJ
ajlm-1398	89	18	,	,	PUNCT
ajlm-1398	89	19	while	while	SCONJ
ajlm-1398	89	20	phenylalanine	phenylalanine	ADJ
ajlm-1398	89	21	concentrations	concentration	NOUN
ajlm-1398	89	22	were	be	AUX
ajlm-1398	89	23	lower	low	ADJ
ajlm-1398	89	24	in	in	ADP
ajlm-1398	89	25	the	the	DET
ajlm-1398	89	26	diabetic	diabetic	ADJ
ajlm-1398	89	27	group	group	NOUN
ajlm-1398	89	28	compared	compare	VERB
ajlm-1398	89	29	to	to	ADP
ajlm-1398	89	30	the	the	DET
ajlm-1398	89	31	non	non	ADJ
ajlm-1398	89	32	-	-	ADJ
ajlm-1398	89	33	diabetic	diabetic	ADJ
ajlm-1398	89	34	group	group	NOUN
ajlm-1398	89	35	.	.	PUNCT
ajlm-1398	90	1	table	table	NOUN
ajlm-1398	90	2	4	4	NUM
ajlm-1398	90	3	:	:	PUNCT
ajlm-1398	90	4	 	 	SPACE
ajlm-1398	90	5	differences	difference	NOUN
ajlm-1398	90	6	in	in	ADP
ajlm-1398	90	7	amino	amino	NOUN
ajlm-1398	90	8	acid	acid	NOUN
ajlm-1398	90	9	concentrations	concentration	NOUN
ajlm-1398	90	10	and	and	CCONJ
ajlm-1398	90	11	clinical	clinical	ADJ
ajlm-1398	90	12	parameters	parameter	NOUN
ajlm-1398	90	13	between	between	ADP
ajlm-1398	90	14	diabetic	diabetic	ADJ
ajlm-1398	90	15	and	and	CCONJ
ajlm-1398	90	16	non	non	ADJ
ajlm-1398	90	17	-	-	ADJ
ajlm-1398	90	18	diabetic	diabetic	ADJ
ajlm-1398	90	19	patients	patient	NOUN
ajlm-1398	90	20	with	with	ADP
ajlm-1398	90	21	declining	decline	VERB
ajlm-1398	90	22	estimated	estimate	VERB
ajlm-1398	90	23	gfr	gfr	PROPN
ajlm-1398	90	24	,	,	PUNCT
ajlm-1398	90	25	johannesburg	johannesburg	PROPN
ajlm-1398	90	26	,	,	PUNCT
ajlm-1398	90	27	south	south	PROPN
ajlm-1398	90	28	africa	africa	PROPN
ajlm-1398	90	29	,	,	PUNCT
ajlm-1398	90	30	november	november	PROPN
ajlm-1398	90	31	2019	2019	NUM
ajlm-1398	90	32	to	to	ADP
ajlm-1398	90	33	january	january	PROPN
ajlm-1398	90	34	2021	2021	NUM
ajlm-1398	90	35	.	.	PUNCT
ajlm-1398	91	1	discussion	discussion	NOUN
ajlm-1398	91	2	the	the	DET
ajlm-1398	91	3	quantitative	quantitative	ADJ
ajlm-1398	91	4	method	method	NOUN
ajlm-1398	91	5	developed	develop	VERB
ajlm-1398	91	6	for	for	ADP
ajlm-1398	91	7	the	the	DET
ajlm-1398	91	8	analysis	analysis	NOUN
ajlm-1398	91	9	of	of	ADP
ajlm-1398	91	10	amino	amino	ADJ
ajlm-1398	91	11	acids	acid	NOUN
ajlm-1398	91	12	in	in	ADP
ajlm-1398	91	13	urine	urine	NOUN
ajlm-1398	91	14	was	be	AUX
ajlm-1398	91	15	validated	validate	VERB
ajlm-1398	91	16	and	and	CCONJ
ajlm-1398	91	17	found	find	VERB
ajlm-1398	91	18	to	to	PART
ajlm-1398	91	19	be	be	AUX
ajlm-1398	91	20	reliable	reliable	ADJ
ajlm-1398	91	21	,	,	PUNCT
ajlm-1398	91	22	selective	selective	ADJ
ajlm-1398	91	23	,	,	PUNCT
ajlm-1398	91	24	sensitive	sensitive	ADJ
ajlm-1398	91	25	,	,	PUNCT
ajlm-1398	91	26	and	and	CCONJ
ajlm-1398	91	27	accurate	accurate	ADJ
ajlm-1398	91	28	.	.	PUNCT
ajlm-1398	92	1	we	we	PRON
ajlm-1398	92	2	could	could	AUX
ajlm-1398	92	3	relate	relate	VERB
ajlm-1398	92	4	the	the	DET
ajlm-1398	92	5	alterations	alteration	NOUN
ajlm-1398	92	6	in	in	ADP
ajlm-1398	92	7	urinary	urinary	ADJ
ajlm-1398	92	8	amino	amino	NOUN
ajlm-1398	92	9	acid	acid	NOUN
ajlm-1398	92	10	ratios	ratio	NOUN
ajlm-1398	92	11	at	at	ADP
ajlm-1398	92	12	different	different	ADJ
ajlm-1398	92	13	stages	stage	NOUN
ajlm-1398	92	14	of	of	ADP
ajlm-1398	92	15	ckd	ckd	NOUN
ajlm-1398	92	16	to	to	ADP
ajlm-1398	92	17	the	the	DET
ajlm-1398	92	18	egfr	egfr	NOUN
ajlm-1398	92	19	and	and	CCONJ
ajlm-1398	92	20	some	some	DET
ajlm-1398	92	21	clinical	clinical	ADJ
ajlm-1398	92	22	characteristics	characteristic	NOUN
ajlm-1398	92	23	associated	associate	VERB
ajlm-1398	92	24	with	with	ADP
ajlm-1398	92	25	the	the	DET
ajlm-1398	92	26	disease	disease	NOUN
ajlm-1398	92	27	.	.	PUNCT
ajlm-1398	93	1	the	the	DET
ajlm-1398	93	2	analysis	analysis	NOUN
ajlm-1398	93	3	showed	show	VERB
ajlm-1398	93	4	that	that	SCONJ
ajlm-1398	93	5	the	the	DET
ajlm-1398	93	6	amino	amino	NOUN
ajlm-1398	93	7	acid	acid	NOUN
ajlm-1398	93	8	ratios	ratio	NOUN
ajlm-1398	93	9	of	of	ADP
ajlm-1398	93	10	ornithine	ornithine	NOUN
ajlm-1398	93	11	/	/	SYM
ajlm-1398	93	12	arginine	arginine	NOUN
ajlm-1398	93	13	,	,	PUNCT
ajlm-1398	93	14	tyrosine	tyrosine	NOUN
ajlm-1398	93	15	/	/	SYM
ajlm-1398	93	16	phenylalanine	phenylalanine	NOUN
ajlm-1398	93	17	and	and	CCONJ
ajlm-1398	93	18	arginine	arginine	NOUN
ajlm-1398	93	19	/	/	SYM
ajlm-1398	93	20	citrulline	citrulline	NOUN
ajlm-1398	93	21	are	be	AUX
ajlm-1398	93	22	affected	affect	VERB
ajlm-1398	93	23	by	by	ADP
ajlm-1398	93	24	the	the	DET
ajlm-1398	93	25	progression	progression	NOUN
ajlm-1398	93	26	of	of	ADP
ajlm-1398	93	27	diabetes	diabetes	NOUN
ajlm-1398	93	28	and	and	CCONJ
ajlm-1398	93	29	can	can	AUX
ajlm-1398	93	30	be	be	AUX
ajlm-1398	93	31	correlated	correlate	VERB
ajlm-1398	93	32	to	to	ADP
ajlm-1398	93	33	renal	renal	ADJ
ajlm-1398	93	34	function	function	NOUN
ajlm-1398	93	35	.	.	PUNCT
ajlm-1398	94	1	there	there	PRON
ajlm-1398	94	2	were	be	VERB
ajlm-1398	94	3	significant	significant	ADJ
ajlm-1398	94	4	changes	change	NOUN
ajlm-1398	94	5	in	in	ADP
ajlm-1398	94	6	amino	amino	NOUN
ajlm-1398	94	7	acid	acid	NOUN
ajlm-1398	94	8	ratios	ratio	NOUN
ajlm-1398	94	9	between	between	ADP
ajlm-1398	94	10	the	the	DET
ajlm-1398	94	11	diabetic	diabetic	ADJ
ajlm-1398	94	12	and	and	CCONJ
ajlm-1398	94	13	non	non	ADJ
ajlm-1398	94	14	-	-	ADJ
ajlm-1398	94	15	diabetic	diabetic	ADJ
ajlm-1398	94	16	patients	patient	NOUN
ajlm-1398	94	17	in	in	ADP
ajlm-1398	94	18	stage	stage	NOUN
ajlm-1398	94	19	1	1	NUM
ajlm-1398	94	20	of	of	ADP
ajlm-1398	94	21	ckd	ckd	PROPN
ajlm-1398	94	22	,	,	PUNCT
ajlm-1398	94	23	and	and	CCONJ
ajlm-1398	94	24	this	this	PRON
ajlm-1398	94	25	could	could	AUX
ajlm-1398	94	26	be	be	AUX
ajlm-1398	94	27	utilised	utilise	VERB
ajlm-1398	94	28	to	to	PART
ajlm-1398	94	29	predict	predict	VERB
ajlm-1398	94	30	the	the	DET
ajlm-1398	94	31	onset	onset	NOUN
ajlm-1398	94	32	of	of	ADP
ajlm-1398	94	33	ckd	ckd	PROPN
ajlm-1398	94	34	.	.	PUNCT
ajlm-1398	95	1	the	the	DET
ajlm-1398	95	2	accuracy	accuracy	NOUN
ajlm-1398	95	3	of	of	ADP
ajlm-1398	95	4	the	the	DET
ajlm-1398	95	5	analytical	analytical	ADJ
ajlm-1398	95	6	method	method	NOUN
ajlm-1398	95	7	used	use	VERB
ajlm-1398	95	8	to	to	PART
ajlm-1398	95	9	obtain	obtain	VERB
ajlm-1398	95	10	the	the	DET
ajlm-1398	95	11	lloq	lloq	NOUN
ajlm-1398	95	12	was	be	AUX
ajlm-1398	95	13	determined	determined	ADJ
ajlm-1398	95	14	to	to	PART
ajlm-1398	95	15	be	be	AUX
ajlm-1398	95	16	within	within	ADP
ajlm-1398	95	17	the	the	DET
ajlm-1398	95	18	acceptable	acceptable	ADJ
ajlm-1398	95	19	range	range	NOUN
ajlm-1398	95	20	for	for	ADP
ajlm-1398	95	21	all	all	DET
ajlm-1398	95	22	the	the	DET
ajlm-1398	95	23	amino	amino	ADJ
ajlm-1398	95	24	acids	acid	NOUN
ajlm-1398	95	25	analysed	analyse	VERB
ajlm-1398	95	26	.	.	PUNCT
ajlm-1398	96	1	the	the	DET
ajlm-1398	96	2	linearity	linearity	NOUN
ajlm-1398	96	3	(	(	PUNCT
ajlm-1398	96	4	r2	r2	PROPN
ajlm-1398	96	5	)	)	PUNCT
ajlm-1398	96	6	ranged	range	VERB
ajlm-1398	96	7	from	from	ADP
ajlm-1398	96	8	0.983	0.983	NUM
ajlm-1398	96	9	to	to	ADP
ajlm-1398	96	10	0.999	0.999	NUM
ajlm-1398	96	11	,	,	PUNCT
ajlm-1398	96	12	the	the	DET
ajlm-1398	96	13	percentage	percentage	NOUN
ajlm-1398	96	14	recovery	recovery	NOUN
ajlm-1398	96	15	ranged	range	VERB
ajlm-1398	96	16	from	from	ADP
ajlm-1398	96	17	90	90	NUM
ajlm-1398	96	18	%	%	NOUN
ajlm-1398	96	19	to	to	PART
ajlm-1398	96	20	130	130	NUM
ajlm-1398	96	21	%	%	NOUN
ajlm-1398	96	22	,	,	PUNCT
ajlm-1398	96	23	and	and	CCONJ
ajlm-1398	96	24	the	the	DET
ajlm-1398	96	25	precision	precision	NOUN
ajlm-1398	96	26	(	(	PUNCT
ajlm-1398	96	27	%	%	INTJ
ajlm-1398	96	28	rsd	rsd	NOUN
ajlm-1398	96	29	)	)	PUNCT
ajlm-1398	96	30	was	be	AUX
ajlm-1398	96	31	less	less	ADJ
ajlm-1398	96	32	than	than	ADP
ajlm-1398	96	33	30	30	NUM
ajlm-1398	96	34	%	%	NOUN
ajlm-1398	96	35	,	,	PUNCT
ajlm-1398	96	36	except	except	SCONJ
ajlm-1398	96	37	for	for	ADP
ajlm-1398	96	38	ornithine	ornithine	NOUN
ajlm-1398	96	39	.	.	PUNCT
ajlm-1398	97	1	the	the	DET
ajlm-1398	97	2	method	method	NOUN
ajlm-1398	97	3	was	be	AUX
ajlm-1398	97	4	also	also	ADV
ajlm-1398	97	5	selective	selective	ADJ
ajlm-1398	97	6	and	and	CCONJ
ajlm-1398	97	7	sensitive	sensitive	ADJ
ajlm-1398	97	8	as	as	SCONJ
ajlm-1398	97	9	shown	show	VERB
ajlm-1398	97	10	by	by	ADP
ajlm-1398	97	11	the	the	DET
ajlm-1398	97	12	lowest	low	ADJ
ajlm-1398	97	13	limit	limit	NOUN
ajlm-1398	97	14	of	of	ADP
ajlm-1398	97	15	detection	detection	NOUN
ajlm-1398	97	16	and	and	CCONJ
ajlm-1398	97	17	lloq	lloq	NOUN
ajlm-1398	97	18	,	,	PUNCT
ajlm-1398	97	19	and	and	CCONJ
ajlm-1398	97	20	all	all	DET
ajlm-1398	97	21	the	the	DET
ajlm-1398	97	22	analytes	analyte	NOUN
ajlm-1398	97	23	of	of	ADP
ajlm-1398	97	24	interest	interest	NOUN
ajlm-1398	97	25	were	be	AUX
ajlm-1398	97	26	well	well	ADV
ajlm-1398	97	27	separated	separate	VERB
ajlm-1398	97	28	in	in	ADP
ajlm-1398	97	29	the	the	DET
ajlm-1398	97	30	liquid	liquid	ADJ
ajlm-1398	97	31	chromatography	chromatography	NOUN
ajlm-1398	97	32	and	and	CCONJ
ajlm-1398	97	33	accurately	accurately	ADV
ajlm-1398	97	34	identified	identify	VERB
ajlm-1398	97	35	by	by	ADP
ajlm-1398	97	36	the	the	DET
ajlm-1398	97	37	mass	mass	NOUN
ajlm-1398	97	38	spectrometer	spectrometer	NOUN
ajlm-1398	97	39	.	.	PUNCT
ajlm-1398	98	1	hence	hence	ADV
ajlm-1398	98	2	,	,	PUNCT
ajlm-1398	98	3	the	the	DET
ajlm-1398	98	4	method	method	NOUN
ajlm-1398	98	5	is	be	AUX
ajlm-1398	98	6	reliable	reliable	ADJ
ajlm-1398	98	7	and	and	CCONJ
ajlm-1398	98	8	can	can	AUX
ajlm-1398	98	9	be	be	AUX
ajlm-1398	98	10	used	use	VERB
ajlm-1398	98	11	to	to	PART
ajlm-1398	98	12	quantify	quantify	VERB
ajlm-1398	98	13	the	the	DET
ajlm-1398	98	14	amino	amino	ADJ
ajlm-1398	98	15	acids	acid	NOUN
ajlm-1398	98	16	of	of	ADP
ajlm-1398	98	17	interest	interest	NOUN
ajlm-1398	98	18	within	within	ADP
ajlm-1398	98	19	the	the	DET
ajlm-1398	98	20	analytical	analytical	ADJ
ajlm-1398	98	21	range	range	NOUN
ajlm-1398	98	22	of	of	ADP
ajlm-1398	98	23	0.01	0.01	NUM
ajlm-1398	98	24	mg	mg	PROPN
ajlm-1398	98	25	/	/	SYM
ajlm-1398	98	26	l	l	NOUN
ajlm-1398	98	27	to	to	ADP
ajlm-1398	98	28	5	5	NUM
ajlm-1398	98	29	mg	mg	PROPN
ajlm-1398	98	30	/	/	SYM
ajlm-1398	98	31	l.	l.	NOUN
ajlm-1398	98	32	in	in	ADP
ajlm-1398	98	33	diabetics	diabetic	NOUN
ajlm-1398	98	34	patients	patient	NOUN
ajlm-1398	98	35	,	,	PUNCT
ajlm-1398	98	36	the	the	DET
ajlm-1398	98	37	concentrations	concentration	NOUN
ajlm-1398	98	38	of	of	ADP
ajlm-1398	98	39	citrulline	citrulline	NOUN
ajlm-1398	98	40	,	,	PUNCT
ajlm-1398	98	41	isoleucine	isoleucine	NOUN
ajlm-1398	98	42	,	,	PUNCT
ajlm-1398	98	43	phenylalanine	phenylalanine	NOUN
ajlm-1398	98	44	and	and	CCONJ
ajlm-1398	98	45	ornithine	ornithine	NOUN
ajlm-1398	98	46	correlated	correlate	VERB
ajlm-1398	98	47	positively	positively	ADV
ajlm-1398	98	48	with	with	ADP
ajlm-1398	98	49	hba1c	hba1c	PROPN
ajlm-1398	98	50	(	(	PUNCT
ajlm-1398	98	51	[	[	X
ajlm-1398	98	52	r	r	X
ajlm-1398	98	53	=	=	SYM
ajlm-1398	98	54	0.76	0.76	NUM
ajlm-1398	98	55	;	;	PUNCT
ajlm-1398	98	56	p	p	X
ajlm-1398	98	57	=	=	NOUN
ajlm-1398	98	58	0.24	0.24	NUM
ajlm-1398	98	59	)	)	PUNCT
ajlm-1398	98	60	]	]	PUNCT
ajlm-1398	98	61	,	,	PUNCT
ajlm-1398	99	1	[	[	X
ajlm-1398	99	2	r	r	NOUN
ajlm-1398	99	3	=	=	SYM
ajlm-1398	99	4	0.83	0.83	NUM
ajlm-1398	99	5	;	;	PUNCT
ajlm-1398	99	6	p	p	X
ajlm-1398	99	7	=	=	PROPN
ajlm-1398	99	8	0.17	0.17	NUM
ajlm-1398	99	9	]	]	PUNCT
ajlm-1398	99	10	,	,	PUNCT
ajlm-1398	100	1	[	[	X
ajlm-1398	100	2	r	r	X
ajlm-1398	100	3	=	=	SYM
ajlm-1398	100	4	0.54	0.54	NUM
ajlm-1398	100	5	;	;	PUNCT
ajlm-1398	100	6	p	p	X
ajlm-1398	101	1	=	=	NOUN
ajlm-1398	101	2	0.46	0.46	NUM
ajlm-1398	101	3	]	]	PUNCT
ajlm-1398	101	4	,	,	PUNCT
ajlm-1398	101	5	[	[	X
ajlm-1398	101	6	r	r	NOUN
ajlm-1398	101	7	=	=	NOUN
ajlm-1398	101	8	0.86	0.86	NUM
ajlm-1398	101	9	;	;	PUNCT
ajlm-1398	102	1	p	p	X
ajlm-1398	102	2	=	=	PROPN
ajlm-1398	102	3	0.41	0.41	NUM
ajlm-1398	102	4	]	]	PUNCT
ajlm-1398	102	5	)	)	PUNCT
ajlm-1398	102	6	and	and	CCONJ
ajlm-1398	102	7	egfr	egfr	NOUN
ajlm-1398	102	8	(	(	PUNCT
ajlm-1398	102	9	[	[	X
ajlm-1398	102	10	r	r	NOUN
ajlm-1398	102	11	=	=	NOUN
ajlm-1398	102	12	0.33	0.33	NUM
ajlm-1398	102	13	;	;	PUNCT
ajlm-1398	102	14	p	p	X
ajlm-1398	102	15	=	=	NOUN
ajlm-1398	102	16	0.67	0.67	NUM
ajlm-1398	102	17	]	]	PUNCT
ajlm-1398	102	18	,	,	PUNCT
ajlm-1398	102	19	[	[	X
ajlm-1398	102	20	r	r	X
ajlm-1398	102	21	=	=	SYM
ajlm-1398	102	22	0.94	0.94	NUM
ajlm-1398	102	23	,	,	PUNCT
ajlm-1398	102	24	p	p	NOUN
ajlm-1398	102	25	=	=	PROPN
ajlm-1398	102	26	0.06	0.06	NUM
ajlm-1398	102	27	]	]	PUNCT
ajlm-1398	102	28	,	,	PUNCT
ajlm-1398	103	1	[	[	X
ajlm-1398	103	2	r	r	X
ajlm-1398	103	3	=	=	SYM
ajlm-1398	103	4	1.00	1.00	NUM
ajlm-1398	103	5	;	;	PUNCT
ajlm-1398	103	6	p	p	X
ajlm-1398	103	7	=	=	NOUN
ajlm-1398	103	8	0.004	0.004	NUM
ajlm-1398	103	9	]	]	PUNCT
ajlm-1398	103	10	,	,	PUNCT
ajlm-1398	103	11	[	[	X
ajlm-1398	103	12	r	r	NOUN
ajlm-1398	103	13	=	=	SYM
ajlm-1398	103	14	0.83	0.83	NUM
ajlm-1398	103	15	;	;	PUNCT
ajlm-1398	103	16	p	p	X
ajlm-1398	103	17	=	=	NOUN
ajlm-1398	103	18	0.17	0.17	NUM
ajlm-1398	103	19	]	]	PUNCT
ajlm-1398	103	20	)	)	PUNCT
ajlm-1398	103	21	.	.	PUNCT
ajlm-1398	104	1	the	the	DET
ajlm-1398	104	2	concentrations	concentration	NOUN
ajlm-1398	104	3	of	of	ADP
ajlm-1398	104	4	these	these	DET
ajlm-1398	104	5	amino	amino	ADJ
ajlm-1398	104	6	acids	acid	NOUN
ajlm-1398	104	7	decreased	decrease	VERB
ajlm-1398	104	8	with	with	ADP
ajlm-1398	104	9	egfr	egfr	ADJ
ajlm-1398	104	10	decline	decline	NOUN
ajlm-1398	104	11	,	,	PUNCT
ajlm-1398	104	12	meaning	mean	VERB
ajlm-1398	104	13	that	that	SCONJ
ajlm-1398	104	14	the	the	DET
ajlm-1398	104	15	disease	disease	NOUN
ajlm-1398	104	16	and	and	CCONJ
ajlm-1398	104	17	renal	renal	ADJ
ajlm-1398	104	18	function	function	NOUN
ajlm-1398	104	19	may	may	AUX
ajlm-1398	104	20	alter	alter	VERB
ajlm-1398	104	21	these	these	DET
ajlm-1398	104	22	amino	amino	ADJ
ajlm-1398	104	23	acids	acid	NOUN
ajlm-1398	104	24	.	.	PUNCT
ajlm-1398	105	1	in	in	ADP
ajlm-1398	105	2	non	non	ADJ
ajlm-1398	105	3	-	-	ADJ
ajlm-1398	105	4	diabetic	diabetic	ADJ
ajlm-1398	105	5	patients	patient	NOUN
ajlm-1398	105	6	,	,	PUNCT
ajlm-1398	105	7	arginine	arginine	NOUN
ajlm-1398	105	8	,	,	PUNCT
ajlm-1398	105	9	citrulline	citrulline	NOUN
ajlm-1398	105	10	and	and	CCONJ
ajlm-1398	105	11	isoleucine	isoleucine	NOUN
ajlm-1398	105	12	correlated	correlate	VERB
ajlm-1398	105	13	positively	positively	ADV
ajlm-1398	105	14	with	with	ADP
ajlm-1398	105	15	hba1c	hba1c	PROPN
ajlm-1398	105	16	,	,	PUNCT
ajlm-1398	105	17	meaning	mean	VERB
ajlm-1398	105	18	that	that	SCONJ
ajlm-1398	105	19	these	these	DET
ajlm-1398	105	20	amino	amino	NOUN
ajlm-1398	105	21	acid	acid	NOUN
ajlm-1398	105	22	concentrations	concentration	NOUN
ajlm-1398	105	23	fluctuate	fluctuate	NOUN
ajlm-1398	105	24	with	with	ADP
ajlm-1398	105	25	glucose	glucose	NOUN
ajlm-1398	105	26	levels	level	NOUN
ajlm-1398	105	27	.	.	PUNCT
ajlm-1398	106	1	even	even	ADV
ajlm-1398	106	2	though	though	SCONJ
ajlm-1398	106	3	citrulline	citrulline	NOUN
ajlm-1398	106	4	showed	show	VERB
ajlm-1398	106	5	a	a	DET
ajlm-1398	106	6	positive	positive	ADJ
ajlm-1398	106	7	correlation	correlation	NOUN
ajlm-1398	106	8	with	with	ADP
ajlm-1398	106	9	hba1c	hba1c	PROPN
ajlm-1398	106	10	in	in	ADP
ajlm-1398	106	11	both	both	CCONJ
ajlm-1398	106	12	the	the	DET
ajlm-1398	106	13	diabetic	diabetic	ADJ
ajlm-1398	106	14	and	and	CCONJ
ajlm-1398	106	15	non	non	ADJ
ajlm-1398	106	16	-	-	ADJ
ajlm-1398	106	17	diabetic	diabetic	ADJ
ajlm-1398	106	18	groups	group	NOUN
ajlm-1398	106	19	,	,	PUNCT
ajlm-1398	106	20	its	its	PRON
ajlm-1398	106	21	concentrations	concentration	NOUN
ajlm-1398	106	22	levels	level	NOUN
ajlm-1398	106	23	were	be	AUX
ajlm-1398	106	24	significantly	significantly	ADV
ajlm-1398	106	25	(	(	PUNCT
ajlm-1398	106	26	p	p	X
ajlm-1398	106	27	<	<	X
ajlm-1398	106	28	0.001	0.001	NUM
ajlm-1398	106	29	)	)	PUNCT
ajlm-1398	106	30	higher	high	ADJ
ajlm-1398	106	31	in	in	ADP
ajlm-1398	106	32	the	the	DET
ajlm-1398	106	33	diabetic	diabetic	ADJ
ajlm-1398	106	34	group	group	NOUN
ajlm-1398	106	35	.	.	PUNCT
ajlm-1398	107	1	a	a	DET
ajlm-1398	107	2	study	study	NOUN
ajlm-1398	107	3	conducted	conduct	VERB
ajlm-1398	107	4	in	in	ADP
ajlm-1398	107	5	france	france	PROPN
ajlm-1398	107	6	in	in	ADP
ajlm-1398	107	7	2014	2014	NUM
ajlm-1398	107	8	reported	report	VERB
ajlm-1398	107	9	that	that	SCONJ
ajlm-1398	107	10	citrulline	citrulline	NOUN
ajlm-1398	107	11	concentration	concentration	NOUN
ajlm-1398	107	12	and	and	CCONJ
ajlm-1398	107	13	citrulline	citrulline	NOUN
ajlm-1398	107	14	/	/	SYM
ajlm-1398	107	15	ornithine	ornithine	NOUN
ajlm-1398	107	16	ratio	ratio	NOUN
ajlm-1398	107	17	increased	increase	VERB
ajlm-1398	107	18	while	while	SCONJ
ajlm-1398	107	19	the	the	DET
ajlm-1398	107	20	tyrosine	tyrosine	NOUN
ajlm-1398	107	21	/	/	SYM
ajlm-1398	107	22	phenylalanine	phenylalanine	NOUN
ajlm-1398	107	23	ratio	ratio	NOUN
ajlm-1398	107	24	decreased	decrease	VERB
ajlm-1398	107	25	(	(	PUNCT
ajlm-1398	107	26	in	in	ADP
ajlm-1398	107	27	plasma	plasma	NOUN
ajlm-1398	107	28	samples	sample	NOUN
ajlm-1398	107	29	)	)	PUNCT
ajlm-1398	107	30	in	in	ADP
ajlm-1398	107	31	the	the	DET
ajlm-1398	107	32	late	late	ADJ
ajlm-1398	107	33	stages	stage	NOUN
ajlm-1398	107	34	of	of	ADP
ajlm-1398	107	35	ckd.17	ckd.17	NOUN
ajlm-1398	107	36	similarly	similarly	ADV
ajlm-1398	107	37	,	,	PUNCT
ajlm-1398	107	38	in	in	ADP
ajlm-1398	107	39	this	this	DET
ajlm-1398	107	40	study	study	NOUN
ajlm-1398	107	41	,	,	PUNCT
ajlm-1398	107	42	we	we	PRON
ajlm-1398	107	43	observed	observe	VERB
ajlm-1398	107	44	(	(	PUNCT
ajlm-1398	107	45	in	in	ADP
ajlm-1398	107	46	urine	urine	NOUN
ajlm-1398	107	47	samples	sample	NOUN
ajlm-1398	107	48	)	)	PUNCT
ajlm-1398	107	49	an	an	DET
ajlm-1398	107	50	increase	increase	NOUN
ajlm-1398	107	51	in	in	ADP
ajlm-1398	107	52	citrulline	citrulline	NOUN
ajlm-1398	107	53	concentrations	concentration	NOUN
ajlm-1398	107	54	and	and	CCONJ
ajlm-1398	107	55	citrulline	citrulline	NOUN
ajlm-1398	107	56	/	/	SYM
ajlm-1398	107	57	ornithine	ornithine	NOUN
ajlm-1398	107	58	ratios	ratio	NOUN
ajlm-1398	107	59	in	in	ADP
ajlm-1398	107	60	stage	stage	NOUN
ajlm-1398	107	61	1	1	NUM
ajlm-1398	107	62	;	;	PUNCT
ajlm-1398	107	63	however	however	ADV
ajlm-1398	107	64	,	,	PUNCT
ajlm-1398	107	65	tyrosine	tyrosine	NOUN
ajlm-1398	107	66	/	/	SYM
ajlm-1398	107	67	phenylalanine	phenylalanine	NOUN
ajlm-1398	107	68	ratios	ratio	NOUN
ajlm-1398	107	69	increased	increase	VERB
ajlm-1398	107	70	from	from	ADP
ajlm-1398	107	71	stage	stage	NOUN
ajlm-1398	107	72	1	1	NUM
ajlm-1398	107	73	to	to	PART
ajlm-1398	107	74	stage	stage	VERB
ajlm-1398	107	75	4	4	NUM
ajlm-1398	107	76	of	of	ADP
ajlm-1398	107	77	ckd	ckd	PROPN
ajlm-1398	107	78	with	with	ADP
ajlm-1398	107	79	decreasing	decrease	VERB
ajlm-1398	107	80	concentrations	concentration	NOUN
ajlm-1398	107	81	of	of	ADP
ajlm-1398	107	82	phenylalanine	phenylalanine	NOUN
ajlm-1398	107	83	.	.	PUNCT
ajlm-1398	108	1	amino	amino	NOUN
ajlm-1398	108	2	acid	acid	NOUN
ajlm-1398	108	3	concentrations	concentration	NOUN
ajlm-1398	108	4	have	have	AUX
ajlm-1398	108	5	been	be	AUX
ajlm-1398	108	6	reported	report	VERB
ajlm-1398	108	7	to	to	PART
ajlm-1398	108	8	decrease	decrease	VERB
ajlm-1398	108	9	in	in	ADP
ajlm-1398	108	10	diabetic	diabetic	ADJ
ajlm-1398	108	11	groups	group	NOUN
ajlm-1398	108	12	,	,	PUNCT
ajlm-1398	108	13	and	and	CCONJ
ajlm-1398	108	14	this	this	DET
ajlm-1398	108	15	decrease	decrease	NOUN
ajlm-1398	108	16	is	be	AUX
ajlm-1398	108	17	attributed	attribute	VERB
ajlm-1398	108	18	to	to	ADP
ajlm-1398	108	19	the	the	DET
ajlm-1398	108	20	conversion	conversion	NOUN
ajlm-1398	108	21	of	of	ADP
ajlm-1398	108	22	these	these	DET
ajlm-1398	108	23	amino	amino	ADJ
ajlm-1398	108	24	acids	acid	NOUN
ajlm-1398	108	25	to	to	AUX
ajlm-1398	108	26	glucose.18	glucose.18	VERB
ajlm-1398	108	27	our	our	PRON
ajlm-1398	108	28	findings	finding	NOUN
ajlm-1398	108	29	show	show	VERB
ajlm-1398	108	30	that	that	SCONJ
ajlm-1398	108	31	phenylalanine	phenylalanine	NOUN
ajlm-1398	108	32	follows	follow	VERB
ajlm-1398	108	33	this	this	DET
ajlm-1398	108	34	trend	trend	NOUN
ajlm-1398	108	35	,	,	PUNCT
ajlm-1398	108	36	as	as	SCONJ
ajlm-1398	108	37	its	its	PRON
ajlm-1398	108	38	concentrations	concentration	NOUN
ajlm-1398	108	39	decreased	decrease	VERB
ajlm-1398	108	40	from	from	ADP
ajlm-1398	108	41	stage	stage	NOUN
ajlm-1398	108	42	1	1	NUM
ajlm-1398	108	43	to	to	PART
ajlm-1398	108	44	stage	stage	VERB
ajlm-1398	108	45	4	4	NUM
ajlm-1398	108	46	of	of	ADP
ajlm-1398	108	47	ckd	ckd	PROPN
ajlm-1398	108	48	.	.	PUNCT
ajlm-1398	109	1	the	the	DET
ajlm-1398	109	2	observed	observed	ADJ
ajlm-1398	109	3	trend	trend	NOUN
ajlm-1398	109	4	can	can	AUX
ajlm-1398	109	5	be	be	AUX
ajlm-1398	109	6	explained	explain	VERB
ajlm-1398	109	7	by	by	ADP
ajlm-1398	109	8	looking	look	VERB
ajlm-1398	109	9	at	at	ADP
ajlm-1398	109	10	the	the	DET
ajlm-1398	109	11	metabolic	metabolic	NOUN
ajlm-1398	109	12	pathways	pathway	NOUN
ajlm-1398	109	13	of	of	ADP
ajlm-1398	109	14	the	the	DET
ajlm-1398	109	15	studied	study	VERB
ajlm-1398	109	16	amino	amino	NOUN
ajlm-1398	109	17	acids	acid	NOUN
ajlm-1398	109	18	that	that	PRON
ajlm-1398	109	19	occur	occur	VERB
ajlm-1398	109	20	in	in	ADP
ajlm-1398	109	21	the	the	DET
ajlm-1398	109	22	liver	liver	NOUN
ajlm-1398	109	23	and	and	CCONJ
ajlm-1398	109	24	kidneys	kidney	NOUN
ajlm-1398	109	25	.	.	PUNCT
ajlm-1398	110	1	arginine	arginine	NOUN
ajlm-1398	110	2	is	be	AUX
ajlm-1398	110	3	converted	convert	VERB
ajlm-1398	110	4	to	to	ADP
ajlm-1398	110	5	ornithine	ornithine	VERB
ajlm-1398	110	6	,	,	PUNCT
ajlm-1398	110	7	ornithine	ornithine	NOUN
ajlm-1398	110	8	to	to	ADP
ajlm-1398	110	9	citrulline	citrulline	NOUN
ajlm-1398	110	10	and	and	CCONJ
ajlm-1398	110	11	citrulline	citrulline	NOUN
ajlm-1398	110	12	to	to	ADP
ajlm-1398	110	13	arginine	arginine	NOUN
ajlm-1398	110	14	,	,	PUNCT
ajlm-1398	110	15	while	while	SCONJ
ajlm-1398	110	16	phenylalanine	phenylalanine	NOUN
ajlm-1398	110	17	is	be	AUX
ajlm-1398	110	18	converted	convert	VERB
ajlm-1398	110	19	to	to	ADP
ajlm-1398	110	20	tyrosine.17	tyrosine.17	PROPN
ajlm-1398	110	21	thus	thus	ADV
ajlm-1398	110	22	,	,	PUNCT
ajlm-1398	110	23	the	the	DET
ajlm-1398	110	24	declining	decline	VERB
ajlm-1398	110	25	kidney	kidney	NOUN
ajlm-1398	110	26	function	function	NOUN
ajlm-1398	110	27	may	may	AUX
ajlm-1398	110	28	affect	affect	VERB
ajlm-1398	110	29	the	the	DET
ajlm-1398	110	30	proper	proper	ADJ
ajlm-1398	110	31	conversion	conversion	NOUN
ajlm-1398	110	32	of	of	ADP
ajlm-1398	110	33	citrulline	citrulline	NOUN
ajlm-1398	110	34	to	to	ADP
ajlm-1398	110	35	arginine	arginine	NOUN
ajlm-1398	110	36	,	,	PUNCT
ajlm-1398	110	37	as	as	SCONJ
ajlm-1398	110	38	shown	show	VERB
ajlm-1398	110	39	also	also	ADV
ajlm-1398	110	40	by	by	ADP
ajlm-1398	110	41	the	the	DET
ajlm-1398	110	42	significant	significant	ADJ
ajlm-1398	110	43	(	(	PUNCT
ajlm-1398	110	44	p	p	X
ajlm-1398	110	45	=	=	NOUN
ajlm-1398	110	46	0.05	0.05	NUM
ajlm-1398	110	47	)	)	PUNCT
ajlm-1398	110	48	decrease	decrease	NOUN
ajlm-1398	110	49	in	in	ADP
ajlm-1398	110	50	the	the	DET
ajlm-1398	110	51	ratio	ratio	NOUN
ajlm-1398	110	52	of	of	ADP
ajlm-1398	110	53	arginine	arginine	NOUN
ajlm-1398	110	54	/	/	SYM
ajlm-1398	110	55	citrulline	citrulline	NOUN
ajlm-1398	110	56	in	in	ADP
ajlm-1398	110	57	stage	stage	NOUN
ajlm-1398	110	58	3	3	NUM
ajlm-1398	110	59	of	of	ADP
ajlm-1398	110	60	ckd	ckd	PROPN
ajlm-1398	110	61	.	.	PUNCT
ajlm-1398	111	1	citrulline	citrulline	NOUN
ajlm-1398	111	2	is	be	AUX
ajlm-1398	111	3	a	a	DET
ajlm-1398	111	4	non	non	ADJ
ajlm-1398	111	5	-	-	ADJ
ajlm-1398	111	6	essential	essential	ADJ
ajlm-1398	111	7	amino	amino	NOUN
ajlm-1398	111	8	acid	acid	NOUN
ajlm-1398	111	9	that	that	PRON
ajlm-1398	111	10	is	be	AUX
ajlm-1398	111	11	mainly	mainly	ADV
ajlm-1398	111	12	synthesised	synthesise	VERB
ajlm-1398	111	13	in	in	ADP
ajlm-1398	111	14	the	the	DET
ajlm-1398	111	15	gut	gut	NOUN
ajlm-1398	111	16	and	and	CCONJ
ajlm-1398	111	17	then	then	ADV
ajlm-1398	111	18	taken	take	VERB
ajlm-1398	111	19	up	up	ADP
ajlm-1398	111	20	by	by	ADP
ajlm-1398	111	21	the	the	DET
ajlm-1398	111	22	kidneys	kidney	NOUN
ajlm-1398	111	23	,	,	PUNCT
ajlm-1398	111	24	wherein	wherein	SCONJ
ajlm-1398	111	25	it	it	PRON
ajlm-1398	111	26	is	be	AUX
ajlm-1398	111	27	converted	convert	VERB
ajlm-1398	111	28	to	to	ADP
ajlm-1398	111	29	arginine.19	arginine.19	PROPN
ajlm-1398	111	30	the	the	DET
ajlm-1398	111	31	increased	increase	VERB
ajlm-1398	111	32	concentration	concentration	NOUN
ajlm-1398	111	33	of	of	ADP
ajlm-1398	111	34	citrulline	citrulline	NOUN
ajlm-1398	111	35	in	in	ADP
ajlm-1398	111	36	diabetic	diabetic	ADJ
ajlm-1398	111	37	patients	patient	NOUN
ajlm-1398	111	38	could	could	AUX
ajlm-1398	111	39	be	be	AUX
ajlm-1398	111	40	attributed	attribute	VERB
ajlm-1398	111	41	to	to	ADP
ajlm-1398	111	42	the	the	DET
ajlm-1398	111	43	inability	inability	NOUN
ajlm-1398	111	44	of	of	ADP
ajlm-1398	111	45	the	the	DET
ajlm-1398	111	46	kidneys	kidney	NOUN
ajlm-1398	111	47	to	to	PART
ajlm-1398	111	48	carry	carry	VERB
ajlm-1398	111	49	out	out	ADP
ajlm-1398	111	50	this	this	DET
ajlm-1398	111	51	function	function	NOUN
ajlm-1398	111	52	.	.	PUNCT
ajlm-1398	112	1	the	the	DET
ajlm-1398	112	2	kidneys	kidney	NOUN
ajlm-1398	112	3	convert	convert	VERB
ajlm-1398	112	4	50	50	NUM
ajlm-1398	112	5	%	%	NOUN
ajlm-1398	112	6	of	of	ADP
ajlm-1398	112	7	the	the	DET
ajlm-1398	112	8	total	total	ADJ
ajlm-1398	112	9	body	body	NOUN
ajlm-1398	112	10	phenylalanine	phenylalanine	NOUN
ajlm-1398	112	11	to	to	ADP
ajlm-1398	112	12	tyrosine	tyrosine	NOUN
ajlm-1398	112	13	through	through	ADP
ajlm-1398	112	14	hydroxylation	hydroxylation	NOUN
ajlm-1398	112	15	by	by	ADP
ajlm-1398	112	16	the	the	DET
ajlm-1398	112	17	action	action	NOUN
ajlm-1398	112	18	of	of	ADP
ajlm-1398	112	19	the	the	DET
ajlm-1398	112	20	phenylalanine-4	phenylalanine-4	NOUN
ajlm-1398	112	21	-	-	PUNCT
ajlm-1398	112	22	hydroxylase	hydroxylase	NOUN
ajlm-1398	112	23	enzyme.19	enzyme.19	NOUN
ajlm-1398	112	24	at	at	ADP
ajlm-1398	112	25	stage	stage	NOUN
ajlm-1398	112	26	4	4	NUM
ajlm-1398	112	27	of	of	ADP
ajlm-1398	112	28	ckd	ckd	PROPN
ajlm-1398	112	29	,	,	PUNCT
ajlm-1398	112	30	the	the	DET
ajlm-1398	112	31	tyrosine	tyrosine	NOUN
ajlm-1398	112	32	/	/	SYM
ajlm-1398	112	33	phenylalanine	phenylalanine	NOUN
ajlm-1398	112	34	ratios	ratio	NOUN
ajlm-1398	112	35	were	be	AUX
ajlm-1398	112	36	significantly	significantly	ADV
ajlm-1398	112	37	different	different	ADJ
ajlm-1398	112	38	between	between	ADP
ajlm-1398	112	39	the	the	DET
ajlm-1398	112	40	diabetic	diabetic	ADJ
ajlm-1398	112	41	and	and	CCONJ
ajlm-1398	112	42	non	non	ADJ
ajlm-1398	112	43	-	-	ADJ
ajlm-1398	112	44	diabetic	diabetic	ADJ
ajlm-1398	112	45	groups	group	NOUN
ajlm-1398	112	46	,	,	PUNCT
ajlm-1398	112	47	and	and	CCONJ
ajlm-1398	112	48	the	the	DET
ajlm-1398	112	49	phenylalanine	phenylalanine	ADJ
ajlm-1398	112	50	concentrations	concentration	NOUN
ajlm-1398	112	51	were	be	AUX
ajlm-1398	112	52	lower	low	ADJ
ajlm-1398	112	53	in	in	ADP
ajlm-1398	112	54	the	the	DET
ajlm-1398	112	55	diabetic	diabetic	ADJ
ajlm-1398	112	56	group	group	NOUN
ajlm-1398	112	57	.	.	PUNCT
ajlm-1398	113	1	the	the	DET
ajlm-1398	113	2	metabolism	metabolism	NOUN
ajlm-1398	113	3	of	of	ADP
ajlm-1398	113	4	phenylalanine	phenylalanine	NOUN
ajlm-1398	113	5	has	have	VERB
ajlm-1398	113	6	two	two	NUM
ajlm-1398	113	7	outcomes	outcome	NOUN
ajlm-1398	113	8	–	–	PUNCT
ajlm-1398	113	9	the	the	DET
ajlm-1398	113	10	production	production	NOUN
ajlm-1398	113	11	of	of	ADP
ajlm-1398	113	12	tyrosine	tyrosine	NOUN
ajlm-1398	113	13	,	,	PUNCT
ajlm-1398	113	14	and	and	CCONJ
ajlm-1398	113	15	the	the	DET
ajlm-1398	113	16	complete	complete	ADJ
ajlm-1398	113	17	oxidation	oxidation	NOUN
ajlm-1398	113	18	of	of	ADP
ajlm-1398	113	19	phenylalanine	phenylalanine	NOUN
ajlm-1398	113	20	to	to	ADP
ajlm-1398	113	21	carbon	carbon	NOUN
ajlm-1398	113	22	dioxide	dioxide	NOUN
ajlm-1398	113	23	and	and	CCONJ
ajlm-1398	113	24	water	water	NOUN
ajlm-1398	113	25	to	to	PART
ajlm-1398	113	26	drive	drive	VERB
ajlm-1398	113	27	the	the	DET
ajlm-1398	113	28	production	production	NOUN
ajlm-1398	113	29	of	of	ADP
ajlm-1398	113	30	glucose.20	glucose.20	NOUN
ajlm-1398	113	31	we	we	PRON
ajlm-1398	113	32	observed	observe	VERB
ajlm-1398	113	33	an	an	DET
ajlm-1398	113	34	increase	increase	NOUN
ajlm-1398	113	35	in	in	ADP
ajlm-1398	113	36	tyrosine	tyrosine	NOUN
ajlm-1398	113	37	/	/	SYM
ajlm-1398	113	38	phenylalanine	phenylalanine	NOUN
ajlm-1398	113	39	ratios	ratio	NOUN
ajlm-1398	113	40	with	with	ADP
ajlm-1398	113	41	egfr	egfr	ADJ
ajlm-1398	113	42	decline	decline	NOUN
ajlm-1398	113	43	,	,	PUNCT
ajlm-1398	113	44	which	which	PRON
ajlm-1398	113	45	suggests	suggest	VERB
ajlm-1398	113	46	an	an	DET
ajlm-1398	113	47	increased	increase	VERB
ajlm-1398	113	48	production	production	NOUN
ajlm-1398	113	49	of	of	ADP
ajlm-1398	113	50	tyrosine	tyrosine	NOUN
ajlm-1398	113	51	in	in	ADP
ajlm-1398	113	52	the	the	DET
ajlm-1398	113	53	kidneys	kidney	NOUN
ajlm-1398	113	54	as	as	ADP
ajlm-1398	113	55	renal	renal	ADJ
ajlm-1398	113	56	function	function	NOUN
ajlm-1398	113	57	decreases	decrease	VERB
ajlm-1398	113	58	and	and	CCONJ
ajlm-1398	113	59	could	could	AUX
ajlm-1398	113	60	explain	explain	VERB
ajlm-1398	113	61	the	the	DET
ajlm-1398	113	62	low	low	ADJ
ajlm-1398	113	63	phenylalanine	phenylalanine	ADJ
ajlm-1398	113	64	concentrations	concentration	NOUN
ajlm-1398	113	65	in	in	ADP
ajlm-1398	113	66	stage	stage	NOUN
ajlm-1398	113	67	4	4	NUM
ajlm-1398	113	68	of	of	ADP
ajlm-1398	113	69	ckd	ckd	PROPN
ajlm-1398	113	70	.	.	PUNCT
ajlm-1398	114	1	limitations	limitation	VERB
ajlm-1398	114	2	the	the	DET
ajlm-1398	114	3	exact	exact	ADJ
ajlm-1398	114	4	cut	cut	NOUN
ajlm-1398	114	5	-	-	PUNCT
ajlm-1398	114	6	off	off	ADP
ajlm-1398	114	7	values	value	NOUN
ajlm-1398	114	8	for	for	ADP
ajlm-1398	114	9	amino	amino	NOUN
ajlm-1398	114	10	acid	acid	NOUN
ajlm-1398	114	11	concentrations	concentration	NOUN
ajlm-1398	114	12	and	and	CCONJ
ajlm-1398	114	13	ratios	ratio	NOUN
ajlm-1398	114	14	,	,	PUNCT
ajlm-1398	114	15	which	which	PRON
ajlm-1398	114	16	indicate	indicate	VERB
ajlm-1398	114	17	the	the	DET
ajlm-1398	114	18	onset	onset	NOUN
ajlm-1398	114	19	of	of	ADP
ajlm-1398	114	20	diabetic	diabetic	ADJ
ajlm-1398	114	21	nephropathy	nephropathy	NOUN
ajlm-1398	114	22	or	or	CCONJ
ajlm-1398	114	23	ckd	ckd	PROPN
ajlm-1398	114	24	,	,	PUNCT
ajlm-1398	114	25	could	could	AUX
ajlm-1398	114	26	not	not	PART
ajlm-1398	114	27	be	be	AUX
ajlm-1398	114	28	determined	determine	VERB
ajlm-1398	114	29	.	.	PUNCT
ajlm-1398	115	1	also	also	ADV
ajlm-1398	115	2	,	,	PUNCT
ajlm-1398	115	3	the	the	DET
ajlm-1398	115	4	sample	sample	NOUN
ajlm-1398	115	5	size	size	NOUN
ajlm-1398	115	6	for	for	ADP
ajlm-1398	115	7	non	non	ADJ
ajlm-1398	115	8	-	-	ADJ
ajlm-1398	115	9	diabetic	diabetic	ADJ
ajlm-1398	115	10	patients	patient	NOUN
ajlm-1398	115	11	was	be	AUX
ajlm-1398	115	12	below	below	ADP
ajlm-1398	115	13	30	30	NUM
ajlm-1398	115	14	(	(	PUNCT
ajlm-1398	115	15	n	n	NOUN
ajlm-1398	115	16	=	=	SYM
ajlm-1398	115	17	22	22	NUM
ajlm-1398	115	18	)	)	PUNCT
ajlm-1398	115	19	,	,	PUNCT
ajlm-1398	115	20	which	which	PRON
ajlm-1398	115	21	is	be	AUX
ajlm-1398	115	22	the	the	DET
ajlm-1398	115	23	acceptable	acceptable	ADJ
ajlm-1398	115	24	size	size	NOUN
ajlm-1398	115	25	for	for	ADP
ajlm-1398	115	26	accurate	accurate	ADJ
ajlm-1398	115	27	statistical	statistical	ADJ
ajlm-1398	115	28	evaluation	evaluation	NOUN
ajlm-1398	115	29	,	,	PUNCT
ajlm-1398	115	30	and	and	CCONJ
ajlm-1398	115	31	this	this	PRON
ajlm-1398	115	32	may	may	AUX
ajlm-1398	115	33	have	have	AUX
ajlm-1398	115	34	influenced	influence	VERB
ajlm-1398	115	35	the	the	DET
ajlm-1398	115	36	results	result	NOUN
ajlm-1398	115	37	of	of	ADP
ajlm-1398	115	38	comparisons	comparison	NOUN
ajlm-1398	115	39	between	between	ADP
ajlm-1398	115	40	the	the	DET
ajlm-1398	115	41	two	two	NUM
ajlm-1398	115	42	groups	group	NOUN
ajlm-1398	115	43	of	of	ADP
ajlm-1398	115	44	patients	patient	NOUN
ajlm-1398	115	45	.	.	PUNCT
ajlm-1398	116	1	a	a	DET
ajlm-1398	116	2	more	more	ADV
ajlm-1398	116	3	detailed	detailed	ADJ
ajlm-1398	116	4	statistical	statistical	ADJ
ajlm-1398	116	5	evaluation	evaluation	NOUN
ajlm-1398	116	6	would	would	AUX
ajlm-1398	116	7	have	have	VERB
ajlm-1398	116	8	to	to	PART
ajlm-1398	116	9	be	be	AUX
ajlm-1398	116	10	conducted	conduct	VERB
ajlm-1398	116	11	to	to	PART
ajlm-1398	116	12	indicate	indicate	VERB
ajlm-1398	116	13	early	early	ADJ
ajlm-1398	116	14	ckd	ckd	NOUN
ajlm-1398	116	15	using	use	VERB
ajlm-1398	116	16	amino	amino	NOUN
ajlm-1398	116	17	acid	acid	NOUN
ajlm-1398	116	18	ratios	ratio	NOUN
ajlm-1398	116	19	.	.	PUNCT
ajlm-1398	117	1	conclusion	conclusion	NOUN
ajlm-1398	117	2	the	the	DET
ajlm-1398	117	3	amino	amino	NOUN
ajlm-1398	117	4	acid	acid	NOUN
ajlm-1398	117	5	concentrations	concentration	NOUN
ajlm-1398	117	6	and	and	CCONJ
ajlm-1398	117	7	ratios	ratio	NOUN
ajlm-1398	117	8	in	in	ADP
ajlm-1398	117	9	human	human	ADJ
ajlm-1398	117	10	urine	urine	NOUN
ajlm-1398	117	11	samples	sample	NOUN
ajlm-1398	117	12	could	could	AUX
ajlm-1398	117	13	provide	provide	VERB
ajlm-1398	117	14	valuable	valuable	ADJ
ajlm-1398	117	15	information	information	NOUN
ajlm-1398	117	16	about	about	ADP
ajlm-1398	117	17	the	the	DET
ajlm-1398	117	18	onset	onset	NOUN
ajlm-1398	117	19	and	and	CCONJ
ajlm-1398	117	20	progression	progression	NOUN
ajlm-1398	117	21	of	of	ADP
ajlm-1398	117	22	diabetic	diabetic	ADJ
ajlm-1398	117	23	nephropathy	nephropathy	NOUN
ajlm-1398	117	24	as	as	SCONJ
ajlm-1398	117	25	there	there	PRON
ajlm-1398	117	26	appeared	appear	VERB
ajlm-1398	117	27	to	to	PART
ajlm-1398	117	28	be	be	AUX
ajlm-1398	117	29	significant	significant	ADJ
ajlm-1398	117	30	correlations	correlation	NOUN
ajlm-1398	117	31	between	between	ADP
ajlm-1398	117	32	the	the	DET
ajlm-1398	117	33	amino	amino	NOUN
ajlm-1398	117	34	acid	acid	NOUN
ajlm-1398	117	35	concentrations	concentration	NOUN
ajlm-1398	117	36	and	and	CCONJ
ajlm-1398	117	37	declining	decline	VERB
ajlm-1398	117	38	egfr	egfr	NOUN
ajlm-1398	117	39	.	.	PUNCT
ajlm-1398	118	1	amino	amino	NOUN
ajlm-1398	118	2	acid	acid	NOUN
ajlm-1398	118	3	ratios	ratio	NOUN
ajlm-1398	118	4	(	(	PUNCT
ajlm-1398	118	5	ornithine	ornithine	NOUN
ajlm-1398	118	6	/	/	SYM
ajlm-1398	118	7	arginine	arginine	NOUN
ajlm-1398	118	8	and	and	CCONJ
ajlm-1398	118	9	tyrosine	tyrosine	NOUN
ajlm-1398	118	10	/	/	SYM
ajlm-1398	118	11	phenylalanine	phenylalanine	NOUN
ajlm-1398	118	12	)	)	PUNCT
ajlm-1398	118	13	are	be	AUX
ajlm-1398	118	14	affected	affect	VERB
ajlm-1398	118	15	by	by	ADP
ajlm-1398	118	16	decreased	decrease	VERB
ajlm-1398	118	17	renal	renal	ADJ
ajlm-1398	118	18	function	function	NOUN
ajlm-1398	118	19	,	,	PUNCT
ajlm-1398	118	20	and	and	CCONJ
ajlm-1398	118	21	citrulline	citrulline	NOUN
ajlm-1398	118	22	/	/	SYM
ajlm-1398	118	23	ornithine	ornithine	NOUN
ajlm-1398	118	24	ratios	ratio	NOUN
ajlm-1398	118	25	may	may	AUX
ajlm-1398	118	26	predict	predict	VERB
ajlm-1398	118	27	early	early	ADJ
ajlm-1398	118	28	ckd	ckd	PROPN
ajlm-1398	118	29	.	.	PUNCT
ajlm-1398	119	1	acknowledgements	acknowledgement	VERB
ajlm-1398	119	2	the	the	DET
ajlm-1398	119	3	authors	author	NOUN
ajlm-1398	119	4	would	would	AUX
ajlm-1398	119	5	like	like	VERB
ajlm-1398	119	6	to	to	PART
ajlm-1398	119	7	thank	thank	VERB
ajlm-1398	119	8	the	the	DET
ajlm-1398	119	9	chris	chris	PROPN
ajlm-1398	119	10	hani	hani	PROPN
ajlm-1398	119	11	baragwanath	baragwanath	PROPN
ajlm-1398	119	12	academic	academic	PROPN
ajlm-1398	119	13	hospital	hospital	NOUN
ajlm-1398	119	14	chemical	chemical	NOUN
ajlm-1398	119	15	pathology	pathology	NOUN
ajlm-1398	119	16	staff	staff	NOUN
ajlm-1398	119	17	for	for	ADP
ajlm-1398	119	18	the	the	DET
ajlm-1398	119	19	collection	collection	NOUN
ajlm-1398	119	20	and	and	CCONJ
ajlm-1398	119	21	transportation	transportation	NOUN
ajlm-1398	119	22	of	of	ADP
ajlm-1398	119	23	samples	sample	NOUN
ajlm-1398	119	24	,	,	PUNCT
ajlm-1398	119	25	and	and	CCONJ
ajlm-1398	119	26	the	the	DET
ajlm-1398	119	27	national	national	PROPN
ajlm-1398	119	28	institute	institute	PROPN
ajlm-1398	119	29	of	of	ADP
ajlm-1398	119	30	occupational	occupational	ADJ
ajlm-1398	119	31	health	health	NOUN
ajlm-1398	119	32	staff	staff	NOUN
ajlm-1398	119	33	for	for	ADP
ajlm-1398	119	34	long	long	ADJ
ajlm-1398	119	35	-	-	PUNCT
ajlm-1398	119	36	term	term	NOUN
ajlm-1398	119	37	storage	storage	NOUN
ajlm-1398	119	38	,	,	PUNCT
ajlm-1398	119	39	sorting	sorting	NOUN
ajlm-1398	119	40	,	,	PUNCT
ajlm-1398	119	41	and	and	CCONJ
ajlm-1398	119	42	transportation	transportation	NOUN
ajlm-1398	119	43	of	of	ADP
ajlm-1398	119	44	samples	sample	NOUN
ajlm-1398	119	45	.	.	PUNCT
ajlm-1398	120	1	we	we	PRON
ajlm-1398	120	2	also	also	ADV
ajlm-1398	120	3	thank	thank	VERB
ajlm-1398	120	4	the	the	DET
ajlm-1398	120	5	witwatersrand	witwatersrand	NOUN
ajlm-1398	120	6	mass	mass	PROPN
ajlm-1398	120	7	spectrometry	spectrometry	NOUN
ajlm-1398	120	8	team	team	NOUN
ajlm-1398	120	9	for	for	ADP
ajlm-1398	120	10	granting	grant	VERB
ajlm-1398	120	11	access	access	NOUN
ajlm-1398	120	12	to	to	ADP
ajlm-1398	120	13	the	the	DET
ajlm-1398	120	14	analytical	analytical	ADJ
ajlm-1398	120	15	instruments	instrument	NOUN
ajlm-1398	120	16	.	.	PUNCT
ajlm-1398	121	1	this	this	DET
ajlm-1398	121	2	article	article	NOUN
ajlm-1398	121	3	is	be	AUX
ajlm-1398	121	4	partially	partially	ADV
ajlm-1398	121	5	based	base	VERB
ajlm-1398	121	6	on	on	ADP
ajlm-1398	121	7	the	the	DET
ajlm-1398	121	8	second	second	ADJ
ajlm-1398	121	9	author	author	NOUN
ajlm-1398	121	10	’s	’s	PART
ajlm-1398	121	11	thesis21	thesis21	NOUN
ajlm-1398	121	12	of	of	ADP
ajlm-1398	121	13	the	the	DET
ajlm-1398	121	14	degree	degree	NOUN
ajlm-1398	121	15	of	of	ADP
ajlm-1398	121	16	doctor	doctor	NOUN
ajlm-1398	121	17	of	of	ADP
ajlm-1398	121	18	philosophy	philosophy	NOUN
ajlm-1398	121	19	in	in	ADP
ajlm-1398	121	20	division	division	NOUN
ajlm-1398	121	21	of	of	ADP
ajlm-1398	121	22	human	human	ADJ
ajlm-1398	121	23	genetics	genetic	NOUN
ajlm-1398	121	24	,	,	PUNCT
ajlm-1398	121	25	department	department	NOUN
ajlm-1398	121	26	of	of	ADP
ajlm-1398	121	27	pathology	pathology	PROPN
ajlm-1398	121	28	,	,	PUNCT
ajlm-1398	121	29	faculty	faculty	NOUN
ajlm-1398	121	30	of	of	ADP
ajlm-1398	121	31	health	health	NOUN
ajlm-1398	121	32	sciences	science	NOUN
ajlm-1398	121	33	at	at	ADP
ajlm-1398	121	34	the	the	DET
ajlm-1398	121	35	university	university	PROPN
ajlm-1398	121	36	of	of	ADP
ajlm-1398	121	37	cape	cape	PROPN
ajlm-1398	121	38	town	town	NOUN
ajlm-1398	121	39	,	,	PUNCT
ajlm-1398	121	40	south	south	PROPN
ajlm-1398	121	41	africa	africa	PROPN
ajlm-1398	121	42	,	,	PUNCT
ajlm-1398	121	43	with	with	ADP
ajlm-1398	121	44	supervisor	supervisor	NOUN
ajlm-1398	121	45	prof	prof	NOUN
ajlm-1398	121	46	.	.	PUNCT
ajlm-1398	122	1	collet	collet	PROPN
ajlm-1398	122	2	dandara	dandara	PROPN
ajlm-1398	122	3	,	,	PUNCT
ajlm-1398	122	4	received	receive	VERB
ajlm-1398	122	5	september	september	PROPN
ajlm-1398	122	6	2018	2018	NUM
ajlm-1398	122	7	,	,	PUNCT
ajlm-1398	122	8	available	available	ADJ
ajlm-1398	122	9	here	here	ADV
ajlm-1398	122	10	:	:	PUNCT
ajlm-1398	122	11	http://hdl.handle.net/11427/30132	http://hdl.handle.net/11427/30132	X
ajlm-1398	122	12	.	.	PUNCT
ajlm-1398	123	1	competing	compete	VERB
ajlm-1398	123	2	interests	interest	NOUN
ajlm-1398	123	3	the	the	DET
ajlm-1398	123	4	authors	author	NOUN
ajlm-1398	123	5	declare	declare	VERB
ajlm-1398	123	6	that	that	SCONJ
ajlm-1398	123	7	they	they	PRON
ajlm-1398	123	8	have	have	VERB
ajlm-1398	123	9	no	no	DET
ajlm-1398	123	10	financial	financial	ADJ
ajlm-1398	123	11	or	or	CCONJ
ajlm-1398	123	12	personal	personal	ADJ
ajlm-1398	123	13	relationships	relationship	NOUN
ajlm-1398	123	14	that	that	PRON
ajlm-1398	123	15	may	may	AUX
ajlm-1398	123	16	have	have	AUX
ajlm-1398	123	17	inappropriately	inappropriately	ADV
ajlm-1398	123	18	influenced	influence	VERB
ajlm-1398	123	19	them	they	PRON
ajlm-1398	123	20	in	in	ADP
ajlm-1398	123	21	writing	write	VERB
ajlm-1398	123	22	this	this	DET
ajlm-1398	123	23	article	article	NOUN
ajlm-1398	123	24	.	.	PUNCT
ajlm-1398	124	1	authors	author	NOUN
ajlm-1398	124	2	’	’	PART
ajlm-1398	124	3	contributions	contribution	NOUN
ajlm-1398	124	4	d.m.t	d.m.t	PROPN
ajlm-1398	124	5	.	.	PUNCT
ajlm-1398	124	6	generated	generate	VERB
ajlm-1398	124	7	the	the	DET
ajlm-1398	124	8	hypothesis	hypothesis	NOUN
ajlm-1398	124	9	and	and	CCONJ
ajlm-1398	124	10	planned	plan	VERB
ajlm-1398	124	11	the	the	DET
ajlm-1398	124	12	patient	patient	ADJ
ajlm-1398	124	13	recruitment	recruitment	NOUN
ajlm-1398	124	14	and	and	CCONJ
ajlm-1398	124	15	sample	sample	NOUN
ajlm-1398	124	16	collection	collection	NOUN
ajlm-1398	124	17	logistics	logistic	NOUN
ajlm-1398	124	18	.	.	PUNCT
ajlm-1398	125	1	t.m	t.m	PROPN
ajlm-1398	125	2	.	.	PROPN
ajlm-1398	125	3	ran	run	VERB
ajlm-1398	125	4	the	the	DET
ajlm-1398	125	5	project	project	NOUN
ajlm-1398	125	6	,	,	PUNCT
ajlm-1398	125	7	analysed	analyse	VERB
ajlm-1398	125	8	the	the	DET
ajlm-1398	125	9	samples	sample	NOUN
ajlm-1398	125	10	,	,	PUNCT
ajlm-1398	125	11	carried	carry	VERB
ajlm-1398	125	12	out	out	ADP
ajlm-1398	125	13	the	the	DET
ajlm-1398	125	14	statistical	statistical	ADJ
ajlm-1398	125	15	analysis	analysis	NOUN
ajlm-1398	125	16	and	and	CCONJ
ajlm-1398	125	17	wrote	write	VERB
ajlm-1398	125	18	the	the	DET
ajlm-1398	125	19	manuscript	manuscript	NOUN
ajlm-1398	125	20	.	.	PUNCT
ajlm-1398	126	1	m.m.m	m.m.m	AUX
ajlm-1398	126	2	.	.	PROPN
ajlm-1398	126	3	supervised	supervise	VERB
ajlm-1398	126	4	the	the	DET
ajlm-1398	126	5	project	project	NOUN
ajlm-1398	126	6	and	and	CCONJ
ajlm-1398	126	7	provided	provide	VERB
ajlm-1398	126	8	expert	expert	ADJ
ajlm-1398	126	9	analytical	analytical	ADJ
ajlm-1398	126	10	interpretation	interpretation	NOUN
ajlm-1398	126	11	.	.	PUNCT
ajlm-1398	127	1	r.j.m	r.j.m	NOUN
ajlm-1398	127	2	.	.	PROPN
ajlm-1398	127	3	assisted	assist	VERB
ajlm-1398	127	4	with	with	ADP
ajlm-1398	127	5	the	the	DET
ajlm-1398	127	6	analytical	analytical	ADJ
ajlm-1398	127	7	processes	process	NOUN
ajlm-1398	127	8	.	.	PUNCT
ajlm-1398	128	1	s.b	s.b	PROPN
ajlm-1398	128	2	.	.	PROPN
ajlm-1398	128	3	assisted	assist	VERB
ajlm-1398	128	4	with	with	ADP
ajlm-1398	128	5	patient	patient	ADJ
ajlm-1398	128	6	recruitment	recruitment	NOUN
ajlm-1398	128	7	.	.	PUNCT
ajlm-1398	129	1	sources	source	NOUN
ajlm-1398	129	2	of	of	ADP
ajlm-1398	129	3	support	support	NOUN
ajlm-1398	129	4	the	the	DET
ajlm-1398	129	5	work	work	NOUN
ajlm-1398	129	6	was	be	AUX
ajlm-1398	129	7	supported	support	VERB
ajlm-1398	129	8	by	by	ADP
ajlm-1398	129	9	the	the	DET
ajlm-1398	129	10	national	national	PROPN
ajlm-1398	129	11	research	research	PROPN
ajlm-1398	129	12	foundation	foundation	PROPN
ajlm-1398	129	13	,	,	PUNCT
ajlm-1398	129	14	under	under	ADP
ajlm-1398	129	15	the	the	DET
ajlm-1398	129	16	thuthuka	thuthuka	PROPN
ajlm-1398	129	17	award	award	PROPN
ajlm-1398	129	18	(	(	PUNCT
ajlm-1398	129	19	gun	gun	NOUN
ajlm-1398	129	20	117975	117975	NUM
ajlm-1398	129	21	)	)	PUNCT
ajlm-1398	129	22	.	.	PUNCT
ajlm-1398	130	1	data	datum	NOUN
ajlm-1398	130	2	availability	availability	NOUN
ajlm-1398	130	3	data	datum	NOUN
ajlm-1398	130	4	sharing	sharing	NOUN
ajlm-1398	130	5	is	be	AUX
ajlm-1398	130	6	not	not	PART
ajlm-1398	130	7	applicable	applicable	ADJ
ajlm-1398	130	8	to	to	ADP
ajlm-1398	130	9	this	this	DET
ajlm-1398	130	10	article	article	NOUN
ajlm-1398	130	11	.	.	PUNCT
ajlm-1398	131	1	disclaimer	disclaimer	VERB
ajlm-1398	131	2	the	the	DET
ajlm-1398	131	3	views	view	NOUN
ajlm-1398	131	4	and	and	CCONJ
ajlm-1398	131	5	opinions	opinion	NOUN
ajlm-1398	131	6	expressed	express	VERB
ajlm-1398	131	7	in	in	ADP
ajlm-1398	131	8	this	this	DET
ajlm-1398	131	9	article	article	NOUN
ajlm-1398	131	10	are	be	AUX
ajlm-1398	131	11	those	those	PRON
ajlm-1398	131	12	of	of	ADP
ajlm-1398	131	13	the	the	DET
ajlm-1398	131	14	authors	author	NOUN
ajlm-1398	131	15	and	and	CCONJ
ajlm-1398	131	16	do	do	AUX
ajlm-1398	131	17	not	not	PART
ajlm-1398	131	18	necessarily	necessarily	ADV
ajlm-1398	131	19	reflect	reflect	VERB
ajlm-1398	131	20	the	the	DET
ajlm-1398	131	21	official	official	ADJ
ajlm-1398	131	22	policy	policy	NOUN
ajlm-1398	131	23	or	or	CCONJ
ajlm-1398	131	24	position	position	NOUN
ajlm-1398	131	25	of	of	ADP
ajlm-1398	131	26	any	any	DET
ajlm-1398	131	27	affiliated	affiliated	ADJ
ajlm-1398	131	28	agency	agency	NOUN
ajlm-1398	131	29	of	of	ADP
ajlm-1398	131	30	the	the	DET
ajlm-1398	131	31	authors	author	NOUN
ajlm-1398	131	32	.	.	PUNCT
ajlm-1398	132	1	references	reference	NOUN
ajlm-1398	132	2	brenneman	brenneman	PROPN
ajlm-1398	132	3	j	j	PROPN
ajlm-1398	132	4	,	,	PUNCT
ajlm-1398	132	5	hill	hill	PROPN
ajlm-1398	132	6	j	j	PROPN
ajlm-1398	132	7	,	,	PUNCT
ajlm-1398	132	8	pullen	pullen	PROPN
ajlm-1398	132	9	s.	s.	PROPN
ajlm-1398	132	10	emerging	emerge	VERB
ajlm-1398	132	11	therapeutics	therapeutic	NOUN
ajlm-1398	132	12	for	for	ADP
ajlm-1398	132	13	the	the	DET
ajlm-1398	132	14	treatment	treatment	NOUN
ajlm-1398	132	15	of	of	ADP
ajlm-1398	132	16	diabetic	diabetic	ADJ
ajlm-1398	132	17	nephropathy	nephropathy	NOUN
ajlm-1398	132	18	.	.	PUNCT
ajlm-1398	133	1	bioorg	bioorg	PROPN
ajlm-1398	133	2	med	med	PROPN
ajlm-1398	133	3	chem	chem	NOUN
ajlm-1398	133	4	lett	lett	PROPN
ajlm-1398	133	5	.	.	PUNCT
ajlm-1398	134	1	2016;26(18):4394–4402	2016;26(18):4394–4402	PROPN
ajlm-1398	134	2	.	.	PUNCT
ajlm-1398	135	1	https://doi.org/10.1016/j.bmcl.2016.07.079	https://doi.org/10.1016/j.bmcl.2016.07.079	PROPN
ajlm-1398	135	2	kanwar	kanwar	PROPN
ajlm-1398	135	3	ys	ys	PROPN
ajlm-1398	135	4	,	,	PUNCT
ajlm-1398	135	5	wada	wada	PROPN
ajlm-1398	135	6	j	j	PROPN
ajlm-1398	135	7	,	,	PUNCT
ajlm-1398	135	8	sun	sun	PROPN
ajlm-1398	135	9	l	l	PROPN
ajlm-1398	135	10	,	,	PUNCT
ajlm-1398	135	11	et	et	PROPN
ajlm-1398	135	12	al	al	PROPN
ajlm-1398	135	13	.	.	PUNCT
ajlm-1398	136	1	diabetic	diabetic	ADJ
ajlm-1398	136	2	nephropathy	nephropathy	NOUN
ajlm-1398	136	3	:	:	PUNCT
ajlm-1398	136	4	mechanisms	mechanism	NOUN
ajlm-1398	136	5	of	of	ADP
ajlm-1398	136	6	renal	renal	ADJ
ajlm-1398	136	7	disease	disease	NOUN
ajlm-1398	136	8	progression	progression	NOUN
ajlm-1398	136	9	.	.	PUNCT
ajlm-1398	137	1	exp	exp	NOUN
ajlm-1398	137	2	bio	bio	PROPN
ajlm-1398	137	3	med	med	PROPN
ajlm-1398	137	4	.	.	PUNCT
ajlm-1398	137	5	2008;233(1):4–11	2008;233(1):4–11	NUM
ajlm-1398	137	6	.	.	PUNCT
ajlm-1398	138	1	https://doi.org/10.3181/0705-mr-134	https://doi.org/10.3181/0705-mr-134	PROPN
ajlm-1398	138	2	moosa	moosa	PROPN
ajlm-1398	138	3	mr	mr	PROPN
ajlm-1398	138	4	,	,	PUNCT
ajlm-1398	138	5	van	van	PROPN
ajlm-1398	138	6	der	der	PROPN
ajlm-1398	138	7	walt	walt	PROPN
ajlm-1398	138	8	i	i	PROPN
ajlm-1398	138	9	,	,	PUNCT
ajlm-1398	138	10	naicker	naicker	PROPN
ajlm-1398	138	11	s	s	PROPN
ajlm-1398	138	12	,	,	PUNCT
ajlm-1398	138	13	meyers	meyer	NOUN
ajlm-1398	138	14	am	be	AUX
ajlm-1398	138	15	.	.	PUNCT
ajlm-1398	139	1	important	important	ADJ
ajlm-1398	139	2	causes	cause	NOUN
ajlm-1398	139	3	of	of	ADP
ajlm-1398	139	4	chronic	chronic	ADJ
ajlm-1398	139	5	kidney	kidney	NOUN
ajlm-1398	139	6	disease	disease	NOUN
ajlm-1398	139	7	in	in	ADP
ajlm-1398	139	8	south	south	PROPN
ajlm-1398	139	9	africa	africa	PROPN
ajlm-1398	139	10	.	.	PUNCT
ajlm-1398	140	1	south	south	PROPN
ajlm-1398	140	2	african	african	PROPN
ajlm-1398	140	3	med	med	PROPN
ajlm-1398	140	4	j.	j.	PROPN
ajlm-1398	140	5	2015;105(4):1–8	2015;105(4):1–8	PROPN
ajlm-1398	140	6	.	.	PUNCT
ajlm-1398	141	1	https://doi.org/10.7196/samj.9535	https://doi.org/10.7196/samj.9535	PROPN
ajlm-1398	141	2	adeniyi	adeniyi	PROPN
ajlm-1398	141	3	ab	ab	PROPN
ajlm-1398	141	4	,	,	PUNCT
ajlm-1398	141	5	laurence	laurence	PROPN
ajlm-1398	141	6	ce	ce	PROPN
ajlm-1398	141	7	,	,	PUNCT
ajlm-1398	141	8	volmink	volmink	PROPN
ajlm-1398	141	9	ja	ja	PROPN
ajlm-1398	141	10	,	,	PUNCT
ajlm-1398	141	11	davids	davids	PROPN
ajlm-1398	141	12	mr	mr	PROPN
ajlm-1398	141	13	.	.	PROPN
ajlm-1398	141	14	prevalence	prevalence	NOUN
ajlm-1398	141	15	of	of	ADP
ajlm-1398	141	16	chronic	chronic	ADJ
ajlm-1398	141	17	kidney	kidney	NOUN
ajlm-1398	141	18	disease	disease	NOUN
ajlm-1398	141	19	and	and	CCONJ
ajlm-1398	141	20	association	association	NOUN
ajlm-1398	141	21	with	with	ADP
ajlm-1398	141	22	cardiovascular	cardiovascular	ADJ
ajlm-1398	141	23	risk	risk	NOUN
ajlm-1398	141	24	factors	factor	NOUN
ajlm-1398	141	25	among	among	ADP
ajlm-1398	141	26	teachers	teacher	NOUN
ajlm-1398	141	27	in	in	ADP
ajlm-1398	141	28	cape	cape	NOUN
ajlm-1398	141	29	town	town	NOUN
ajlm-1398	141	30	,	,	PUNCT
ajlm-1398	141	31	south	south	PROPN
ajlm-1398	141	32	africa	africa	PROPN
ajlm-1398	141	33	.	.	PUNCT
ajlm-1398	142	1	clin	clin	PROPN
ajlm-1398	142	2	kidney	kidney	PROPN
ajlm-1398	142	3	j.	j.	PROPN
ajlm-1398	142	4	2017;10(3):1–7	2017;10(3):1–7	PROPN
ajlm-1398	142	5	.	.	PUNCT
ajlm-1398	143	1	https://doi.org/10.1093/ckj/sfw138	https://doi.org/10.1093/ckj/sfw138	PROPN
ajlm-1398	143	2	motta	motta	PROPN
ajlm-1398	143	3	la	la	PROPN
ajlm-1398	143	4	,	,	PUNCT
ajlm-1398	143	5	shephard	shephard	PROPN
ajlm-1398	143	6	mds	mds	PROPN
ajlm-1398	143	7	,	,	PUNCT
ajlm-1398	143	8	brink	brink	PROPN
ajlm-1398	143	9	j	j	PROPN
ajlm-1398	143	10	,	,	PUNCT
ajlm-1398	143	11	lawson	lawson	PROPN
ajlm-1398	143	12	s	s	PROPN
ajlm-1398	143	13	,	,	PUNCT
ajlm-1398	143	14	rheeder	rheeder	ADJ
ajlm-1398	143	15	p.	p.	NOUN
ajlm-1398	143	16	point	point	NOUN
ajlm-1398	143	17	-	-	PUNCT
ajlm-1398	143	18	of	of	ADP
ajlm-1398	143	19	-	-	PUNCT
ajlm-1398	143	20	care	care	NOUN
ajlm-1398	143	21	testing	testing	NOUN
ajlm-1398	143	22	improves	improve	VERB
ajlm-1398	143	23	diabetes	diabetes	NOUN
ajlm-1398	143	24	management	management	NOUN
ajlm-1398	143	25	in	in	ADP
ajlm-1398	143	26	a	a	DET
ajlm-1398	143	27	primary	primary	ADJ
ajlm-1398	143	28	care	care	NOUN
ajlm-1398	143	29	clinic	clinic	NOUN
ajlm-1398	143	30	in	in	ADP
ajlm-1398	143	31	south	south	PROPN
ajlm-1398	143	32	africa	africa	PROPN
ajlm-1398	143	33	.	.	PUNCT
ajlm-1398	144	1	prim	prim	ADJ
ajlm-1398	144	2	care	care	NOUN
ajlm-1398	144	3	diabetes	diabetes	NOUN
ajlm-1398	144	4	.	.	PUNCT
ajlm-1398	145	1	2017;11(3):248–253	2017;11(3):248–253	NUM
ajlm-1398	145	2	.	.	PUNCT
ajlm-1398	145	3	https://doi.org/10.1016/j.pcd.2016.09.008	https://doi.org/10.1016/j.pcd.2016.09.008	PROPN
ajlm-1398	145	4	alhajim	alhajim	PROPN
ajlm-1398	145	5	sa	sa	PROPN
ajlm-1398	145	6	,	,	PUNCT
ajlm-1398	145	7	sherhan	sherhan	PROPN
ajlm-1398	145	8	aa	aa	PROPN
ajlm-1398	145	9	.	.	PUNCT
ajlm-1398	146	1	albumin	albumin	PROPN
ajlm-1398	146	2	to	to	ADP
ajlm-1398	146	3	creatinine	creatinine	NOUN
ajlm-1398	146	4	ratio	ratio	NOUN
ajlm-1398	146	5	is	be	AUX
ajlm-1398	146	6	fairly	fairly	ADV
ajlm-1398	146	7	correlated	correlate	VERB
ajlm-1398	146	8	with	with	ADP
ajlm-1398	146	9	albumin	albumin	ADJ
ajlm-1398	146	10	excretion	excretion	NOUN
ajlm-1398	146	11	rate	rate	NOUN
ajlm-1398	146	12	in	in	ADP
ajlm-1398	146	13	chronic	chronic	ADJ
ajlm-1398	146	14	kidney	kidney	NOUN
ajlm-1398	146	15	disease	disease	NOUN
ajlm-1398	146	16	.	.	PUNCT
ajlm-1398	147	1	am	be	AUX
ajlm-1398	147	2	j	j	PROPN
ajlm-1398	147	3	lab	lab	NOUN
ajlm-1398	147	4	med	me	VERB
ajlm-1398	147	5	.	.	PUNCT
ajlm-1398	148	1	2018;3(6):48–52	2018;3(6):48–52	NUM
ajlm-1398	148	2	.	.	PUNCT
ajlm-1398	149	1	colhoun	colhoun	PROPN
ajlm-1398	149	2	hm	hm	INTJ
ajlm-1398	149	3	,	,	PUNCT
ajlm-1398	149	4	marcovecchio	marcovecchio	PROPN
ajlm-1398	149	5	ml	ml	NOUN
ajlm-1398	149	6	.	.	PUNCT
ajlm-1398	150	1	biomarkers	biomarker	NOUN
ajlm-1398	150	2	of	of	ADP
ajlm-1398	150	3	diabetic	diabetic	ADJ
ajlm-1398	150	4	kidney	kidney	NOUN
ajlm-1398	150	5	disease	disease	NOUN
ajlm-1398	150	6	.	.	PUNCT
ajlm-1398	151	1	diabetologia	diabetologia	NOUN
ajlm-1398	151	2	.	.	PUNCT
ajlm-1398	152	1	2018;61(5):996–1011	2018;61(5):996–1011	X
ajlm-1398	152	2	.	.	PUNCT
ajlm-1398	153	1	https://doi.org/10.1007/s00125-018-4567-5	https://doi.org/10.1007/s00125-018-4567-5	NUM
ajlm-1398	153	2	lopez	lopez	NOUN
ajlm-1398	153	3	-	-	PUNCT
ajlm-1398	153	4	giacoman	giacoman	NOUN
ajlm-1398	153	5	s.	s.	PROPN
ajlm-1398	153	6	biomarkers	biomarker	NOUN
ajlm-1398	153	7	in	in	ADP
ajlm-1398	153	8	chronic	chronic	ADJ
ajlm-1398	153	9	kidney	kidney	NOUN
ajlm-1398	153	10	disease	disease	NOUN
ajlm-1398	153	11	,	,	PUNCT
ajlm-1398	153	12	from	from	ADP
ajlm-1398	153	13	kidney	kidney	NOUN
ajlm-1398	153	14	function	function	NOUN
ajlm-1398	153	15	to	to	ADP
ajlm-1398	153	16	kidney	kidney	NOUN
ajlm-1398	153	17	damage	damage	NOUN
ajlm-1398	153	18	.	.	PUNCT
ajlm-1398	154	1	world	world	NOUN
ajlm-1398	154	2	j	j	PROPN
ajlm-1398	154	3	nephrol	nephrol	PROPN
ajlm-1398	154	4	.	.	PUNCT
ajlm-1398	155	1	2015;4(1):57–73	2015;4(1):57–73	NUM
ajlm-1398	155	2	.	.	PUNCT
ajlm-1398	156	1	https://doi.org/10.5527/wjn.v4.i1.57	https://doi.org/10.5527/wjn.v4.i1.57	PUNCT
ajlm-1398	156	2	canal	canal	PROPN
ajlm-1398	156	3	c	c	NOUN
ajlm-1398	156	4	,	,	PUNCT
ajlm-1398	156	5	pellicer	pellicer	VERB
ajlm-1398	156	6	r	r	PROPN
ajlm-1398	156	7	,	,	PUNCT
ajlm-1398	156	8	rocha	rocha	PROPN
ajlm-1398	156	9	ci	ci	PROPN
ajlm-1398	156	10	,	,	PUNCT
ajlm-1398	157	1	et	et	PROPN
ajlm-1398	157	2	al	al	PROPN
ajlm-1398	157	3	.	.	PUNCT
ajlm-1398	157	4	tables	table	NOUN
ajlm-1398	157	5	for	for	ADP
ajlm-1398	157	6	estimating	estimate	VERB
ajlm-1398	157	7	glomerular	glomerular	ADJ
ajlm-1398	157	8	filtration	filtration	NOUN
ajlm-1398	157	9	rate	rate	NOUN
ajlm-1398	157	10	from	from	ADP
ajlm-1398	157	11	plasma	plasma	NOUN
ajlm-1398	157	12	creatinine	creatinine	NOUN
ajlm-1398	157	13	.	.	PUNCT
ajlm-1398	158	1	nefrologia	nefrologia	ADJ
ajlm-1398	158	2	.	.	PUNCT
ajlm-1398	159	1	2008;28(3):317–324	2008;28(3):317–324	X
ajlm-1398	159	2	.	.	PUNCT
ajlm-1398	160	1	currie	currie	PROPN
ajlm-1398	160	2	g.	g.	PROPN
ajlm-1398	160	3	biomarkers	biomarker	NOUN
ajlm-1398	160	4	in	in	ADP
ajlm-1398	160	5	diabetic	diabetic	ADJ
ajlm-1398	160	6	nephropathy	nephropathy	NOUN
ajlm-1398	160	7	:	:	PUNCT
ajlm-1398	160	8	present	present	ADJ
ajlm-1398	160	9	and	and	CCONJ
ajlm-1398	160	10	future	future	NOUN
ajlm-1398	160	11	.	.	PUNCT
ajlm-1398	161	1	world	world	NOUN
ajlm-1398	161	2	j	j	PROPN
ajlm-1398	161	3	diabetes	diabetes	NOUN
ajlm-1398	161	4	.	.	PUNCT
ajlm-1398	162	1	2014;5(6):763–776	2014;5(6):763–776	X
ajlm-1398	162	2	.	.	PUNCT
ajlm-1398	162	3	https://doi.org/10.4239/wjd.v5.i6.763	https://doi.org/10.4239/wjd.v5.i6.763	PROPN
ajlm-1398	162	4	le	le	PROPN
ajlm-1398	163	1	a	a	X
ajlm-1398	163	2	,	,	PUNCT
ajlm-1398	163	3	ng	ng	PROPN
ajlm-1398	163	4	a	a	X
ajlm-1398	163	5	,	,	PUNCT
ajlm-1398	163	6	kwan	kwan	PROPN
ajlm-1398	163	7	t	t	PROPN
ajlm-1398	163	8	,	,	PUNCT
ajlm-1398	163	9	cusmano	cusmano	PROPN
ajlm-1398	163	10	-	-	PUNCT
ajlm-1398	163	11	ozog	ozog	PROPN
ajlm-1398	163	12	k	k	PROPN
ajlm-1398	163	13	,	,	PUNCT
ajlm-1398	163	14	cowan	cowan	PROPN
ajlm-1398	163	15	tm	tm	PROPN
ajlm-1398	163	16	.	.	PUNCT
ajlm-1398	164	1	a	a	DET
ajlm-1398	164	2	rapid	rapid	ADJ
ajlm-1398	164	3	,	,	PUNCT
ajlm-1398	164	4	sensitive	sensitive	ADJ
ajlm-1398	164	5	method	method	NOUN
ajlm-1398	164	6	for	for	ADP
ajlm-1398	164	7	quantitative	quantitative	ADJ
ajlm-1398	164	8	analysis	analysis	NOUN
ajlm-1398	164	9	of	of	ADP
ajlm-1398	164	10	underivatized	underivatized	ADJ
ajlm-1398	164	11	amino	amino	NOUN
ajlm-1398	164	12	acids	acid	NOUN
ajlm-1398	164	13	by	by	ADP
ajlm-1398	164	14	liquid	liquid	ADJ
ajlm-1398	164	15	chromatography	chromatography	NOUN
ajlm-1398	164	16	-	-	PUNCT
ajlm-1398	164	17	tandem	tandem	NOUN
ajlm-1398	164	18	mass	mass	ADJ
ajlm-1398	164	19	spectrometry	spectrometry	NOUN
ajlm-1398	164	20	(	(	PUNCT
ajlm-1398	164	21	lc	lc	PROPN
ajlm-1398	164	22	-	-	PUNCT
ajlm-1398	164	23	ms	ms	PROPN
ajlm-1398	164	24	/	/	SYM
ajlm-1398	164	25	ms	ms	PROPN
ajlm-1398	164	26	)	)	PUNCT
ajlm-1398	164	27	.	.	PUNCT
ajlm-1398	165	1	j	j	PROPN
ajlm-1398	165	2	chromatogr	chromatogr	PROPN
ajlm-1398	165	3	b	b	PROPN
ajlm-1398	165	4	anal	anal	ADJ
ajlm-1398	165	5	technol	technol	NOUN
ajlm-1398	165	6	biomed	biome	VERB
ajlm-1398	165	7	life	life	NOUN
ajlm-1398	165	8	sci	sci	PROPN
ajlm-1398	165	9	.	.	PUNCT
ajlm-1398	165	10	2014;944:166–174	2014;944:166–174	NUM
ajlm-1398	165	11	.	.	PUNCT
ajlm-1398	166	1	https://doi.org/10.1016/j.jchromb.2013.11.017	https://doi.org/10.1016/j.jchromb.2013.11.017	PROPN
ajlm-1398	166	2	kopple	kopple	PROPN
ajlm-1398	166	3	jd	jd	PROPN
ajlm-1398	166	4	.	.	PROPN
ajlm-1398	166	5	phenylalanine	phenylalanine	NOUN
ajlm-1398	166	6	and	and	CCONJ
ajlm-1398	166	7	tyrosine	tyrosine	NOUN
ajlm-1398	166	8	metabolism	metabolism	NOUN
ajlm-1398	166	9	in	in	ADP
ajlm-1398	166	10	chronic	chronic	ADJ
ajlm-1398	166	11	kidney	kidney	NOUN
ajlm-1398	166	12	failure	failure	NOUN
ajlm-1398	166	13	.	.	PUNCT
ajlm-1398	167	1	j	j	PROPN
ajlm-1398	167	2	nutr	nutr	PROPN
ajlm-1398	167	3	.	.	PROPN
ajlm-1398	168	1	2007;137(6	2007;137(6	NUM
ajlm-1398	168	2	suppl	suppl	PROPN
ajlm-1398	168	3	1):1586s–1590s	1):1586s–1590s	PROPN
ajlm-1398	168	4	.	.	PUNCT
ajlm-1398	169	1	https://doi.org/10.1093/jn/137.6.1586s	https://doi.org/10.1093/jn/137.6.1586s	NOUN
ajlm-1398	169	2	kemperman	kemperman	PROPN
ajlm-1398	169	3	rfj	rfj	NOUN
ajlm-1398	169	4	,	,	PUNCT
ajlm-1398	169	5	horvatovich	horvatovich	ADV
ajlm-1398	169	6	pl	pl	NOUN
ajlm-1398	169	7	,	,	PUNCT
ajlm-1398	169	8	hoekman	hoekman	NOUN
ajlm-1398	169	9	b	b	NUM
ajlm-1398	169	10	,	,	PUNCT
ajlm-1398	169	11	reijmers	reijmer	NOUN
ajlm-1398	169	12	th	th	NUM
ajlm-1398	169	13	,	,	PUNCT
ajlm-1398	169	14	muskiet	muskiet	PROPN
ajlm-1398	169	15	faj	faj	PROPN
ajlm-1398	169	16	,	,	PUNCT
ajlm-1398	169	17	bischoff	bischoff	PROPN
ajlm-1398	169	18	r.	r.	PROPN
ajlm-1398	169	19	comparative	comparative	ADJ
ajlm-1398	169	20	urine	urine	NOUN
ajlm-1398	169	21	analysis	analysis	NOUN
ajlm-1398	169	22	by	by	ADP
ajlm-1398	169	23	liquid	liquid	ADJ
ajlm-1398	169	24	chromatography	chromatography	NOUN
ajlm-1398	169	25	–	–	PUNCT
ajlm-1398	169	26	mass	mass	NOUN
ajlm-1398	169	27	spectrometry	spectrometry	NOUN
ajlm-1398	169	28	and	and	CCONJ
ajlm-1398	169	29	multivariate	multivariate	NOUN
ajlm-1398	169	30	statistics	statistic	NOUN
ajlm-1398	169	31	:	:	PUNCT
ajlm-1398	169	32	method	method	NOUN
ajlm-1398	169	33	development	development	NOUN
ajlm-1398	169	34	,	,	PUNCT
ajlm-1398	169	35	evaluation	evaluation	NOUN
ajlm-1398	169	36	,	,	PUNCT
ajlm-1398	169	37	and	and	CCONJ
ajlm-1398	169	38	application	application	NOUN
ajlm-1398	169	39	to	to	ADP
ajlm-1398	169	40	proteinuria	proteinuria	PROPN
ajlm-1398	169	41	.	.	PUNCT
ajlm-1398	170	1	j	j	PROPN
ajlm-1398	170	2	proteome	proteome	PROPN
ajlm-1398	170	3	.	.	PUNCT
ajlm-1398	171	1	2007;6(1):194–206	2007;6(1):194–206	X
ajlm-1398	171	2	.	.	PUNCT
ajlm-1398	171	3	https://doi.org/10.1021/pr060362r	https://doi.org/10.1021/pr060362r	PROPN
ajlm-1398	171	4	kalantari	kalantari	PROPN
ajlm-1398	171	5	s	s	PROPN
ajlm-1398	171	6	,	,	PUNCT
ajlm-1398	171	7	jafari	jafari	PROPN
ajlm-1398	171	8	a	a	X
ajlm-1398	171	9	,	,	PUNCT
ajlm-1398	171	10	moradpoor	moradpoor	NOUN
ajlm-1398	171	11	r	r	NOUN
ajlm-1398	171	12	,	,	PUNCT
ajlm-1398	171	13	ghasemi	ghasemi	NOUN
ajlm-1398	171	14	e	e	NOUN
ajlm-1398	171	15	,	,	PUNCT
ajlm-1398	171	16	khalkhal	khalkhal	VERB
ajlm-1398	171	17	e.	e.	PROPN
ajlm-1398	171	18	human	human	ADJ
ajlm-1398	171	19	urine	urine	NOUN
ajlm-1398	171	20	proteomics	proteomic	NOUN
ajlm-1398	171	21	:	:	PUNCT
ajlm-1398	171	22	analytical	analytical	ADJ
ajlm-1398	171	23	techniques	technique	NOUN
ajlm-1398	171	24	and	and	CCONJ
ajlm-1398	171	25	clinical	clinical	ADJ
ajlm-1398	171	26	applications	application	NOUN
ajlm-1398	171	27	in	in	ADP
ajlm-1398	171	28	renal	renal	ADJ
ajlm-1398	171	29	diseases	disease	NOUN
ajlm-1398	171	30	.	.	PUNCT
ajlm-1398	172	1	int	int	NOUN
ajlm-1398	172	2	j	j	PROPN
ajlm-1398	172	3	proteomics	proteomic	NOUN
ajlm-1398	172	4	.	.	PUNCT
ajlm-1398	173	1	2015;2015:782798	2015;2015:782798	NUM
ajlm-1398	173	2	.	.	PUNCT
ajlm-1398	173	3	https://doi.org/10.1155/2015/782798	https://doi.org/10.1155/2015/782798	PROPN
ajlm-1398	173	4	tang	tang	PROPN
ajlm-1398	173	5	x	x	NOUN
ajlm-1398	173	6	,	,	PUNCT
ajlm-1398	173	7	gu	gu	PROPN
ajlm-1398	173	8	y	y	PROPN
ajlm-1398	173	9	,	,	PUNCT
ajlm-1398	173	10	nie	nie	PROPN
ajlm-1398	173	11	j	j	PROPN
ajlm-1398	173	12	,	,	PUNCT
ajlm-1398	173	13	fan	fan	PROPN
ajlm-1398	173	14	s	s	PROPN
ajlm-1398	173	15	,	,	PUNCT
ajlm-1398	173	16	wang	wang	PROPN
ajlm-1398	173	17	c.	c.	PROPN
ajlm-1398	173	18	quantification	quantification	NOUN
ajlm-1398	173	19	of	of	ADP
ajlm-1398	173	20	amino	amino	ADJ
ajlm-1398	173	21	acids	acid	NOUN
ajlm-1398	173	22	in	in	ADP
ajlm-1398	173	23	rat	rat	NOUN
ajlm-1398	173	24	urine	urine	NOUN
ajlm-1398	173	25	by	by	ADP
ajlm-1398	173	26	solid	solid	ADJ
ajlm-1398	173	27	-	-	PUNCT
ajlm-1398	173	28	phase	phase	NOUN
ajlm-1398	173	29	extraction	extraction	NOUN
ajlm-1398	173	30	and	and	CCONJ
ajlm-1398	173	31	liquid	liquid	ADJ
ajlm-1398	173	32	chromatography	chromatography	NOUN
ajlm-1398	173	33	/	/	SYM
ajlm-1398	173	34	electrospray	electrospray	NOUN
ajlm-1398	173	35	tandem	tandem	PROPN
ajlm-1398	173	36	mass	mass	PROPN
ajlm-1398	173	37	spectrometry	spectrometry	NOUN
ajlm-1398	173	38	:	:	PUNCT
ajlm-1398	173	39	application	application	NOUN
ajlm-1398	173	40	to	to	ADP
ajlm-1398	173	41	radiation	radiation	NOUN
ajlm-1398	173	42	injury	injury	NOUN
ajlm-1398	173	43	rat	rat	NOUN
ajlm-1398	173	44	model	model	NOUN
ajlm-1398	173	45	.	.	PUNCT
ajlm-1398	174	1	j	j	PROPN
ajlm-1398	174	2	liq	liq	PROPN
ajlm-1398	174	3	chromatogr	chromatogr	PROPN
ajlm-1398	174	4	relat	relat	PROPN
ajlm-1398	174	5	technol	technol	NOUN
ajlm-1398	174	6	.	.	PUNCT
ajlm-1398	175	1	2014;37(7):951–973	2014;37(7):951–973	X
ajlm-1398	175	2	.	.	X
ajlm-1398	175	3	https://doi.org/10.1080/10826076.2013.765451	https://doi.org/10.1080/10826076.2013.765451	PROPN
ajlm-1398	175	4	waterval	waterval	PROPN
ajlm-1398	175	5	wah	wah	PROPN
ajlm-1398	175	6	,	,	PUNCT
ajlm-1398	175	7	scheijen	scheijen	PROPN
ajlm-1398	175	8	jljm	jljm	PROPN
ajlm-1398	175	9	,	,	PUNCT
ajlm-1398	175	10	ortmans	ortman	NOUN
ajlm-1398	175	11	-	-	PUNCT
ajlm-1398	175	12	ploemen	ploeman	NOUN
ajlm-1398	175	13	mmjc	mmjc	PROPN
ajlm-1398	175	14	,	,	PUNCT
ajlm-1398	175	15	habets	habet	NOUN
ajlm-1398	175	16	-	-	PUNCT
ajlm-1398	175	17	van	van	PROPN
ajlm-1398	175	18	der	der	NOUN
ajlm-1398	175	19	poel	poel	PROPN
ajlm-1398	175	20	cd	cd	PROPN
ajlm-1398	175	21	,	,	PUNCT
ajlm-1398	175	22	bierau	bierau	PROPN
ajlm-1398	175	23	j.	j.	PROPN
ajlm-1398	175	24	quantitative	quantitative	PROPN
ajlm-1398	175	25	uplc	uplc	PROPN
ajlm-1398	175	26	-	-	PUNCT
ajlm-1398	175	27	ms	ms	PROPN
ajlm-1398	175	28	/	/	SYM
ajlm-1398	175	29	ms	ms	NOUN
ajlm-1398	175	30	analysis	analysis	NOUN
ajlm-1398	175	31	of	of	ADP
ajlm-1398	175	32	underivatised	underivatised	ADJ
ajlm-1398	175	33	amino	amino	ADJ
ajlm-1398	175	34	acids	acid	NOUN
ajlm-1398	175	35	in	in	ADP
ajlm-1398	175	36	body	body	NOUN
ajlm-1398	175	37	fluids	fluid	NOUN
ajlm-1398	175	38	is	be	AUX
ajlm-1398	175	39	a	a	DET
ajlm-1398	175	40	reliable	reliable	ADJ
ajlm-1398	175	41	tool	tool	NOUN
ajlm-1398	175	42	for	for	ADP
ajlm-1398	175	43	the	the	DET
ajlm-1398	175	44	diagnosis	diagnosis	NOUN
ajlm-1398	175	45	and	and	CCONJ
ajlm-1398	175	46	follow	follow	VERB
ajlm-1398	175	47	-	-	PUNCT
ajlm-1398	175	48	up	up	NOUN
ajlm-1398	175	49	of	of	ADP
ajlm-1398	175	50	patients	patient	NOUN
ajlm-1398	175	51	with	with	ADP
ajlm-1398	175	52	inborn	inborn	ADJ
ajlm-1398	175	53	errors	error	NOUN
ajlm-1398	175	54	of	of	ADP
ajlm-1398	175	55	metabolism	metabolism	NOUN
ajlm-1398	175	56	.	.	PUNCT
ajlm-1398	176	1	clin	clin	PROPN
ajlm-1398	176	2	chim	chim	PROPN
ajlm-1398	176	3	acta	acta	PROPN
ajlm-1398	176	4	.	.	PUNCT
ajlm-1398	177	1	2009;407(1–2):36–42	2009;407(1–2):36–42	NOUN
ajlm-1398	177	2	.	.	PUNCT
ajlm-1398	178	1	https://doi.org/10.1016/j.cca.2009.06.023	https://doi.org/10.1016/j.cca.2009.06.023	PROPN
ajlm-1398	178	2	duranton	duranton	PROPN
ajlm-1398	178	3	f	f	PROPN
ajlm-1398	178	4	,	,	PUNCT
ajlm-1398	178	5	lundin	lundin	PROPN
ajlm-1398	178	6	u	u	PROPN
ajlm-1398	178	7	,	,	PUNCT
ajlm-1398	178	8	gayrard	gayrard	NOUN
ajlm-1398	178	9	n	n	CCONJ
ajlm-1398	178	10	,	,	PUNCT
ajlm-1398	178	11	et	et	PROPN
ajlm-1398	178	12	al	al	PROPN
ajlm-1398	178	13	.	.	PUNCT
ajlm-1398	178	14	plasma	plasma	PROPN
ajlm-1398	178	15	and	and	CCONJ
ajlm-1398	178	16	urinary	urinary	ADJ
ajlm-1398	178	17	amino	amino	NOUN
ajlm-1398	178	18	acid	acid	NOUN
ajlm-1398	178	19	metabolomic	metabolomic	ADJ
ajlm-1398	178	20	profiling	profiling	NOUN
ajlm-1398	178	21	in	in	ADP
ajlm-1398	178	22	patients	patient	NOUN
ajlm-1398	178	23	with	with	ADP
ajlm-1398	178	24	different	different	ADJ
ajlm-1398	178	25	levels	level	NOUN
ajlm-1398	178	26	of	of	ADP
ajlm-1398	178	27	kidney	kidney	NOUN
ajlm-1398	178	28	function	function	NOUN
ajlm-1398	178	29	.	.	PUNCT
ajlm-1398	179	1	clin	clin	PROPN
ajlm-1398	179	2	j	j	PROPN
ajlm-1398	179	3	am	be	AUX
ajlm-1398	179	4	soc	soc	NOUN
ajlm-1398	179	5	nephrol	nephrol	NOUN
ajlm-1398	179	6	.	.	PUNCT
ajlm-1398	180	1	2014;9(1):37–45	2014;9(1):37–45	NUM
ajlm-1398	180	2	.	.	PUNCT
ajlm-1398	181	1	https://doi.org/10.2215/cjn.06000613	https://doi.org/10.2215/cjn.06000613	PROPN
ajlm-1398	181	2	durá	durá	NOUN
ajlm-1398	181	3	-	-	PUNCT
ajlm-1398	181	4	travé	travé	PROPN
ajlm-1398	181	5	t	t	PROPN
ajlm-1398	181	6	,	,	PUNCT
ajlm-1398	181	7	gallinas	gallinas	PROPN
ajlm-1398	181	8	-	-	PUNCT
ajlm-1398	181	9	victoriano	victoriano	ADJ
ajlm-1398	181	10	f	f	NOUN
ajlm-1398	181	11	,	,	PUNCT
ajlm-1398	181	12	cortes	corte	NOUN
ajlm-1398	181	13	-	-	PUNCT
ajlm-1398	181	14	castel	castel	NOUN
ajlm-1398	181	15	e	e	NOUN
ajlm-1398	181	16	,	,	PUNCT
ajlm-1398	181	17	moya	moya	PROPN
ajlm-1398	181	18	-	-	PUNCT
ajlm-1398	181	19	benavent	benavent	NOUN
ajlm-1398	181	20	m.	m.	NOUN
ajlm-1398	181	21	amino	amino	NOUN
ajlm-1398	181	22	acid	acid	NOUN
ajlm-1398	181	23	plasma	plasma	NOUN
ajlm-1398	181	24	concentrations	concentration	NOUN
ajlm-1398	181	25	and	and	CCONJ
ajlm-1398	181	26	urinary	urinary	ADJ
ajlm-1398	181	27	excretion	excretion	NOUN
ajlm-1398	181	28	in	in	ADP
ajlm-1398	181	29	young	young	ADJ
ajlm-1398	181	30	diabetics	diabetic	NOUN
ajlm-1398	181	31	.	.	PUNCT
ajlm-1398	182	1	in	in	ADP
ajlm-1398	182	2	:	:	PUNCT
ajlm-1398	182	3	ahmed	ahmed	PROPN
ajlm-1398	182	4	ag	ag	PROPN
ajlm-1398	182	5	,	,	PUNCT
ajlm-1398	182	6	editor	editor	NOUN
ajlm-1398	182	7	.	.	PUNCT
ajlm-1398	183	1	diabetes	diabetes	NOUN
ajlm-1398	183	2	and	and	CCONJ
ajlm-1398	183	3	its	its	PRON
ajlm-1398	183	4	complications	complication	NOUN
ajlm-1398	183	5	.	.	PUNCT
ajlm-1398	184	1	london	london	PROPN
ajlm-1398	184	2	:	:	PUNCT
ajlm-1398	184	3	intechopen	intechopen	ADJ
ajlm-1398	184	4	,	,	PUNCT
ajlm-1398	184	5	2018	2018	NUM
ajlm-1398	184	6	;	;	PUNCT
ajlm-1398	184	7	p.	p.	NOUN
ajlm-1398	184	8	109–118	109–118	NUM
ajlm-1398	184	9	.	.	PUNCT
ajlm-1398	185	1	https://doi.org/10.5772/intechopen.72080	https://doi.org/10.5772/intechopen.72080	NOUN
ajlm-1398	185	2	van	van	PROPN
ajlm-1398	185	3	de	de	PROPN
ajlm-1398	185	4	poll	poll	PROPN
ajlm-1398	185	5	mgc	mgc	PROPN
ajlm-1398	185	6	,	,	PUNCT
ajlm-1398	185	7	soeters	soeter	VERB
ajlm-1398	185	8	pb	pb	ADP
ajlm-1398	185	9	,	,	PUNCT
ajlm-1398	185	10	deutz	deutz	NOUN
ajlm-1398	185	11	nep	nep	PROPN
ajlm-1398	185	12	,	,	PUNCT
ajlm-1398	185	13	fearon	fearon	PROPN
ajlm-1398	185	14	kch	kch	PROPN
ajlm-1398	185	15	,	,	PUNCT
ajlm-1398	185	16	dejong	dejong	PROPN
ajlm-1398	185	17	chc	chc	PROPN
ajlm-1398	185	18	.	.	PUNCT
ajlm-1398	186	1	renal	renal	ADJ
ajlm-1398	186	2	metabolism	metabolism	NOUN
ajlm-1398	186	3	of	of	ADP
ajlm-1398	186	4	amino	amino	ADJ
ajlm-1398	186	5	acids	acid	NOUN
ajlm-1398	186	6	:	:	PUNCT
ajlm-1398	186	7	its	its	PRON
ajlm-1398	186	8	role	role	NOUN
ajlm-1398	186	9	in	in	ADP
ajlm-1398	186	10	interorgan	interorgan	ADJ
ajlm-1398	186	11	amino	amino	NOUN
ajlm-1398	186	12	acid	acid	NOUN
ajlm-1398	186	13	exchange	exchange	NOUN
ajlm-1398	186	14	.	.	PUNCT
ajlm-1398	187	1	am	be	AUX
ajlm-1398	187	2	j	j	PROPN
ajlm-1398	187	3	clin	clin	PROPN
ajlm-1398	187	4	nutr	nutr	PROPN
ajlm-1398	187	5	.	.	PUNCT
ajlm-1398	188	1	2004;79(1):185–197	2004;79(1):185–197	X
ajlm-1398	188	2	.	.	PUNCT
ajlm-1398	188	3	https://doi.org/10.1093/ajcn/79.2.185	https://doi.org/10.1093/ajcn/79.2.185	NUM
ajlm-1398	188	4	williams	williams	PROPN
ajlm-1398	188	5	ra	ra	PROPN
ajlm-1398	188	6	,	,	PUNCT
ajlm-1398	188	7	mamotte	mamotte	NOUN
ajlm-1398	188	8	cds	cds	PROPN
ajlm-1398	188	9	,	,	PUNCT
ajlm-1398	188	10	burnett	burnett	PROPN
ajlm-1398	188	11	jr	jr	PROPN
ajlm-1398	188	12	.	.	PROPN
ajlm-1398	188	13	phenylketonuria	phenylketonuria	PROPN
ajlm-1398	188	14	:	:	PUNCT
ajlm-1398	188	15	an	an	DET
ajlm-1398	188	16	inborn	inborn	ADJ
ajlm-1398	188	17	error	error	NOUN
ajlm-1398	188	18	of	of	ADP
ajlm-1398	188	19	phenylalanine	phenylalanine	ADJ
ajlm-1398	188	20	metabolism	metabolism	NOUN
ajlm-1398	188	21	.	.	PUNCT
ajlm-1398	189	1	clin	clin	PROPN
ajlm-1398	189	2	biochem	biochem	PROPN
ajlm-1398	189	3	rev	rev	VERB
ajlm-1398	189	4	.	.	PUNCT
ajlm-1398	190	1	2008;29(1):31–41	2008;29(1):31–41	NUM
ajlm-1398	190	2	.	.	PUNCT
ajlm-1398	191	1	tanyanyiwa	tanyanyiwa	PROPN
ajlm-1398	191	2	dm	dm	PROPN
ajlm-1398	191	3	.	.	PUNCT
ajlm-1398	191	4	type	type	NOUN
ajlm-1398	191	5	2	2	NUM
ajlm-1398	191	6	diabetes	diabetes	NOUN
ajlm-1398	191	7	mellitus	mellitus	NOUN
ajlm-1398	191	8	and	and	CCONJ
ajlm-1398	191	9	dyslipidaemia	dyslipidaemia	NOUN
ajlm-1398	191	10	:	:	PUNCT
ajlm-1398	191	11	effects	effect	NOUN
ajlm-1398	191	12	of	of	ADP
ajlm-1398	191	13	genetic	genetic	ADJ
ajlm-1398	191	14	variation	variation	NOUN
ajlm-1398	191	15	in	in	ADP
ajlm-1398	191	16	african	african	ADJ
ajlm-1398	191	17	populations	population	NOUN
ajlm-1398	192	1	[	[	X
ajlm-1398	192	2	homepage	homepage	NOUN
ajlm-1398	192	3	on	on	ADP
ajlm-1398	192	4	the	the	DET
ajlm-1398	192	5	internet	internet	NOUN
ajlm-1398	192	6	]	]	PUNCT
ajlm-1398	192	7	.	.	PUNCT
ajlm-1398	193	1	cape	cape	NOUN
ajlm-1398	193	2	town	town	NOUN
ajlm-1398	193	3	:	:	PUNCT
ajlm-1398	193	4	university	university	NOUN
ajlm-1398	193	5	of	of	ADP
ajlm-1398	193	6	cape	cape	NOUN
ajlm-1398	193	7	town	town	NOUN
ajlm-1398	193	8	;	;	PUNCT
ajlm-1398	193	9	2018	2018	NUM
ajlm-1398	194	1	[	[	X
ajlm-1398	194	2	cited	cite	VERB
ajlm-1398	194	3	2021	2021	NUM
ajlm-1398	194	4	feb	feb	NOUN
ajlm-1398	194	5	24	24	NUM
ajlm-1398	194	6	]	]	PUNCT
ajlm-1398	194	7	.	.	PUNCT
ajlm-1398	195	1	available	available	ADJ
ajlm-1398	195	2	from	from	ADP
ajlm-1398	195	3	:	:	PUNCT
ajlm-1398	195	4	http://hdl.handle.net/11427/30132	http://hdl.handle.net/11427/30132	NOUN